gestures	NNS	O
improved	VBD	B-REL
performance	NN	I-REL
in	IN	O
spatial	JJ	O
visualization	NN	O
problems	NNS	O

We	PRP	O
concluded	VBD	O
that	IN	O
gestures	NNS	O
enhance	VBP	B-REL
performance	NN	I-REL
on	IN	O
spatial	JJ	O
visualization	NN	O
tasks	NNS	O

Gesturing	VBG	O
with	IN	O
our	PRP$	O
hands	NNS	O
helps	VBZ	B-REL
us	PRP	I-REL
to	TO	I-REL
solve	VB	O
spatial	JJ	O
visualisation	NN	O
problems	NNS	O

bereavement	NN	O
is	VBZ	O
associated	VBN	B-REL
with	IN	O
reduced	VBN	O
neutrophil	NN	O
bactericidal	JJ	O
function	NN	O

Neutrophil	NN	O
superoxide	NN	O
production	NN	O
was	VBD	O
significantly	RB	B-REL
reduced	VBN	I-REL
among	IN	O
the	DT	O
bereaved	JJ	O

suggest	VBP	O
that	IN	O
bereavement	NN	O
lowers	VBZ	B-REL
physical	JJ	O
immunity	NN	O

losing	VBG	O
a	DT	O
loved	VBN	O
one	NN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
parts	NNS	O
of	IN	O
the	DT	O
immune	JJ	O
system	NN	O
being	VBG	O
suppressed	VBN	O

intense	JJ	O
grief	NN	O
weakens	VBZ	B-REL
the	DT	O
body	NN	O
's	POS	O
immune	JJ	O
system	NN	O

high	JJ	B-REL
levels	NNS	I-REL
of	IN	O
inappropriate	JJ	O
calls	NNS	O

inappropriate	JJ	B-REL
classification	NN	O

There	EX	O
was	VBD	O
a	DT	O
lack	NN	B-REL
of	IN	O
understanding	NN	O

recovery	NN	O
of	IN	O
renal	JJ	O
function	NN	O
in	IN	O
myeloma	NN	O
kidney	NN	O
depends	VBZ	B-REL
on	IN	I-REL
early	JJ	I-REL
reduction	NN	I-REL
of	IN	O
serum	NN	O
FLCs	NNS	O

21	CD	O
day	NN	O
treatment	NN	O
threshold	NN	O
to	TO	O
facilitate	VB	B-REL
renal	JJ	O
recovery	NN	O

CTLA-4	NN	O
molecule	NN	B-REL
plays	VBZ	I-REL
a	DT	I-REL
critical	JJ	I-REL
role	NN	I-REL
in	IN	O
suppressing	VBG	O
autoimmunity	NN	O
and	CC	O
maintaining	VBG	O
immune	JJ	O
homeostasis	NN	O

CTLA-4	NN	O
acts	VBZ	O
as	IN	O
an	DT	O
effector	NN	O
molecule	NN	O
to	TO	O
inhibit	VB	B-REL

prevents	VBZ	B-REL
inappropriate	JJ	O
aggressive	JJ	O
behaviour	NN	O
from	IN	O
T	NN	O
cells	NNS	O

decreases	NNS	B-REL
later	RB	O
food	NN	O
intake	NN	O

can	MD	B-REL
reduce	VB	I-REL
later	RB	O
intake	NN	O

can	MD	B-REL
reduce	VB	I-REL
snacking	VBG	O
in	IN	O
the	DT	O
afternoon	NN	O

caesarean	NN	O
section	NN	O
by	IN	O
clinical	JJ	O
officers	NNS	O
does	VBZ	B-REL
not	RB	I-REL
result	VB	I-REL
in	IN	I-REL
a	DT	I-REL
significant	JJ	I-REL
increase	NN	I-REL
in	IN	O
maternal	JJ	O
or	CC	O
perinatal	JJ	O
mortality	NN	O
significant	JJ	O
increase	NN	O
.	.	O

Clinical	JJ	O
officers	NNS	O
and	CC	O
doctors	NNS	O
did	VBD	B-REL
not	RB	I-REL
differ	VB	I-REL
significantly	RB	I-REL
in	IN	O
key	JJ	O
outcomes	NNS	O
for	IN	O
caesarean	NN	O
section	NN	O
significantly	RB	O
.	.	O

countries	NNS	O
who	WP	O
give	VBP	O
birth	NN	O
by	IN	O
caesarean	NN	O
section	NN	O
are	VBP	O
at	IN	O
no	DT	B-REL
significant	JJ	I-REL
extra	JJ	I-REL
risk	NN	I-REL
from	IN	O
having	VBG	O
the	DT	O
procedure	NN	O
carried	VBD	O
out	RP	O
by	IN	O
non-physician	JJ	O
clinicians	NNS	O

Survivors	NNS	O
of	IN	O
childhood	NN	O
cancer	NN	O
are	VBP	O
at	IN	O
increased	VBN	B-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
subsequent	JJ	O
primary	JJ	O
neoplasms	NNS	O
of	IN	O
developing	VBG	O
.	.	O

the	DT	O
greatest	JJS	O
excess	JJ	O
risk	NN	O
associated	VBN	B-REL
with	IN	O
subsequent	JJ	O
primary	JJ	O
neoplasms	NNS	O
at	IN	O
older	JJR	O
than	IN	O
40	CD	O
years	NNS	O
was	VBD	O
for	IN	O
digestive	JJ	O
and	CC	O
genitourinary	JJ	O
neoplasms	NNS	O

Childhood	NN	O
cancer	NN	O
survivors	NNS	O
at	IN	O
greater	JJR	B-REL
risk	NN	I-REL
in	IN	O
middle	JJ	O
age	NN	O

this	DT	O
elevation	NN	B-REL
of	IN	I-REL
risk	NN	I-REL
in	IN	O
those	DT	O
born	VBN	O
preterm/LBW	NN	O
extends	VBZ	O
to	TO	O
psychiatric	JJ	O
illness	NN	O
of	IN	O
risk	NN	O
...	:	O

Premature	JJ	O
babies	NNS	O
risk	VBP	B-REL
mental	JJ	O
health	NN	O
problems	NNS	O

these	DT	O
studies	NNS	O
revealed	VBD	B-REL
that	IN	O
the	DT	O
outbreak	NN	O
strain	NN	O
belonged	VBD	O
to	TO	O

has	VBZ	O
enabled	VBN	B-REL
the	DT	I-REL
characterisation	NN	I-REL
of	IN	O
the	DT	O
deadly	JJ	O
strain	NN	O
of	IN	O
E.	FW	O
coli	FW	O

...	:	O
Pulse	NN	O
oximetry	NN	O
is	VBZ	B-REL
a	DT	O
safe	JJ	O
,	,	O
non-invasive	JJ	O
,	,	O
feasible	JJ	O
,	,	O
and	CC	O
reasonably	RB	O
accurate	JJ	O
test	NN	O
...	:	O

...	:	O
It	PRP	O
identifies	VBZ	B-REL
cases	NNS	O
of	IN	O
critical	JJ	O
congenital	JJ	O
heart	NN	O
defects	NNS	O
that	WDT	O
go	VBP	O
undetected	JJ	O
with	IN	O
antenatal	JJ	O
ultrasonography	NN	O
...	:	O

...	:	O
A	DT	O
simple	JJ	O
test	NN	O
to	TO	B-REL
measure	VB	O
blood	NN	O
oxygen	NN	O
in	IN	O
newborns	NNS	O
has	VBZ	B-REL
been	VBN	I-REL
shown	VBN	I-REL
to	TO	O
identify	VB	B-REL
babies	NNS	O
with	IN	O
life-threatening	JJ	O
congenital	JJ	O
heart	NN	O
defects	NNS	O
...	:	O

SIMPLE	JJ	O
SENSOR	NN	O
THAT	WDT	O
COULD	NNP	B-REL
SAVE	VB	I-REL
A	DT	O
BABY	NN	O
'S	POS	O
LIFE	NN	O

A	DT	O
sensor	NN	O
measuring	VBG	O
blood	NN	O
oxygen	NN	O
levels	NNS	O
detected	VBD	B-REL
53	CD	O
cases	NNS	O
of	IN	O
major	JJ	O
congenital	JJ	O
heart	NN	O
disease	NN	O

...	:	O
carrying	VBG	O
out	RP	O
a	DT	O
pulse	NN	O
oximetry	NN	O
test	NN	O
...	:	O
would	MD	B-REL
identify	VB	I-REL
newborns	NNS	O
with	IN	O
congenital	JJ	O
heart	NN	O
defects	NNS	O
...	:	O

A	DT	O
routine	JJ	O
screening	NN	O
test	NN	O
for	IN	O
all	DT	O
newborn	JJ	O
babies	NNS	O
could	MD	B-REL
save	VB	I-REL
the	DT	O
lives	NNS	O
of	IN	O
some	DT	O
with	IN	O
congenital	JJ	O
heart	NN	O
defects	NNS	O

Simple	JJ	O
test	NN	O
can	MD	B-REL
detect	VB	I-REL
heart	NN	O
defects	NNS	O
in	IN	O
babies	NNS	O

A	DT	O
quick	JJ	O
and	CC	O
cheap	JJ	O
test	NN	O
could	MD	B-REL
save	VB	I-REL
the	DT	O
lives	NNS	O
of	IN	O
babies	NNS	O
born	VBN	O
with	IN	O
congenital	JJ	O
heart	NN	O
defects	NNS	O

Analogues	NNS	O
of	IN	O
MDMA	NN	O
with	IN	O
modified	VBN	O
a-substituents	NNS	O
were	VBD	O
iteratively	RB	O
designed	VBN	O
and	CC	O
synthesised	VBN	O
,	,	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
up	RB	O
to	TO	O
10-fold	RB	O
-LRB-	-LRB-	O
first	JJ	O
generation	NN	O
-RRB-	-RRB-	O
and	CC	O
100-fold	RB	O
-LRB-	-LRB-	O
second	JJ	O
generation	NN	O
-RRB-	-RRB-	O
more	RBR	B-REL
potent	JJ	I-REL
than	IN	I-REL
the	DT	O
parent	NN	O
amphetamine	NN	O
derivative	NN	O
at	IN	O
promoting	VBG	O
lymphoma	NN	O
cell	NN	O
death	NN	O

incorporating	VBG	O
a	DT	O
phenyl	NN	O
group	NN	O
increased	VBD	B-REL
potency	NN	I-REL
against	IN	O
sensitive	JJ	O
,	,	O
Bcl-2-deplete	JJ	O
,	,	O
Burkitt	NN	O
's	POS	O
lymphoma	NN	O
-LRB-	-LRB-	O
BL	NN	O
-RRB-	-RRB-	O
cells	NNS	O

significant	JJ	O
success	NN	O
in	IN	O
`	``	O
redesigning	VBG	O
the	DT	O
designer	NN	O
drug	NN	O
'	''	O
for	IN	O
potential	JJ	B-REL
use	NN	I-REL
as	IN	O
a	DT	O
cancer-killing	JJ	O
agent	NN	O
in	IN	O
the	DT	O
treatment	NN	O
of	IN	O
leukaemia	NN	O
,	,	O
lymphoma	NN	O
and	CC	O
myeloma	NN	O

Modified	VBN	O
versions	NNS	O
of	IN	O
the	DT	O
dance	NN	O
club	NN	O
drug	NN	O
may	MD	B-REL
help	VB	I-REL
to	TO	I-REL
fight	VB	I-REL
leukaemia	NN	O
,	,	O
lymphoma	NN	O
and	CC	O
myeloma	NN	O

an	DT	O
illegal	JJ	O
rave	VBP	O
drug	NN	O
could	MD	O
hold	VB	B-REL
the	DT	I-REL
key	NN	I-REL
to	TO	I-REL
beating	VBG	I-REL
cancer	NN	O

THE	DT	O
designer	NN	O
drug	NN	O
Ecstasy	NNP	O
has	VBZ	O
been	VBN	O
developed	VBN	O
into	IN	O
a	DT	O
potent	JJ	O
medical	JJ	O
treatment	NN	O
that	WDT	O
could	MD	B-REL
be	VB	I-REL
the	DT	I-REL
key	NN	I-REL
to	TO	I-REL
tackling	VBG	I-REL
blood	NN	O
cancers	NNS	O

the	DT	O
designer	NN	O
drug	NN	O
could	MD	B-REL
be	VB	I-REL
used	VBN	I-REL
to	TO	I-REL
treat	VB	O
leukaemia	NN	O
,	,	O
lymphoma	NN	O
and	CC	O
myeloma	NN	O

Modified	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
drug	NN	O
Ecstasy	NNP	O
may	MD	B-REL
be	VB	I-REL
effective	JJ	I-REL
against	IN	O
leukaemia	NN	O
,	,	O
lymphoma	NN	O
and	CC	O
myeloma	NN	O

modified	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
rave	VBP	O
drug	NN	O
boosted	VBD	B-REL
its	PRP$	I-REL
ability	NN	I-REL
to	TO	I-REL
destroy	VB	I-REL
cancerous	JJ	O
cells	NNS	O

Ecstasy	NNP	O
is	VBZ	O
known	VBN	O
to	TO	O
kill	VB	O
some	DT	O
cancer	NN	O
cells	NNS	O
,	,	O
but	CC	O
scientists	NNS	O
have	VBP	B-REL
increased	VBN	I-REL
its	PRP$	I-REL
effectiveness	NN	I-REL
100-fold	RB	O

Ecstasy	NNP	O
`	``	O
key	JJ	B-REL
to	TO	I-REL
treating	VBG	I-REL
leukaemia	NN	O
'	''	O

...	:	O
abulatory	JJ	O
monitoring	NN	O
as	IN	O
a	DT	O
diagnostic	JJ	O
strategy	NN	O
for	IN	O
hypertension	NN	O
after	IN	O
an	DT	O
initial	JJ	O
raised	VBN	O
reading	NN	O
in	IN	O
the	DT	O
clinic	NN	O
would	MD	B-REL
reduce	VB	I-REL
misdiagnosis	NN	O
and	CC	O
save	VB	O
costs	NNS	O
...	:	O

...	:	O
high	JJ	O
blood	NN	O
pressure	NN	O
should	MD	O
be	VB	O
diagnosed	VBN	O
using	VBG	O
ambulatory	JJ	O
blood	NN	O
pressure	NN	O
monitoring	NN	O
-LRB-	-LRB-	O
repeated	VBN	O
measurements	NNS	O
throughout	IN	O
a	DT	O
24-hour	JJ	O
period	NN	O
-RRB-	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
not	RB	O
only	RB	O
more	RBR	B-REL
clinically	RB	O
accurate	JJ	O
...	:	O

...	:	O
Patients	NNS	O
suspected	VBN	O
of	IN	O
having	VBG	O
high	JJ	O
blood	NN	O
pressure	NN	O
are	VBP	O
to	TO	O
wear	VB	O
a	DT	O
monitor	NN	O
for	IN	O
24	CD	O
hours	NNS	O
because	IN	O
the	DT	O
condition	NN	O
is	VBZ	B-REL
being	VBG	I-REL
wrongly	RB	I-REL
diagnosed	VBN	O
in	IN	O
millions	NNS	O
of	IN	O
people	NNS	O
...	:	O

...	:	O
more	JJR	O
than	IN	O
a	DT	O
quarter	NN	O
of	IN	O
patients	NNS	O
may	MD	B-REL
have	VB	I-REL
been	VBN	I-REL
misdiagnosed	JJ	O
for	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O
...	:	O

...	:	O
their	PRP$	O
blood	NN	O
pressure	NN	O
taken	VBN	O
in	IN	O
the	DT	O
surgery	NN	O
,	,	O
meaning	VBG	O
they	PRP	B-REL
potentially	RB	I-REL
give	VBP	I-REL
a	DT	I-REL
misleading	JJ	O
reading	NN	O
...	:	O

...	:	O
one-quarter	NN	O
of	IN	O
the	DT	O
six	CD	O
million	CD	O
people	NNS	O
being	VBG	O
treated	VBN	O
for	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O
in	IN	O
the	DT	O
UK	NNP	O
may	MD	B-REL
have	VB	I-REL
been	VBN	I-REL
misdiagnosed	JJ	O
...	:	O

...	:	O
potentially	RB	O
a	DT	O
quarter	NN	O
of	IN	O
patients	NNS	O
could	MD	B-REL
have	VB	I-REL
been	VBN	I-REL
misdiagnosed	JJ	O
...	:	O

...	:	O
Taking	VBG	O
repeated	VBN	O
blood	NN	O
pressure	NN	O
readings	NNS	O
over	IN	O
a	DT	O
24-hour	JJ	O
period	NN	O
rather	RB	O
than	IN	O
a	DT	O
one-off	JJ	O
measurement	NN	O
in	IN	O
the	DT	B-REL
clinic	NN	O
is	VBZ	B-REL
the	DT	O
most	RBS	B-REL
cost-effective	JJ	I-REL
way	NN	I-REL
of	IN	O
deciding	VBG	O
who	WP	O
should	MD	O
be	VB	O
prescribed	VBN	O
drugs	NNS	O
for	IN	O
hypertension	NN	O
...	:	O

...	:	O
one	CD	O
in	IN	O
four	CD	O
patients	NNS	O
may	MD	B-REL
be	VB	I-REL
wrongly	RB	I-REL
diagnosed	VBN	O
with	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O
...	:	O

Urine	NN	O
steroid	NN	O
metabolomics	NNS	O
is	VBZ	O
a	DT	O
novel	JJ	B-REL
,	,	I-REL
highly	RB	I-REL
sensitive	JJ	I-REL
,	,	O
and	CC	B-REL
specific	JJ	I-REL
biomarker	NN	I-REL
tool	NN	I-REL
for	IN	O
discriminating	VBG	O
benign	JJ	O
from	IN	O
malignant	JJ	O
adrenal	JJ	O
tumors	NNS	O

a	DT	O
urine	NN	O
test	NN	O
to	TO	B-REL
help	VB	I-REL
to	TO	O
diagnose	VB	B-REL
adrenal	JJ	O
cancer	NN	O

the	DT	O
repeated	VBN	O
pairing	NN	O
of	IN	O
alcohol	NN	O
's	POS	O
effects	NNS	O
with	IN	O
a	DT	O
particular	JJ	O
context	NN	O
produced	VBD	B-REL
conditioned	JJ	O
tolerance	NN	O
to	TO	O
alcohol	NN	O
's	POS	O
effects	NNS	O
on	IN	O
a	DT	O
simple	JJ	O
test	NN	O
of	IN	O
behavioural	JJ	O
inhibition	NN	O

Repeated	JJ	O
consumption	NN	O
of	IN	O
alcohol	NN	O
in	IN	O
a	DT	O
particular	JJ	O
environment	NN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
the	DT	O
emergence	NN	O
of	IN	O
a	DT	O
context-specific	JJ	O
CCR	NN	O

drinking	VBG	O
alcohol	NN	O
in	IN	O
a	DT	O
context	NN	O
that	WDT	O
is	VBZ	O
unknown	JJ	O
can	MD	B-REL
lead	VB	I-REL
people	NNS	O
to	TO	O
behave	VB	O
in	IN	O
a	DT	O
more	RBR	O
disinhibited	JJ	O
way	NN	O
than	IN	O
if	IN	O
they	PRP	O
had	VBD	O
been	VBN	O
drinking	VBG	O
in	IN	O
a	DT	O
familiar	JJ	O
environment	NN	O

It	PRP	O
's	VBZ	O
all	DT	O
down	IN	B-REL
to	TO	I-REL
the	DT	O
environment	NN	O
,	,	O
see	VB	O

...	:	O
supplementation	NN	O
with	IN	O
an	DT	O
encapsulated	VBN	O
FV	NN	O
juice	NN	O
powder	NN	O
concentrate	NN	O
,	,	O
during	IN	O
non-surgical	JJ	O
periodontal	JJ	O
therapy	NN	O
,	,	O
appears	VBZ	B-REL
to	TO	I-REL
offer	VB	I-REL
additional	JJ	O
initial	JJ	O
pocket	NN	O
depth	NN	O
reductions	NNS	O
...	:	O

...	:	O
adjunctive	JJ	O
juice	NN	O
powder	NN	O
concentrates	VBZ	O
appear	VB	B-REL
to	TO	I-REL
improve	VB	I-REL
initial	JJ	O
pocket	NN	O
depth	NN	O
reductions	NNS	O
...	:	O

...	:	O
capsules	NNS	O
containing	VBG	O
concentrated	JJ	O
phytonnutrients	NNS	O
improved	VBD	B-REL
clinical	JJ	O
outcomes	NNS	O
...	:	O

reactivation	NN	O
+	CC	O
extinction	NN	O
impacts	NNS	B-REL
on	IN	I-REL
memory	NN	O
mechanisms	NNS	O

a	DT	O
similar	JJ	O
strategy	NN	O
is	VBZ	B-REL
equally	RB	I-REL
effective	JJ	I-REL
in	IN	I-REL
the	DT	O
disruption	NN	O
of	IN	O
appetitive	JJ	O
pavlovian	JJ	O
cue-food	JJ	O
memories	NNS	O

Retrieving	VBG	O
a	DT	O
memory	NN	O
is	VBZ	B-REL
crucial	JJ	I-REL
when	WRB	O
trying	VBG	O
to	TO	O
extinguish	VB	O
it	PRP	O
completely	RB	O

...	:	O
most	RBS	O
men	NNS	O
treted	VBN	O
for	IN	O
colorectal	JJ	O
cancer	NN	O
experience	NN	B-REL
erectile	NN	O
dysfunction	NN	O
as	IN	O
a	DT	O
consequence	NN	O
...	:	O

...	:	O
most	RBS	O
men	NNS	O
treated	VBN	O
for	IN	O
colorectal	JJ	O
cancer	NN	O
experience	NN	B-REL
erectile	NN	O
dysfunction	NN	O
as	IN	O
a	DT	O
consequence	NN	O
...	:	O

...	:	O
men	NNS	O
suffering	VBG	O
from	IN	O
bowel	NN	O
cancer	NN	O
are	VBP	B-REL
prone	JJ	I-REL
to	TO	I-REL
erectile	VB	O
dysfunction	NN	O
...	:	O

only	RB	O
participants	NNS	O
in	IN	O
the	DT	O
commercially	RB	O
run	VBN	O
programmes	NNS	O
-LRB-	-LRB-	O
Weight	NNP	O
Watchers	NNPS	O
and	CC	O
Rosemary	NNP	O
Conley	NNP	O
-RRB-	-RRB-	O
had	VBD	O
significantly	RB	B-REL
greater	JJR	I-REL
weight	NN	O
loss	NN	O

Commercially	RB	O
provided	VBN	O
weight	NN	O
management	NN	O
services	NNS	O
are	VBP	O
more	RBR	B-REL
effective	JJ	O
and	CC	O
cheaper	JJR	O
than	IN	O
primary	JJ	O
care	NN	O
based	VBN	O
services	NNS	O

Commercial	JJ	O
weight	NN	O
loss	NN	O
services	NNS	O
more	RBR	B-REL
effective	JJ	I-REL
than	IN	O
primary	JJ	O
care	NN	O

Lose	VB	O
just	RB	O
7lbs	NNS	O
and	CC	O
you	PRP	B-REL
could	MD	I-REL
add	VB	I-REL
a	DT	O
year	NN	O
to	TO	O
your	PRP$	O
life	NN	O

If	IN	O
you	PRP	O
want	VBP	O
to	TO	O
fight	VB	O
the	DT	O
flab	NN	O
join	VB	O
a	DT	O
group	NN	O
like	IN	O
Weight	NNP	O
Watchers	NNPS	O
-	:	O
it	PRP	O
'll	MD	O
shift	VB	O
the	DT	O
pounds	NNS	O
far	RB	B-REL
better	JJR	I-REL
than	IN	I-REL
following	VBG	O
an	DT	O
NHS	NN	O
diet	NN	O
plan	NN	O

Commericial	JJ	O
weight	NN	O
loss	NN	O
programmes	NNS	O
are	VBP	O
more	RBR	B-REL
effective	JJ	O
and	CC	O
cheaper	JJR	O
than	IN	O
schemes	NNS	O
run	VBN	O
by	IN	O
the	DT	O
NHS	NN	O

NHS	NN	O
weight	NN	O
loss	NN	O
programmes	NNS	O
are	VBP	O
more	RBR	B-REL
expensive	JJ	O
and	CC	O
less	RBR	O
effective	JJ	O
than	IN	O
WeightWatchers	NNS	O

the	DT	O
private	JJ	O
sector	NN	O
comprehensively	RB	B-REL
beats	VBZ	I-REL
the	DT	O
NHS	NN	O
when	WRB	O
it	PRP	O
comes	VBZ	O
to	TO	O
helping	VBG	O
people	NNS	O
slim	JJ	O

Commercial	JJ	O
weight-loss	JJ	O
programs	NNS	O
such	JJ	O
as	IN	O
Weight	NNP	O
Watchers	NNPS	O
and	CC	O
Slimming	NNP	O
World	NNP	O
are	VBP	O
more	RBR	B-REL
effective	JJ	O
and	CC	O
cheaper	JJR	O
than	IN	O
family	NN	O
doctor-based	JJ	O
services	NNS	O

schemes	NNS	O
run	VBN	O
by	IN	O
Weight	NNP	O
Watchers	NNPS	O
,	,	O
Slimming	VBG	O
World	NNP	O
,	,	O
Rosemary	NNP	O
Conley	NNP	O
and	CC	O
the	DT	O
like	JJ	O
lose	VBP	B-REL
more	JJR	I-REL
weight	NN	O

evidence	NN	O
for	IN	O
an	DT	O
association	NN	B-REL
between	IN	O
earlier	JJR	O
menarche	NN	O
and	CC	O
increased	VBN	O
levels	NNS	O
of	IN	O
depressive	JJ	O
symptoms	NNS	O
in	IN	O
mid-adolescence	NN	O

Early	RB	O
maturing	VBG	O
girls	NNS	O
are	VBP	O
at	IN	O
increased	VBN	B-REL
risk	NN	I-REL
of	IN	O
depressive	JJ	O
symptoms	NNS	O
in	IN	O
adolescence	NN	O

Girls	NNS	O
who	WP	O
begin	VBP	O
menstruating	VBG	O
at	IN	O
an	DT	O
early	JJ	O
age	NN	O
are	VBP	O
at	IN	O
greater	JJR	B-REL
risk	NN	I-REL
of	IN	O
depressive	JJ	O
symptoms	NNS	O
during	IN	O
their	PRP$	O
adolescence	NN	O

Girls	NNS	O
who	WP	O
mature	VBP	O
early	RB	O
are	VBP	O
at	IN	O
greater	JJR	B-REL
risk	NN	I-REL
of	IN	O
depression	NN	O
when	WRB	O
they	PRP	O
reach	VBP	O
their	PRP$	O
teens	NNS	O

we	PRP	O
report	VBP	O
weak	JJ	O
but	CC	O
novel	JJ	O
associations	NNS	B-REL
between	IN	O
dietary	JJ	O
patterns	NNS	O
in	IN	O
early	JJ	O
childhood	NN	O
,	,	O
and	CC	O
current	JJ	O
diet	NN	O
,	,	O
with	IN	O
general	JJ	O
intelligence	NN	O
assessed	VBN	O
at	IN	O
8.5	CD	O
years	NNS	O
of	IN	O
age	NN	O

a	DT	O
poor	JJ	O
diet	NN	O
associated	VBN	B-REL
with	IN	O
high	JJ	O
fat	NN	O
,	,	O
sugar	NN	O
and	CC	O
processed	VBN	O
food	NN	O
content	NN	O
in	IN	O
early	JJ	O
childhood	NN	O
may	MD	B-REL
be	VB	I-REL
associated	VBN	O
with	IN	O
small	JJ	O
reductions	NNS	O
in	IN	O
IQ	NNP	O
in	IN	O
later	JJ	O
childhood	NN	O

A	DT	O
diet	NN	O
,	,	O
high	JJ	O
in	IN	O
fats	NNS	O
,	,	O
sugars	NNS	O
,	,	O
and	CC	O
processed	VBN	O
foods	NNS	O
in	IN	O
early	JJ	O
childhood	NN	O
may	MD	B-REL
lower	VB	I-REL
IQ	NNP	O

toddlers	NNS	O
who	WP	O
eat	VBP	O
more	JJR	O
chips	NNS	O
,	,	O
crisps	NNS	O
,	,	O
biscuits	NNS	O
and	CC	O
pizza	NN	O
have	VBP	B-REL
lower	JJR	I-REL
IQ	NNP	O

junk	NN	O
food	NN	O
lowers	VBZ	B-REL
a	DT	O
child	NN	O
's	POS	O
IQ	NNP	O

Youngsters	NNS	O
who	WP	O
eat	VBP	O
plenty	NN	O
of	IN	O
fruit	NN	O
and	CC	O
salad	NN	O
aged	JJ	O
three	CD	O
have	VBP	B-REL
higher	JJR	I-REL
IQs	NNS	O
at	IN	O
eight	CD	O

Proof	NN	O
junk	NN	O
food	NN	O
lowers	VBZ	B-REL
a	DT	O
child	NN	O
's	POS	O
IQ	NNP	O

Feeding	NNP	O
children	NNS	O
processed	VBN	O
foods	NNS	O
at	IN	O
a	DT	O
young	JJ	O
age	NN	O
lowers	VBZ	B-REL
their	PRP$	O
future	JJ	O
IQ	NNP	O

diet	NN	O
does	VBZ	O
boost	VB	B-REL
your	PRP$	O
intelligence	NN	O

Poor	NNP	O
diet	NN	O
may	MD	B-REL
impact	VB	I-REL
on	IN	O
IQ	NNP	O
of	IN	O
younger	JJR	O
children	NNS	O

Junk	NN	O
food	NN	O
diet	NN	O
`	``	O
could	MD	O
damage	VB	B-REL
your	PRP$	O
child	NN	O
's	POS	O
IQ	NNP	O

higher	JJR	O
dietary	JJ	O
intakes	NN	O
of	IN	O
carotenoids	NNS	O
and	CC	O
fruit	NN	O
and	CC	O
vegetables	NNS	O
have	VBP	B-REL
increased	VBN	I-REL
skin	NN	O
b	NN	O
*	SYM	O
values	NNS	O

fruit	NN	O
and	CC	O
vegetables	NNS	O
is	VBZ	O
by	IN	O
far	RB	O
the	DT	O
most	RBS	B-REL
effective	JJ	I-REL
way	NN	I-REL
to	TO	O
achieve	VB	O
a	DT	O
healthy	JJ	O
,	,	O
golden	JJ	O
glow	NN	O

...	:	O
study	NN	O
showed	VBD	O
that	IN	O
both	CC	O
miR-503	NN	O
and	CC	O
miR-320	NN	O
are	VBP	O
upregulated	VBN	B-REL
...	:	O

...	:	O
microRNA-503	NN	O
expression	NN	O
in	IN	O
EC	NNP	O
is	VBZ	B-REL
upregulated	VBN	I-REL
in	IN	O
culture	NN	O
conditions	NNS	O
mimicking	VBG	O
diabetes	NN	O
mellitis	NN	O
and	CC	O
ischaemia-associated	JJ	O
starvation	NN	O
...	:	O

...	:	O
micro-RNA	NN	O
could	MD	O
increase	VB	B-REL
the	DT	O
risk	NN	O
of	IN	O
limb	NN	O
amputation	NN	O
in	IN	O
diabetic	JJ	O
patients	NNS	O
...	:	O

The	DT	O
data	NNS	O
reported	VBN	O
here	RB	O
indicate	VBP	O
that	IN	O
the	DT	O
physical	JJ	O
activity	NN	O
patterns	NNS	O
of	IN	O
10	CD	O
-	:	O
to	TO	O
11-yr-old	JJ	O
children	NNS	O
are	VBP	O
associated	VBN	B-REL
with	IN	O
the	DT	O
physical	JJ	O
activity	NN	O
of	IN	O
their	PRP$	O
``	``	O
best	JJS	O
friends	NNS	O

Boys	NNS	O
and	CC	O
girls	NNS	O
who	WP	O
take	VBP	O
part	NN	O
in	IN	B-REL
physical	JJ	O
activity	NN	O
with	IN	O
their	PRP$	O
best	JJS	O
friend	NN	O
at	IN	O
home	NN	O
or	CC	O
in	IN	O
the	DT	O
neighborhood	NN	O
where	WRB	O
they	PRP	O
live	VBP	O
engage	VB	B-REL
in	IN	O
higher	JJR	B-REL
levels	NNS	I-REL
of	IN	O
physical	JJ	O
activity	NN	O

Boys	NNS	O
and	CC	O
girls	NNS	O
who	WP	O
take	VBP	O
part	NN	O
in	IN	O
physical	JJ	O
activity	NN	O
with	IN	O
their	PRP$	O
best	JJS	O
friend	NN	O
in	IN	O
the	DT	O
neighbourhood	NN	O
where	WRB	O
they	PRP	O
live	VBP	O
have	VBP	B-REL
higher	JJR	I-REL
levels	NNS	I-REL
of	IN	O
physical	JJ	O
activity	NN	O

four-year	JJ	O
incidence	NN	O
of	IN	O
obesity	NN	O
was	VBD	B-REL
higher	JJR	I-REL
between	IN	O
ages	NNS	O
7	CD	O
and	CC	O
11	CD	O
years	NNS	O
than	IN	O
between	IN	O
11	CD	O
and	CC	O
15	CD	O
years	NNS	O

...	:	O
This	DT	O
paper	NN	O
provides	VBZ	O
clear	JJ	O
evidence	NN	O
that	IN	O
it	PRP	O
is	VBZ	O
the	DT	O
transmission	NN	O
of	IN	O
intergenerational	JJ	O
wealth	NN	O
that	WDT	O
drives	VBZ	B-REL
male	JJ	O
sibling	NN	O
competition	NN	O
for	IN	O
marriage	NN	O
and	CC	O
reproduction	NN	O
...	:	O

...	:	O
In	IN	O
households	NNS	O
where	WRB	O
land	NN	O
is	VBZ	O
inherited	VBN	O
,	,	O
the	DT	O
number	NN	O
of	IN	O
elder	JJR	O
brothers	NNS	O
reduces	VBZ	O
a	DT	O
man	NN	O
's	POS	O
agricultural	JJ	O
productivity	NN	O
,	,	O
marriage	NN	O
,	,	O
and	CC	O
reproductive	JJ	O
success	NN	O
,	,	O
as	IN	O
resources	NNS	O
diminish	VBP	O
and	CC	O
competition	NN	B-REL
increases	NNS	I-REL
with	IN	O
each	DT	O
additional	JJ	O
sibling	NN	O
...	:	O

...	:	O
Inherited	VBN	O
wealth	NN	O
leads	VBZ	B-REL
to	TO	I-REL
sibling	NN	O
rivalry	NN	O
...	:	O

...	:	O
This	DT	O
study	NN	O
shows	VBZ	O
that	IN	O
aworkplacetransportplan	JJ	O
aimed	VBN	O
at	IN	O
decreasing	VBG	O
car	NN	O
usage	NN	O
through	IN	O
restricted	JJ	O
parking	NN	O
can	MD	B-REL
significantly	RB	I-REL
increase	VB	I-REL
active	JJ	O
travel	NN	O
through	IN	O
walking	NN	O
and	CC	O
cycling	NN	O
...	:	O

...	:	O
This	DT	O
study	NN	O
suggests	VBZ	O
that	IN	O
transport	NN	O
plans	NNS	B-REL
aimed	VBN	I-REL
at	IN	I-REL
reducing	VBG	I-REL
car	NN	I-REL
usage	NN	I-REL
should	MD	I-REL
be	VB	I-REL
considered	VBN	I-REL
as	IN	I-REL
a	DT	I-REL
feasible	JJ	I-REL
and	CC	I-REL
effective	JJ	I-REL
strategy	NN	I-REL
for	IN	I-REL
increasing	VBG	I-REL
health-enhancing	JJ	O
physical	JJ	O
activity	NN	O
among	IN	O
the	DT	O
workforce	NN	O
...	:	O

...	:	O
A	DT	O
new	JJ	O
study	NN	O
suggests	VBZ	O
that	IN	O
transport	NN	O
plans	NNS	O
aimed	VBN	O
at	IN	O
reducing	VBG	O
car	NN	O
usage	NN	O
should	MD	B-REL
be	VB	I-REL
considered	VBN	I-REL
as	IN	I-REL
a	DT	I-REL
feasible	JJ	I-REL
and	CC	I-REL
effective	JJ	I-REL
strategy	NN	I-REL
for	IN	I-REL
increasing	VBG	I-REL
physical	JJ	O
activity	NN	O
among	IN	O
the	DT	O
workforce	NN	O
and	CC	O
improving	VBG	O
health	NN	O
...	:	O

...	:	O
children	NNS	O
do	VBP	B-REL
engage	VB	I-REL
in	IN	I-REL
active	JJ	O
play	NN	O
consistent	JJ	O
with	IN	O
that	DT	O
of	IN	O
previous	JJ	O
generations	NNS	O
and	CC	O
value	NN	O
both	CC	O
the	DT	O
physical	JJ	O
and	CC	O
social	JJ	O
benefits	NNS	O
it	PRP	O
provides	VBZ	O
...	:	O

...	:	O
Promoting	VBG	O
active	JJ	O
play	NN	O
in	IN	O
children	NNS	O
's	POS	O
leisure	NN	O
time	NN	O
may	MD	B-REL
increase	VB	I-REL
the	DT	O
physical	JJ	O
activity	NN	O
of	IN	O
children	NNS	O
,	,	O
but	CC	O
interventions	NNS	O
may	MD	O
need	VB	O
to	TO	O
be	VB	O
tailored	VBN	O
according	VBG	O
to	TO	O
gender	VB	O
...	:	O

...	:	O
Today	NN	O
's	POS	O
children	NNS	O
do	VBP	B-REL
engage	VB	I-REL
in	IN	I-REL
active	JJ	O
play	NN	O
...	:	O

...	:	O
Rather	RB	O
,	,	O
previous	JJ	O
prenatal	JJ	O
loss	NN	O
showed	VBD	B-REL
a	DT	I-REL
persisting	VBG	I-REL
prediction	NN	I-REL
of	IN	I-REL
depressive	JJ	O
and	CC	O
anxiety	NN	O
symptoms	NNS	O
well	RB	O
after	IN	O
what	WP	O
would	MD	O
conventionally	RB	O
be	VB	O
defined	VBN	O
as	IN	O
the	DT	O
postnatal	JJ	O
period	NN	O
...	:	O

...	:	O
Generalised	JJ	O
estimating	NN	O
equations	NNS	O
indicated	VBD	O
that	IN	O
the	DT	O
number	NN	O
of	IN	O
previous	JJ	O
miscarriages/stillbirths	NNS	O
significantly	RB	B-REL
predicted	VBD	I-REL
symptoms	NNS	O
of	IN	O
depression	NN	O
...	:	O

...	:	O
Depression	NN	O
following	VBG	O
miscarriage	NN	O
can	MD	B-REL
continue	VB	I-REL
after	IN	I-REL
healthy	JJ	O
birth	NN	O
...	:	O

...	:	O
Miscarriage	NNP	O
trauma	NN	O
`	``	O
persists	VBZ	B-REL
after	IN	I-REL
successful	JJ	O
birth	NN	O
'	''	O
...	:	O

There	EX	B-REL
is	VBZ	I-REL
little	JJ	I-REL
evidence	NN	I-REL
from	IN	O
the	DT	O
current	JJ	O
epidemiological	JJ	O
literature	NN	O
that	WDT	O
increased	VBD	O
dietary	JJ	O
vitamin	NN	O
D	NN	O
or	CC	O
circulating	VBG	O
concentrations	NNS	O
of	IN	O
25	CD	O
-LRB-	-LRB-	O
OH	NN	O
-RRB-	-RRB-	O
D	NN	O
were	VBD	O
importantly	RB	O
associated	VBN	O
with	IN	O
risk	NN	O
of	IN	O
prostate	NN	O
cancer	NN	O

Published	VBN	O
literature	NN	O
provides	VBZ	B-REL
little	JJ	I-REL
evidence	NN	I-REL
to	TO	I-REL
support	VB	I-REL
a	DT	O
major	JJ	O
role	NN	O
of	IN	O
vitamin	NN	O
D	NN	O
in	IN	O
preventing	VBG	O
prostate	NN	O
cancer	NN	O
or	CC	O
its	PRP$	O
progression	NN	O

Vitamin	NN	O
D	NN	O
levels	NNS	O
do	VBP	B-REL
not	RB	I-REL
affect	VB	I-REL
men	NNS	O
's	POS	O
chances	NNS	O
of	IN	O
developing	VBG	O
prostate	NN	O
cancer	NN	O

...	:	O
In	IN	O
persons	NNS	O
of	IN	O
white	JJ	O
ancestry	NN	O
,	,	O
idiopathic	JJ	O
membranous	JJ	O
nephropathy	NN	O
is	VBZ	O
strongly	RB	O
associated	VBN	B-REL
with	IN	I-REL
risk	NN	I-REL
alleles	NNS	O
within	IN	O
the	DT	O
HLA	NN	O
locus	NN	O
in	IN	O
general	JJ	O
and	CC	O
with	IN	O
HLA-DQA1	NN	O
in	IN	O
particular	JJ	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
PLA2R1	NN	O
alleles	NNS	O
on	IN	O
chromosome	NN	O
2	CD	O
...	:	O

...	:	O
An	DT	O
HLA-DQA1	NN	O
allele	NN	O
on	IN	O
chromosome	NN	O
6p21	NN	O
is	VBZ	B-REL
most	RBS	I-REL
closely	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
idiopathic	JJ	O
membranous	JJ	O
nephropathy	NN	O
in	IN	O
persons	NNS	O
of	IN	O
white	JJ	O
ancestry	NN	O
...	:	O

...	:	O
New	NNP	O
research	NN	O
could	MD	B-REL
help	VB	I-REL
in	IN	I-REL
the	DT	O
treatment	NN	O
of	IN	O
kidney	NN	O
disease	NN	O
...	:	O

...	:	O
we	PRP	O
propose	VBP	O
that	IN	O
exposure	NN	O
to	TO	O
PDGF-BB	NN	O
in	IN	O
response	NN	O
to	TO	O
injury	NN	O
to	TO	O
the	DT	B-REL
blood	NN	O
vessel	NN	O
-LRB-	-LRB-	O
for	IN	O
example	NN	O
after	IN	O
stenting	VBG	O
or	CC	O
vein	NN	O
grafting	NN	O
-RRB-	-RRB-	O
causes	VBZ	O
increased	VBN	O
expression	NN	B-REL
of	IN	I-REL
Wnt4	NN	O
in	IN	O
VSMCs	NNS	O
,	,	O
which	WDT	O
leads	VBZ	O
to	TO	O
activation	NN	O
of	IN	O
Wnt/b-catenin	NN	O
signaling	NN	O
via	IN	O
Fzd1	NN	O
and	CC	B-REL
thereby	RB	I-REL
modulates	VBZ	I-REL
the	DT	O
expression	NN	O
of	IN	O
b-catenin	NN	O
responsive	JJ	O
genes	NNS	O
,	,	O
including	VBG	O
cyclin	NN	O
D1	NN	O
,	,	O
that	WDT	O
cause	VBP	O
VSMC	NNP	O
proliferation	NN	O
...	:	O

...	:	O
b-Catenin	NN	O
signaling	NN	O
was	VBD	B-REL
induced	VBN	O
in	IN	O
the	DT	O
media	NNS	O
and	CC	B-REL
intima	NN	O
at	IN	O
3	CD	O
and	CC	O
28	CD	O
days	NNS	O
after	IN	O
ligation	NN	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
was	VBD	O
associated	VBN	B-REL
with	IN	I-REL
VSMC	NN	O
proliferation	NN	O
and	CC	O
cyclin	NN	O
D1	NN	O
expression	NN	O
...	:	O

...	:	O
Researchers	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
the	DT	O
Wnt/b-catenin	NN	O
signaling	NN	O
pathway	NN	O
plays	VBZ	B-REL
a	DT	I-REL
key	JJ	I-REL
role	NN	I-REL
in	IN	I-REL
encouraging	VBG	I-REL
the	DT	O
growth	NN	O
of	IN	O
VSMC	NNP	O
in	FW	O
vivo	FW	O
...	:	O

...	:	O
We	PRP	O
found	VBD	O
a	DT	B-REL
strong	JJ	I-REL
graded	VBN	I-REL
relationship	NN	I-REL
between	IN	O
increasing	VBG	O
levels	NNS	O
of	IN	O
psychological	JJ	O
distress	NN	O
and	CC	O
the	DT	O
likelihood	NN	O
of	IN	O
being	VBG	O
awarded	VBN	O
a	DT	O
new	JJ	O
disability	NN	O
pension	NN	O
...	:	O

...	:	O
Mild	JJ	O
psychological	JJ	O
distress	NN	O
may	MD	B-REL
be	VB	I-REL
associated	VBN	I-REL
with	IN	I-REL
more	JJR	O
long-term	JJ	O
disability	NN	O
than	IN	O
previously	RB	O
acknowledged	VBN	O
and	CC	O
its	PRP$	O
public	JJ	O
health	NN	O
importance	NN	O
may	MD	O
be	VB	O
underestimated	VBN	O
...	:	O

even	RB	O
relatively	RB	O
mild	JJ	O
symptoms	NNS	O
of	IN	O
psychological	JJ	O
stress	NN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
long-term	JJ	O
disability	NN	O
...	:	O

...	:	O
PA	NN	O
as	IN	O
assessed	VBN	O
by	IN	O
accelerometry	NN	O
was	VBD	B-REL
positively	RB	I-REL
related	JJ	I-REL
to	TO	O
BMCC	NN	O
of	IN	O
the	DT	O
mid	JJ	O
tibia	NN	O
in	IN	O
a	DT	O
population-based	JJ	O
cohort	NN	O
of	IN	O
adolescents	NNS	O
...	:	O

...	:	O
Vigorous	JJ	O
day-to-day	JJ	O
PA	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
indices	NNS	O
of	IN	O
BMCC	NN	O
and	CC	O
geometry	NN	O
in	IN	O
adolescents	NNS	O
...	:	O

...	:	O
A	DT	O
short	JJ	O
burst	NN	O
of	IN	O
vigorous	JJ	O
physical	JJ	O
activity	NN	O
like	IN	O
running	VBG	O
and	CC	O
jogging	NN	O
is	VBZ	B-REL
important	JJ	I-REL
for	IN	I-REL
building	VBG	I-REL
bones	NNS	O
in	IN	O
children	NNS	O
...	:	O

...	:	O
Our	PRP$	O
results	NNS	O
potentially	RB	O
identify	VBP	O
a	DT	O
new	JJ	O
pathway	NN	O
involved	VBN	O
in	IN	O
this	DT	O
process	NN	O
that	WDT	O
may	MD	B-REL
be	VB	I-REL
highly	RB	I-REL
relevant	JJ	I-REL
to	TO	I-REL
the	DT	I-REL
neuropathology	NN	O
of	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O
given	VBN	O
the	DT	O
evidence	NN	O
implicating	VBG	O
both	CC	O
caspases	NNS	O
and	CC	O
GSK-3	NN	O
in	IN	O
this	DT	O
disorder	NN	O
...	:	O

...	:	O
We	PRP	O
found	VBD	O
that	IN	O
a	DT	O
signaling	NN	O
pathway	NN	O
involving	VBG	O
caspase-3	NN	O
,	,	O
Akt1	NN	O
and	CC	O
glycogen	NN	O
synthase	NN	O
kinase-3b	NN	O
is	VBZ	B-REL
an	DT	I-REL
important	JJ	I-REL
mediator	NN	I-REL
of	IN	I-REL
this	DT	I-REL
effect	NN	I-REL
in	IN	O
rats	NNS	O
and	CC	O
mice	NNS	O
...	:	O

...	:	O
How	WRB	O
the	DT	O
toxic	JJ	O
protein	NN	O
,	,	O
amyloid	NN	O
,	,	O
sets	VBZ	O
off	RP	B-REL
a	DT	I-REL
chain	NN	I-REL
of	IN	I-REL
events	NNS	I-REL
that	WDT	I-REL
leads	VBZ	I-REL
to	TO	I-REL
brain	NN	O
cell	NN	O
death	NN	O
during	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O
...	:	O

...	:	O
among	IN	O
non-smokers	NNS	O
andweekly	RB	O
-LRB-	-LRB-	O
i.e.	FW	O
light	JJ	O
,	,	O
non-established	JJ	O
-RRB-	-RRB-	O
cigarette	NN	O
smokers	NNS	O
,	,	O
plain	JJ	O
packaging	NN	O
increases	VBZ	B-REL
visual	JJ	I-REL
attention	NN	I-REL
towards	IN	I-REL
health	NN	O
warning	VBG	O
information	NN	O
and	CC	O
away	RB	O
from	IN	O
brand	NN	O
information	NN	O
...	:	O

...	:	O
Among	IN	O
non-smokers	NNS	O
and	CC	O
non-daily	JJ	O
cigarette	NN	O
smokers	NNS	O
,	,	O
plain	JJ	O
packaging	NN	O
appears	VBZ	B-REL
to	TO	I-REL
increase	VB	I-REL
visual	JJ	O
attention	NN	O
towards	IN	O
health	NN	O
warning	VBG	O
information	NN	O
and	CC	O
away	RB	O
from	IN	O
brand	NN	O
information	NN	O
...	:	O

...	:	O
Plain	JJ	O
cigarette	NN	O
packaging	NN	O
could	MD	B-REL
help	VB	I-REL
prevent	VB	I-REL
people	NNS	O
taking	VBG	O
up	RP	O
the	DT	O
habit	NN	O
but	CC	O
would	MD	O
have	VB	O
little	JJ	O
effect	NN	O
on	IN	O
those	DT	O
who	WP	O
already	RB	O
smoke	VBP	O
on	IN	O
a	DT	O
daily	JJ	O
basis	NN	O
,	,	O
according	VBG	O
to	TO	O
new	JJ	O
research	NN	O
from	IN	O
the	DT	O
UK	NNP	O
Centre	NNP	O
for	IN	O
Tobacco	NN	O
Studies	NNS	O
...	:	O

...	:	O
The	DT	O
heterogeneity	NN	O
was	VBD	O
correlated	VBN	B-REL
with	IN	I-REL
differences	NNS	O
in	IN	O
expression	NN	O
levels	NNS	O
of	IN	O
mGlu2	NN	O
receptors	NNS	O
within	IN	O
our	PRP$	O
Wistar	NNP	O
colony	NN	O
and	CC	O
other	JJ	O
Wistar	JJ	O
substrains	NNS	O
...	:	O

...	:	O
prepregnancy	NN	O
weight	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
greater	JJR	O
adiposity	NN	O
and	CC	O
higher	JJR	O
BP	NNP	O
16	CD	O
y	NN	O
after	IN	O
pregnancy	NN	O
,	,	O
together	RB	O
with	IN	O
our	PRP$	O
recent	JJ	O
findings	NNS	O
from	IN	O
this	DT	O
cohort	NN	O
of	IN	O
increased	VBN	O
obesity	NN	O
and	CC	O
cardiovascular	JJ	O
disease	NN	O
risk	NN	O
factors	NNS	O
in	IN	O
the	DT	O
offspring	NN	O
of	IN	O
women	NNS	O
who	WP	O
had	VBD	O
greater	JJR	O
prepregnancy	NN	O
weight	NN	O
...	:	O

...	:	O
prepregnancy	NN	O
weight	NN	O
was	VBD	B-REL
positively	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
all	DT	O
outcomes	NNS	O
...	:	O

...	:	O
Gaining	NNP	O
more	JJR	O
than	IN	O
the	DT	O
recommended	VBN	O
weight	NN	O
during	IN	O
pregnancy	NN	O
can	MD	B-REL
put	VB	I-REL
women	NNS	I-REL
at	IN	I-REL
increased	VBN	O
risk	NN	O
of	IN	O
becoming	VBG	O
obese	JJ	O
and	CC	O
developing	VBG	O
related	JJ	O
health	NN	O
problems	NNS	O
,	,	O
including	VBG	O
high	JJ	O
blood	NN	O
pressure	NN	O
,	,	O
later	RB	O
in	IN	O
life	NN	O
...	:	O

...	:	O
MOTHERS	NNP	O
WO	NNP	B-REL
N'T	RB	I-REL
LOSE	VBP	I-REL
EXTRA	JJ	I-REL
WEIGHT	NN	I-REL
,	,	I-REL
EXPERTSWARN	NNP	O
...	:	O

...	:	O
overweight-obese	JJ	O
adults	NNS	O
showed	VBD	O
lower	JJR	B-REL
sweet	JJ	O
and	CC	O
salty	JJ	O
taste	NN	O
intensity	NN	O
scores	NNS	O
compared	VBN	O
to	TO	O
normal-weight	JJ	O
controls	NNS	O
...	:	O

...	:	O
overweight/obese	NN	O
individuals	NNS	O
are	VBP	O
more	RBR	B-REL
implicitly	RB	I-REL
attracted	VBN	I-REL
to	TO	I-REL
sweet	JJ	O
...	:	O

...	:	O
people	NNS	O
are	VBP	O
putting	VBG	O
their	PRP$	O
health	NN	O
at	IN	O
risk	NN	O
after	IN	O
research	NN	O
showed	VBD	O
that	IN	O
natural	JJ	O
fruit	NN	O
juice	NN	O
is	VBZ	O
so	RB	O
packed	JJ	O
with	IN	O
sugar	NN	O
it	PRP	B-REL
can	MD	I-REL
be	VB	I-REL
addictive	JJ	I-REL
...	:	O

...	:	O
those	DT	O
who	WP	O
drink	VBP	O
sugary	JJ	O
beverages	NNS	O
are	VBP	B-REL
left	VBN	I-REL
with	IN	I-REL
a	DT	I-REL
dulled	VBN	I-REL
sensitivity	NN	O
to	TO	O
sweet	JJ	O
tastes	NNS	O
...	:	O

...	:	O
too	RB	O
many	JJ	O
sugary	JJ	O
drinks	NNS	O
can	MD	B-REL
dull	JJ	I-REL
taste	NN	O
...	:	O

...	:	O
In	IN	O
this	DT	O
study	NN	O
,	,	O
6	CD	O
*	SYM	O
5	CD	O
h	NN	O
additional	JJ	O
time	NN	O
of	IN	O
dietary	JJ	O
support	NN	O
led	VBD	O
to	TO	O
improved	VBN	B-REL
glycaemic	JJ	O
control	NN	O
and	CC	O
weight	NN	O
loss	NN	O
and	CC	O
reduced	VBN	O
use	NN	O
of	IN	O
diabetes	NN	O
medications	NNS	O
over	IN	O
a	DT	O
12-month	JJ	O
period	NN	O
compared	VBN	O
with	IN	O
usualcare	NN	O
...	:	O

...	:	O
An	DT	O
intensive	JJ	O
diet	NN	O
intervention	NN	O
soon	RB	O
after	IN	O
diagnosis	NN	O
can	MD	B-REL
improve	VB	I-REL
glycaemic	JJ	O
control	NN	O
.	.	O

...	:	O
Dietary	JJ	O
advice	NN	O
improves	VBZ	B-REL
blood	NN	O
sugar	NN	O
control	NN	O
for	IN	O
recently	RB	O
diagnosed	VBN	O
type	NN	O
2	CD	O
diabetes	NN	O
patients	NNS	O
...	:	O

...	:	O
Word	NN	O
forms	NNS	O
,	,	O
in	IN	O
and	CC	O
of	IN	O
themselves	PRP	O
,	,	O
exerting	VBG	B-REL
some	DT	I-REL
control	NN	I-REL
on	IN	I-REL
affect	NN	O
...	:	O

...	:	O
word	NN	O
forms	NNS	O
exert	VBP	B-REL
some	DT	I-REL
control	NN	I-REL
on	IN	I-REL
affect	NN	O
...	:	O

...	:	O
Fewer	JJR	O
than	IN	O
one	CD	O
in	IN	O
six	CD	O
families	NNS	O
that	WDT	O
were	VBD	O
invited	VBN	O
actually	RB	B-REL
engaged	VBN	O
in	IN	O
a	DT	O
weight-related	JJ	O
consultation	NN	O
with	IN	O
their	PRP$	O
GP	NN	O
,	,	O
...	:	O

...	:	O
low	JJ	B-REL
take-up	JJ	I-REL
following	VBG	O
the	DT	O
mail-out	NN	O
of	IN	O
an	DT	O
invitation	NN	O
...	:	O

...	:	O
fewer	JJR	O
than	IN	O
one	CD	O
in	IN	O
six	CD	O
families	NNS	O
engaged	VBN	B-REL
in	IN	O
a	DT	O
weight-related	JJ	O
discussion	NN	O
...	:	O

...	:	O
further	RB	O
non-MHC	JJ	O
genetic	JJ	O
loci	NNS	O
associated	VBN	B-REL
with	IN	I-REL
ankylosing	VBG	O
spondylitis	NNS	O
...	:	O

...	:	O
three	CD	O
variants	NNS	O
in	IN	O
the	DT	O
RUNX3	NN	O
,	,	O
LTBRTNFRSF1A	NN	O
and	CC	O
IL12B	NN	O
regions	NNS	O
convincingly	RB	B-REL
associated	VBN	I-REL
with	IN	I-REL
ankylosing	VBG	O
spondylitis	NNS	O
...	:	O

...	:	O
an	DT	O
individual	NN	O
's	POS	O
genetic	JJ	O
make-up	NN	O
predisposes	VBZ	B-REL
them	PRP	O
to	TO	O
Ankylosing	NNP	O
Spondylitis	NNP	O
...	:	O

...	:	O
has	VBZ	B-REL
linked	VBN	I-REL
eight	CD	O
new	JJ	O
DNA	NN	O
variants	NNS	O
to	TO	O
the	DT	O
autoimmune	JJ	O
disease	NN	O
...	:	O

...	:	O
A	DT	O
genetic	JJ	O
breakthrough	NN	O
into	IN	O
the	DT	O
causes	NNS	B-REL
of	IN	I-REL
an	DT	O
incurable	JJ	O
spine	NN	O
condition	NN	O
.	.	O

...	:	O
established	VBN	O
risk	NN	O
factors	NNS	O
for	IN	O
preeclampsia	NN	O
are	VBP	B-REL
associated	VBN	I-REL
with	IN	I-REL
greater	JJR	O
BP	NN	O
at	IN	O
8	CD	O
weeks	NNS	O
gestation	NN	O
and	CC	O
greater	JJR	O
risk	NN	O
in	IN	O
BP	NN	O
across	IN	O
pregnancy	NN	O
...	:	O

...	:	O
Established	VBN	O
preeclampsia	NN	O
risk	NN	O
factors	NNS	O
are	VBP	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
BP	NN	O
in	IN	O
early	JJ	O
pregnancy	NN	O
and	CC	O
faster	JJR	O
BP	NN	O
increases	NNS	O
later	RB	O
in	IN	O
gestation	NN	O
in	IN	O
normal	JJ	O
pregnancy	NN	O
...	:	O

...	:	O
by	IN	O
defining	VBG	O
pre-eclampsia	JJ	O
instead	RB	O
as	IN	O
the	DT	O
extreme	JJ	O
end	NN	O
of	IN	O
blood	NN	O
pressure	NN	O
-LRB-	-LRB-	O
BP	NN	O
-RRB-	-RRB-	O
risk	NN	O
in	IN	O
pregnancy	NN	O
,	,	O
more	JJR	O
women	NNS	O
who	WP	O
are	VBP	O
at	IN	O
risk	NN	O
could	MD	B-REL
be	VB	I-REL
identified	VBN	I-REL
...	:	O

Poor	NNP	O
complementary	JJ	O
feeding	NN	O
practices	NNS	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
sodium	NN	O
intakes	NN	O
from	IN	O
the	DT	O
diet	NN	O

salt	NN	O
intake	NN	O
higher	JJR	O
than	IN	O
the	DT	O
recommended	VBN	O
UK	NNP	O
maximum	NN	O
level	NN	O
,	,	O
due	JJ	B-REL
to	TO	I-REL
being	VBG	I-REL
fed	VBN	I-REL
salty	JJ	O
and	CC	O
processed	VBN	O
foods	NNS	O

babies	NNS	O
consume	VBP	O
too	RB	B-REL
much	JJ	I-REL
salt	NN	I-REL
because	IN	O
they	PRP	O
are	VBP	O
fed	VBN	O
too	RB	O
much	JJ	O
processed	VBN	O
food	NN	O

the	DT	O
hippocampus	NN	O
plays	VBZ	B-REL
a	DT	I-REL
role	NN	I-REL
in	IN	O
recognition	NN	O
memory	NN	O
when	WRB	O
such	JJ	O
memory	NN	O
involves	VBZ	O
information	NN	O
that	WDT	O
has	VBZ	O
a	DT	O
spatial	JJ	O
component	NN	O
,	,	O
or	CC	O
when	WRB	O
the	DT	O
memory	NN	O
contains	VBZ	O
a	DT	O
temporal/recency	NN	O
component	NN	O

the	DT	O
hippocampus	NN	O
plays	VBZ	B-REL
a	DT	I-REL
role	NN	I-REL
in	IN	I-REL
recognition	NN	O
memory	NN	O
when	WRB	O
such	JJ	O
memory	NN	O
involves	VBZ	O
remembering	VBG	O
that	IN	O
a	DT	O
particular	JJ	O
stimulus	NN	O
occurred	VBD	O
in	IN	O
a	DT	O
particular	JJ	O
place	NN	O
or	CC	O
when	WRB	O
the	DT	O
memory	NN	O
contains	VBZ	O
a	DT	O
temporal	JJ	O
or	CC	O
object	NN	O
recency	NN	O
component	NN	O

Neuroscientists	NNS	O
at	IN	O
the	DT	B-REL
University	NNP	O
of	IN	O
Bristol	NNP	O
have	VBP	O
identified	VBN	O
the	DT	O
reasons	NNS	B-REL
behind	IN	I-REL
why	WRB	O
we	PRP	O
are	VBP	O
,	,	O
at	IN	O
times	NNS	O
,	,	O
unable	JJ	O
to	TO	O
link	VB	O
a	DT	O
face	NN	O
to	TO	O
a	DT	O
name	NN	O

...	:	O
combined	VBN	O
treatment	NN	O
with	IN	O
t-PA	NN	O
and	CC	O
DNase	NN	O
improved	VBD	B-REL
the	DT	O
drainage	NN	O
of	IN	O
infected	JJ	O
fluid	NN	O
...	:	O

...	:	O
intrapleural	JJ	O
t-PA-Dnase	NN	O
therapy	NN	O
improved	VBD	B-REL
fluid	JJ	O
drainage	NN	O
...	:	O

...	:	O
two	CD	O
drugs	NNS	O
for	IN	O
breaking	VBG	O
up	RP	O
the	DT	O
thick	JJ	O
pleural	JJ	O
fluid	NN	O
,	,	O
when	WRB	O
used	VBN	O
together	RB	O
,	,	O
improve	VB	B-REL
drainage	NN	I-REL
of	IN	O
the	DT	O
fluid	NN	O
from	IN	O
the	DT	O
chest	NN	O
...	:	O

OGD	NN	O
induces	VBZ	B-REL
an	DT	O
almost	RB	O
complete	JJ	O
depression	NN	O
of	IN	O
AMPAR-mediated	JJ	O
synaptic	JJ	O
transmission	NN	O
onto	IN	O
CA3	NN	O
pyramidal	JJ	O
neurons	NNS	O
of	IN	O
the	DT	O
hippocampus	NN	O

The	DT	O
depression	NN	O
of	IN	O
synaptic	JJ	O
transmission	NN	O
following	VBG	O
OGD	NNP	O
was	VBD	O
prevented	VBN	O
by	IN	O
metabotropic	JJ	O
glutamate	NN	O
receptor	NN	O
1	CD	O
-LRB-	-LRB-	O
mGluR1	NN	O
-RRB-	-RRB-	O
or	CC	O
A3	NN	O
receptor	NN	O
antagonists	NNS	O
,	,	O
indicating	VBG	B-REL
a	DT	I-REL
role	NN	I-REL
for	IN	O
both	DT	O
glutamate	NN	O
and	CC	O
adenosine	NN	O
release	NN	O
.	.	O

...	:	O
human	JJ	O
SVPs	NNS	O
are	VBP	O
potent	JJ	B-REL
inducers	NNS	I-REL
of	IN	O
reparative	JJ	O
vascularization	NN	O
and	CC	O
cardiac	JJ	O
healing	NN	O
...	:	O

...	:	O
SVP	NN	O
transplantation	NN	O
produces	VBZ	B-REL
long-term	JJ	O
improvement	NN	O
of	IN	O
cardiac	JJ	O
function	NN	O
...	:	O

...	:	O
transplantation	NN	O
of	IN	O
stem	NN	O
cells	NNS	O
that	WDT	O
reside	VBP	O
in	IN	O
human	JJ	O
veins	NNS	O
can	MD	B-REL
help	VB	I-REL
in	IN	O
the	DT	O
recovery	NN	O
of	IN	O
a	DT	O
heart	NN	O
attack	NN	O
...	:	O

...	:	O
this	DT	O
in	FW	O
situ	FW	O
analysis	NN	O
is	VBZ	O
then	RB	O
correlated	VBN	B-REL
with	IN	I-REL
the	DT	O
molecular	JJ	O
structure	NN	O
of	IN	O
UspA1	NN	O
...	:	O

...	:	O
the	DT	O
complex	NN	O
involves	VBZ	O
an	DT	O
angular	JJ	B-REL
association	NN	I-REL
between	IN	O
these	DT	O
two	CD	O
proteins	NNS	O
...	:	O

...	:	O
has	VBZ	O
enabled	VBN	O
the	DT	O
research	NN	O
team	NN	O
to	TO	O
correlate	VB	B-REL
intricate	JJ	O
atomic	JJ	O
level	NN	O
detail	NN	O
of	IN	O
UspA1	NN	O
...	:	O

adolescents	NNS	O
...	:	O
with	IN	O
high	JJ	O
exposure	NN	O
to	TO	B-REL
smoking	NN	O
in	IN	O
films	NNS	O
were	VBD	B-REL
almost	RB	I-REL
twice	RB	I-REL
as	IN	I-REL
likely	JJ	I-REL
to	TO	O
initiate	VB	B-REL
smoking	NN	O
as	IN	O
those	DT	O
with	IN	O
low	JJ	O
exposure	NN	O

adolescents	NNS	O
in	IN	O
the	DT	O
UK	NNP	O
and	CC	O
elsewhere	RB	O
who	WP	O
are	VBP	B-REL
exposed	VBN	O
to	TO	B-REL
smoking	NN	O
depictions	NNS	O
in	IN	O
films	NNS	O
are	VBP	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
initiate	VB	B-REL
smoking	NN	O

Smoking	NN	O
in	IN	O
films	NNS	O
encourages	VBZ	B-REL
teenagers	NNS	O
to	TO	O
take	VB	O
a	DT	O
drag	NN	O

teenagers	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
take	VB	I-REL
up	RP	I-REL
smoking	NN	O
after	IN	O
seeing	VBG	O
film	NN	O
stars	NNS	O
in	IN	O
the	DT	O
act	NN	O

teenagers	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
take	VB	I-REL
up	RP	I-REL
the	DT	O
deadly	JJ	O
habit	NN	O
after	IN	O
watching	VBG	O
movies	NNS	O
which	WDT	O
glamorise	VBP	O
smoking	NN	O

Teenagers	NNS	O
are	VBP	B-REL
more	RBR	I-REL
prone	JJ	I-REL
to	TO	I-REL
take	VB	I-REL
up	RP	I-REL
smoking	NN	O
,	,	O
a	DT	O
report	NN	O
found	VBN	O
last	JJ	O
week	NN	O
,	,	O
if	IN	O
they	PRP	O
watch	VBP	O
films	NNS	O
in	IN	O
which	WDT	O
the	DT	O
characters	NNS	O
smoke	NN	O

Smoking	NN	O
in	IN	O
films	NNS	O
`	``	O
encourages	VBZ	B-REL
teenagers	NNS	O
to	TO	O
take	VB	O
it	PRP	O
up	RP	O
'	''	O

that	IN	O
teenagers	NNS	O
who	WP	O
watch	VBP	O
the	DT	O
most	RBS	O
movies	NNS	O
containing	VBG	O
scenes	NNS	O
of	IN	O
smoking	NN	O
are	VBP	O
up	RB	O
to	TO	B-REL
73	CD	O
per	IN	O
cent	NN	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
try	VB	B-REL
cigarettes	NNS	O

expectations	NNS	O
were	VBD	B-REL
governed	VBN	I-REL
by	IN	I-REL
familiarity	NN	O
with	IN	O
snack	NN	O
foods	NNS	O

Our	PRP$	O
findings	NNS	O
highlight	VBP	O
the	DT	B-REL
role	NN	I-REL
of	IN	O
learning	VBG	O
in	IN	O
shaping	VBG	O
children	NNS	O
's	POS	O
beliefs	NNS	O
about	IN	O
the	DT	O
postingestive	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
consumption	NN	O
of	IN	O
foods	NNS	O

children	NNS	O
who	WP	O
are	VBP	O
familiar	JJ	O
with	IN	O
a	DT	O
snack	NN	O
food	NN	O
will	MD	B-REL
expect	VB	I-REL
it	PRP	O
to	TO	O
be	VB	O
more	RBR	O
filling	VBG	O

...	:	O
The	DT	O
role	NN	B-REL
of	IN	I-REL
syndecan-4	NN	O
as	IN	O
a	DT	O
sensor	NN	O
of	IN	O
tissue	NN	O
damage	NN	O
in	FW	O
vivo	FW	O
is	VBZ	O
now	RB	O
apparent	JJ	O
...	:	O

...	:	O
disruption	NN	O
of	IN	O
syndecan-4	NN	O
or	CC	O
caveolin	NN	O
,	,	O
gene	NN	O
disruption	NN	O
of	IN	O
RhoG	NN	O
in	IN	O
mice	NNS	O
was	VBD	B-REL
found	VBN	I-REL
to	TO	I-REL
retard	VB	I-REL
closure	NN	O
of	IN	O
dermal	JJ	O
wounds	NNS	O
...	:	O

Life	NNP	O
expectancy	NN	O
among	IN	O
people	NNS	O
with	IN	O
HIV	NN	O
has	VBZ	B-REL
considerably	RB	I-REL
improved	VBN	I-REL
in	IN	O
the	DT	O
UK	NNP	O

Life	NNP	O
expectancy	NN	O
in	IN	O
people	NNS	O
treated	VBN	O
for	IN	O
HIV	NN	O
infection	NN	O
has	VBZ	B-REL
increased	VBN	I-REL
by	IN	I-REL
over	IN	O
15	CD	O
years	NNS	O

improvements	NNS	O
in	IN	O
antiretroviral	JJ	O
therapy	NN	O
treatment	NN	O
has	VBZ	B-REL
helped	VBN	I-REL
people	NNS	O
with	IN	O
the	DT	O
disease	NN	O
to	TO	O
live	VB	O
longer	JJR	O

improvements	NNS	O
in	IN	O
antiretroviral	JJ	O
treatments	NNS	O
had	VBD	B-REL
dramatically	RB	I-REL
improved	VBN	I-REL
patients	NNS	O
'	POS	O
outlook	NN	O

Life	NNP	O
expectancy	NN	O
for	IN	O
people	NNS	O
with	IN	O
HIV	NN	O
in	IN	O
the	DT	O
UK	NNP	O
has	VBZ	B-REL
increased	VBN	I-REL
by	IN	O
15	CD	O
years	NNS	O
in	IN	O
the	DT	O
past	JJ	O
decade	NN	O
,	,	O
thanks	NNS	O
to	TO	O
modern	JJ	O
drugs	NNS	O
and	CC	O
earlier	JJR	O
treatment	NN	O

Life	NNP	O
expectancy	NN	O
for	IN	O
people	NNS	O
in	IN	O
Britain	NNP	O
who	WP	O
have	VBP	O
HIV	NN	O
rose	VBD	B-REL
by	IN	O
15	CD	O
years	NNS	O
between	IN	O
1996	CD	O
and	CC	O
2008	CD	O
,	,	O
thanks	NNS	O
largely	RB	O
earlier	RBR	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
with	IN	O
better	JJR	O
,	,	O
less	RBR	O
toxic	JJ	O
drugs	NNS	O

...	:	O
stem	NN	O
cells	NNS	O
from	IN	O
cord	NN	O
blood	NN	O
could	MD	B-REL
help	VB	I-REL
repair	VB	I-REL
damaged	JJ	O
heart	NN	O
muscle	NN	O
...	:	O

The	DT	O
IRIS	NN	O
training	NN	O
and	CC	O
support	NN	O
intervention	NN	O
had	VBD	B-REL
a	DT	I-REL
substantial	JJ	I-REL
effect	NN	I-REL
on	IN	I-REL
...	:	O
recorded	VBN	O
identifi	JJ	O
cation	NN	O
of	IN	O
women	NNS	O
experiencing	VBG	O
domestic	JJ	O
violence	NN	O

A	DT	O
training	NN	O
and	CC	O
support	NN	O
programme	NN	O
targeted	VBN	O
at	IN	O
primary	JJ	O
care	NN	O
clinicians	NNS	O
and	CC	O
administrative	JJ	O
staff	NN	O
...	:	O
recorded	VBN	B-REL
identification	NN	O
of	IN	O
women	NNS	O
experiencing	VBG	O
domestic	JJ	O
violence	NN	O

training	NN	O
and	CC	O
support	NN	O
for	IN	O
GPs	NNS	O
,	,	O
practice	NN	O
nurses	NNS	O
and	CC	O
GP	NN	O
receptionists	NNS	O
can	MD	B-REL
substantially	RB	I-REL
increase	VB	I-REL
the	DT	O
identification	NN	O
of	IN	O
women	NNS	O
experiencing	VBG	O
domestic	JJ	O
violence	NN	O

...	:	O
this	DT	O
study	NN	O
demonstrates	VBZ	O
clear	JJ	O
benefits	NNS	O
of	IN	B-REL
n-3	NN	O
supplementation	NN	O
in	IN	B-REL
reducing	VBG	I-REL
the	DT	I-REL
signs	NNS	I-REL
of	IN	O
OA	NN	O
in	IN	O
a	DT	O
naturally	RB	O
occurring	VBG	O
model	NN	O
of	IN	O
disease	NN	O
...	:	O

...	:	O
Dietary	JJ	O
n-3	NN	O
PUFA	NN	O
reduced	VBD	B-REL
OA	NNP	O
in	IN	O
the	DT	O
prone	JJ	O
strain	NN	O
...	:	O

...	:	O
omega-3-rich	JJ	O
diets	NNS	O
fed	VBN	O
to	TO	O
guinea	NN	O
pigs	NNS	O
,	,	O
which	WDT	O
naturally	RB	O
develop	VBP	O
osteoarthritis	NN	O
,	,	O
reduced	VBD	B-REL
disease	NN	I-REL
by	IN	I-REL
50	CD	I-REL
per	IN	I-REL
cent	NN	I-REL
compared	VBN	O
...	:	O

...	:	O
identify	VB	O
an	DT	O
isolate	NN	O
of	IN	O
Streptococcus	NN	O
thermophilus	NN	O
that	WDT	B-REL
can	MD	I-REL
increase	VB	I-REL
growth	NN	O
rate	NN	O
in	IN	O
response	NN	O
to	TO	O
increased	VBN	O
iron	NN	O
availability	NN	O
...	:	O

These	DT	O
effects	NNS	B-REL
on	IN	I-REL
network	NN	O
oscillations	NNS	O
and	CC	O
interactions	NNS	O
are	VBP	O
likely	JJ	O
to	TO	O
contribute	VB	O
to	TO	O
the	DT	O
cognitive	JJ	O
deficits	NNS	O
elicited	VBN	O
by	IN	O
exogenous	JJ	O
agonists	NNS	O
of	IN	O
brain	NN	O
cannabinoid	NN	O
receptors	NNS	O

disrupted	VBN	O
theta-frequency	NN	O
coordination	NN	O
of	IN	O
CA1	NN	O
-	:	O
mPFC	NN	O
activity	NN	O
in	IN	O
the	DT	O
cognitive	JJ	O
deficits	NNS	O
caused	VBN	B-REL
by	IN	I-REL
exogenous	JJ	O
activation	NN	O
of	IN	O
brain	NN	O
cannabinoid	NN	O
receptors	NNS	O
.	.	O

brain	NN	O
activity	NN	O
becomes	VBZ	B-REL
uncoordinated	JJ	O
and	CC	O
inaccurate	JJ	O
during	IN	O
these	DT	O
altered	JJ	O
states	NNS	O
of	IN	O
mind	NN	O

...	:	O
The	DT	O
three-amino-acid	JJ	O
motif	NN	O
in	IN	O
the	DT	O
S3-S4	NN	O
loop	NN	O
of	IN	O
SK	NN	O
channels	NNS	O
-LRB-	-LRB-	O
SLV	NN	O
in	IN	O
rSK1	NN	O
,	,	O
TYA	NN	O
in	IN	O
hSK1	NN	O
,	,	O
SYA	NN	O
in	IN	O
SK2	NN	O
,	,	O
and	CC	O
SYT	NNP	O
in	IN	O
SK3	NN	O
-RRB-	-RRB-	O
is	VBZ	B-REL
an	DT	I-REL
essential	JJ	I-REL
molecular	JJ	I-REL
determinant	NN	I-REL
for	IN	I-REL
apamin	JJ	O
sensitivity	NN	O
...	:	O

...	:	O
This	DT	O
motif	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
binding	NN	O
and	CC	O
block	NN	O
by	IN	O
apamin	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
a	DT	B-REL
change	NN	I-REL
in	IN	I-REL
pore	NN	I-REL
shape	NN	I-REL
underlies	VBZ	I-REL
allosteric	JJ	O
block	NN	O
...	:	O

Infants	NNS	O
born	VBN	O
between	IN	O
32	CD	O
and	CC	O
36	CD	O
weeks	NNS	O
gestations	NNS	O
are	VBP	O
less	RBR	B-REL
likely	JJ	I-REL
to	TO	O
achieve	VB	O
the	DT	O
expected	VBN	O
level	NN	O
in	IN	O
teacher	NN	O
assessments	NNS	O
at	IN	O
age	NN	O
7	CD	O

Children	NNS	O
born	VBN	O
late-preterm	NN	O
are	VBP	O
less	RBR	B-REL
likely	JJ	I-REL
to	TO	O
be	VB	O
successful	JJ	O
in	IN	O
early	JJ	O
school	NN	O
assessments	NNS	O

Babies	NNS	O
born	VBN	O
32-36	CD	O
weeks	NNS	O
fare	VBP	B-REL
less	RBR	I-REL
well	RB	I-REL
at	IN	O
school	NN	O

...	:	O
These	DT	O
results	NNS	O
indicate	VBP	B-REL
a	DT	I-REL
link	NN	I-REL
between	IN	I-REL
the	DT	O
physiological	JJ	O
role	NN	O
of	IN	O
an	DT	O
important	JJ	O
tumor	NN	O
suppressor	NN	O
gene	NN	O
-LRB-	-LRB-	O
WT1	NN	O
-RRB-	-RRB-	O
and	CC	O
regulation	NN	O
of	IN	O
the	DT	O
angiogenic	JJ	O
or	CC	O
antiangiogenic	JJ	O
properties	NNS	O
of	IN	O
VEGF	NN	O
and	CC	O
other	JJ	O
genes	NNS	O
by	IN	O
alternative	JJ	O
splicing	NN	O
...	:	O

...	:	O
Altered	JJ	O
VEGF	NN	O
splicing	NN	O
was	VBD	B-REL
reversed	VBN	I-REL
by	IN	I-REL
wild-type	JJ	I-REL
WT1	NN	I-REL
,	,	I-REL
knock	VB	O
-	:	O
down	IN	B-REL
of	IN	I-REL
SRSF1	NN	I-REL
,	,	O
or	CC	B-REL
SRPK1	NN	I-REL
and	CC	I-REL
inhibition	NN	I-REL
of	IN	O
SRPK1	NN	O
,	,	O
which	WDT	B-REL
prevented	VBD	I-REL
in	FW	I-REL
vitro	FW	I-REL
and	CC	O
in	FW	O
vivo	FW	B-REL
angiogenesis	NN	O
and	CC	O
associated	VBN	O
tumor	NN	O
growth	NN	O
...	:	O

...	:	O
scientists	NNS	O
have	VBP	O
discovered	VBN	O
a	DT	O
new	JJ	O
way	NN	O
to	TO	O
target	VB	O
cancer	NN	O
through	IN	O
manipulating	VBG	O
a	DT	O
master	NN	O
switch	NN	O
;	:	O
responsible	JJ	B-REL
for	IN	I-REL
cancer	NN	O
cell	NN	O
growth	NN	O
...	:	O

...	:	O
a	DT	O
master	NN	O
switch	NN	O
responsible	JJ	B-REL
for	IN	I-REL
cell	NN	O
growth	NN	O
...	:	O

mutations	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
of	IN	O
cancer	NN	O
control	NN	O
how	WRB	O
parts	NNS	O
of	IN	O
genes	NNS	O
slot	NN	O
together	RB	O
to	TO	O
create	VB	O
proteins	NNS	O
vital	JJ	O
to	TO	O
tumour	NN	O
growth	NN	O
...	:	O

This	DT	O
form	NN	O
of	IN	O
synaptic	JJ	O
plasticity	NN	O
may	MD	B-REL
underlie	VB	I-REL
the	DT	O
mAChR	NN	O
role	NN	O
in	IN	O
prefrontal	JJ	O
cortex-dependent	JJ	O
learning	NN	O
and	CC	O
memory	NN	O

...	:	O
these	DT	O
results	NNS	O
show	VBP	O
that	IN	O
synaptic	JJ	O
stimulation	NN	O
of	IN	O
muscarinic	JJ	O
receptors	NNS	O
alone	RB	O
can	MD	B-REL
be	VB	I-REL
critical	JJ	I-REL
for	IN	I-REL
plastic	JJ	O
changes	NNS	O
in	IN	O
excitatory	JJ	O
synaptic	JJ	O
transmission	NN	O
in	IN	O
the	DT	O
mPFC	NN	O
...	:	O

discovered	VBN	O
that	IN	O
a	DT	O
chemical	JJ	O
compound	NN	O
in	IN	O
the	DT	O
brain	NN	O
can	MD	B-REL
weaken	VB	I-REL
the	DT	O
synaptic	JJ	O
connections	NNS	O
between	IN	O
neurons	NNS	O

it	PRP	O
was	VBD	O
possible	JJ	O
to	TO	O
eat	VB	O
a	DT	O
healthy	JJ	O
diet	NN	O
for	IN	O
virtually	RB	B-REL
the	DT	I-REL
same	JJ	I-REL
cost	NN	I-REL
at	IN	O
a	DT	O
midrange	JJ	O
supermarket	NN	O

eating	VBG	O
healthily	RB	O
would	MD	B-REL
not	RB	I-REL
necessarily	RB	I-REL
incur	VB	I-REL
prohibitive	JJ	O
,	,	O
additional	JJ	O
financial	JJ	O
cost	NN	O

...	:	O
HAVING	VBG	O
a	DT	O
healthy	JJ	O
diet	NN	O
can	MD	B-REL
cost	VB	I-REL
people	NNS	I-REL
less	JJR	I-REL
than	IN	O
eating	VBG	O
junk	NN	O
food	NN	O
...	:	O

...	:	O
AAV-mediated	JJ	O
cardiac	JJ	O
NGF	NN	O
overexpression	NN	O
inhibits	VBZ	B-REL
the	DT	O
development	NN	O
of	IN	O
cardiomyopathy	NN	O
in	IN	O
mice	NNS	O
with	IN	O
streptozotocin-induced	JJ	O
type	NN	O
1	CD	O
diabetes	NN	O
...	:	O

...	:	O
the	DT	O
diabetic	JJ	O
mice	NNS	O
receiving	VBG	O
NGF	NN	O
gene	NN	O
transfer	NN	O
via	IN	O
either	CC	O
AAV2	NN	O
or	CC	O
AAV9	NN	O
were	VBD	B-REL
spared	VBN	I-REL
the	DT	O
progressive	JJ	O
deterioration	NN	O
of	IN	O
cardiac	JJ	O
function	NN	O
and	CC	O
left	VBD	O
ventricular	JJ	O
chamber	NN	O
dilatation	NN	O
observed	VBN	O
in	IN	O
b-Gal-injected	JJ	O
diabetic	JJ	O
mice	NNS	O
...	:	O

three	CD	O
new	JJ	O
genetic	JJ	O
variants	NNS	O
associated	VBN	B-REL
with	IN	I-REL
the	DT	O
skin	NN	O
condition	NN	O
eczema	NN	O

...	:	O
we	PRP	O
found	VBD	O
that	IN	O
fewer	JJR	B-REL
patients	NNS	I-REL
prescribed	VBN	I-REL
ARBs	NNS	I-REL
and	CC	I-REL
ACE-Is	NNS	I-REL
went	VBD	I-REL
on	IN	I-REL
to	TO	I-REL
develop	VB	I-REL
probable	JJ	O
AD	NN	O
...	:	O

...	:	O
there	EX	O
was	VBD	O
an	DT	O
inverse	JJ	B-REL
dose	NN	I-REL
relationship	NN	I-REL
between	IN	I-REL
ARBs	NNS	O
and	CC	O
ACE-Is	NNS	O
with	IN	O
AD	NN	O
...	:	O

...	:	O
taking	VBG	O
newer	JJR	O
blood	NN	O
pressure	NN	O
drugs	NNS	O
cuts	VBZ	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
Alzheimer	NN	O
's	POS	O
by	IN	O
up	RB	O
to	TO	O
50	CD	O
per	IN	O
cent	NN	O
...	:	O

...	:	O
blood	NN	O
pressure	NN	O
drugs	NNS	O
could	MD	B-REL
dramatically	RB	I-REL
slash	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O
...	:	O

...	:	O
a	DT	O
particular	JJ	O
type	NN	O
of	IN	O
blood	NN	O
pressure	NN	O
lowering	VBG	O
drug	NN	O
were	VBD	O
50	CD	B-REL
per	IN	I-REL
cent	NN	I-REL
less	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
develop	VB	I-REL
Alzheimer	NN	O
's	POS	O
...	:	O

closed-loop	JJ	O
insulin	NN	O
delivery	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
nearly	RB	O
normoglycemia	NN	O
overnight	JJ	O
,	,	O
both	CC	O
in	IN	O
early	JJ	O
and	CC	O
in	IN	O
late	JJ	O
pregnancy	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
MPC	NNP	O
algorithm	NN	O
safely	RB	B-REL
adapts	VBZ	I-REL
insulin	NN	O
delivery	NN	O
for	IN	O
advancing	VBG	O
gestational	JJ	O
age	NN	O
.	.	O

...	:	O
MPC	NNP	O
algorithm	NN	O
performance	NN	O
was	VBD	B-REL
maintained	VBN	I-REL
throughout	IN	O
pregnancy	NN	O
...	:	O

...	:	O
an	DT	O
``	``	O
artificial	JJ	O
pancreas	NN	O
''	''	O
can	MD	B-REL
help	VB	I-REL
pregnant	JJ	O
women	NNS	O
with	IN	O
type	NN	O
1	CD	O
diabetes	NN	O
...	:	O

...	:	O
the	DT	O
device	NN	O
,	,	O
which	WDT	O
is	VBZ	O
worn	VBN	O
on	IN	O
the	DT	O
side	NN	O
of	IN	O
the	DT	O
body	NN	O
,	,	O
helps	VBZ	B-REL
to	TO	I-REL
keep	VB	I-REL
blood	NN	O
sugar	NN	O
levels	NNS	O
under	IN	O
control	NN	O
...	:	O

...	:	O
researchers	NNS	O
used	VBD	O
a	DT	O
so-called	JJ	O
``	``	O
closed-loop	JJ	O
insulin	NN	B-REL
delivery	NN	O
system	NN	O
''	''	O
or	CC	O
artificial	JJ	O
pancreas	NN	O
,	,	B-REL
in	IN	O
10	CD	O
pregnant	JJ	O
women	NNS	O
with	IN	O
Type	NN	O
1	CD	O
diabetes	NN	O
and	CC	O
found	VBD	O
it	PRP	O
provided	VBD	B-REL
the	DT	I-REL
right	JJ	I-REL
amount	NN	I-REL
of	IN	I-REL
insulin	NN	O
at	IN	B-REL
the	DT	O
right	JJ	O
time	NN	B-REL
,	,	O
maintained	VBN	B-REL
near	IN	O
normal	JJ	O
blood	NN	O
sugar	NN	O
...	:	O

...	:	O
we	PRP	O
show	VBP	O
here	RB	O
that	IN	O
the	DT	B-REL
allogeneic	JJ	O
paternal	JJ	O
H2-K	NN	O
expressed	VBN	O
on	IN	O
fetal	JJ	O
trophoblast	NN	O
enhances	VBZ	B-REL
the	DT	O
dilation	JJ	B-REL
state	NN	I-REL
of	IN	I-REL
maternal	JJ	O
blood	NN	O
vessels	NNS	O
...	:	O

...	:	O
Antigenic	JJ	O
disparity	NN	O
between	IN	O
parental	JJ	O
MHCs	NNS	O
affects	VBZ	B-REL
trophoblast-induced	JJ	O
transformation	NN	O
of	IN	O
the	DT	O
uterine	JJ	O
vasculature	NN	O
and	CC	O
,	,	O
consequently	RB	O
,	,	O
placental	JJ	O
and	CC	O
fetal	JJ	O
gowth	NN	O
...	:	O

...	:	O
immune	JJ	O
interaction	NN	O
optimises	NNS	B-REL
foetal	JJ	I-REL
nourishment	NN	I-REL
during	IN	O
pregnancy	NN	O
...	:	O

...	:	O
our	PRP$	O
work	NN	O
has	VBZ	O
uncovered	VBN	O
a	DT	B-REL
central	JJ	I-REL
role	NN	I-REL
for	IN	O
the	DT	O
intestine	NN	O
in	IN	O
the	DT	O
execution	NN	O
of	IN	O
extensive	JJ	O
-LRB-	-LRB-	O
and	CC	O
previously	RB	O
uncharacterized	JJ	O
in	IN	O
invertebrates	NNS	O
-RRB-	-RRB-	O
homeostatic	JJ	O
regulation	NN	O
subsequent	JJ	O
to	TO	O
the	DT	O
decision	NN	O
whether	IN	O
or	CC	O
not	RB	O
to	TO	O
eat	VB	O
,	,	O
and	CC	O
has	VBZ	O
identified	VBN	O
intestinalneurons	NNS	O
and	CC	O
systemicsignals	NNS	O
as	IN	O
key	JJ	O
mediators	NNS	O
of	IN	O
the	DT	O
crosstalk	NN	O
between	IN	O
internal	JJ	O
organs	NNS	O
...	:	O

...	:	O
we	PRP	O
then	RB	O
identify	VBP	O
a	DT	B-REL
key	JJ	I-REL
homeostatic	JJ	I-REL
role	NN	I-REL
for	IN	O
autonomic	JJ	O
neurons	NNS	O
and	CC	O
hormones	NNS	O
...	:	O

...	:	O
clues	NNS	O
about	IN	O
how	WRB	O
the	DT	O
human	JJ	O
gut	NN	O
helps	VBZ	B-REL
regulate	VB	I-REL
our	PRP$	O
appetite	NN	O
have	VBP	O
come	VBN	O
from	IN	O
a	DT	O
most	RBS	O
unusual	JJ	O
source	NN	O
-	:	O
fruit	NN	O
fly	NN	O
faeces	NNS	O
...	:	O

...	:	O
patients	NNS	O
randomly	RB	O
assigned	VBN	O
to	TO	O
initial	JJ	O
combination	NN	O
treatment	NN	O
with	IN	O
both	CC	O
aliskiren	NN	O
and	CC	O
amlodipine	NN	O
had	VBD	O
substantially	RB	O
better	JJR	B-REL
mean	JJ	I-REL
blood	NN	I-REL
pressure	NN	I-REL
reduction	NN	O
over	IN	O
the	DT	O
fi	NN	O
rst	NN	O
24	CD	O
weeks	NNS	O
than	IN	O
did	VBD	O
patients	NNS	O
starting	VBG	O
on	IN	O
either	CC	O
drug	NN	O
as	IN	O
monotherapy	NN	O
...	:	O

...	:	O
greater	JJR	O
reduction	NN	B-REL
in	IN	I-REL
mean	JJ	I-REL
systolic	JJ	I-REL
blood	NN	I-REL
pressure	NN	I-REL
than	IN	I-REL
the	DT	O
monotherapy	NN	O
groups	NNS	O
...	:	O

...	:	O
starting	VBG	O
treatment	NN	O
of	IN	O
blood	NN	O
pressure	NN	O
with	IN	O
two	CD	O
medicines	NNS	O
rather	RB	O
than	IN	O
the	DT	O
one	CD	O
produces	VBZ	B-REL
better	JJR	I-REL
and	CC	I-REL
faster	JJR	I-REL
results	NNS	I-REL
and	CC	O
fewer	JJR	O
side	JJ	O
effects	NNS	O
...	:	O

...	:	O
A	DT	O
NEW	JJ	O
two-in-one	JJ	O
pill	NN	O
for	IN	O
treating	VBG	O
high	JJ	O
blood	NN	O
pressure	NN	O
could	MD	B-REL
prevent	VB	I-REL
5,000	CD	O
strokes	NNS	O
a	DT	O
year	NN	O
,	,	O
a	DT	O
study	NN	O
suggests	VBZ	O
...	:	O

...	:	O
patients	NNS	O
started	VBD	O
on	IN	O
the	DT	O
combined	JJ	O
drugs	NNS	O
reduced	VBD	B-REL
their	PRP$	I-REL
blood	NN	I-REL
pressure	NN	I-REL
quickly	RB	I-REL
...	:	O

...	:	O
a	DT	O
combination	NN	O
pill	NN	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
far	RB	B-REL
more	RBR	I-REL
effective	JJ	I-REL
than	IN	O
stand-alone	JJ	O
blood	NN	O
pressure	NN	O
medicines	NNS	O
.	.	O

...	:	O
starting	VBG	O
treatment	NN	O
with	IN	O
two	CD	O
drugs	NNS	O
gave	VBD	B-REL
better	JJR	I-REL
and	CC	I-REL
faster	JJR	I-REL
results	NNS	O
,	,	O
with	IN	O
fewer	JJR	O
side	JJ	O
effects	NNS	O
...	:	O

...	:	O
patients	NNS	O
who	WP	O
switched	VBD	O
from	IN	O
single	JJ	O
drug	NN	O
treatment	NN	O
to	TO	O
combined	JJ	O
therapy	NN	O
improved	VBD	B-REL
their	PRP$	O
response	NN	O
...	:	O

...	:	O
the	DT	O
TG-D5	NN	O
birds	NNS	O
exhibited	VBD	O
a	DT	B-REL
marked	JJ	I-REL
absence	NN	I-REL
of	IN	I-REL
onward	RB	O
transmission	NN	O
of	IN	O
infection	NN	O
,	,	O
even	RB	O
to	TO	O
unprotected	JJ	O
-LRB-	-LRB-	O
nontransgenic	JJ	O
-RRB-	-RRB-	O
chickens	NNS	O
housed	VBN	O
in	IN	O
direct	JJ	O
contact	NN	O
with	IN	O
them	PRP	O
...	:	O

...	:	O
although	IN	O
the	DT	O
transgenic	JJ	O
birds	NNS	O
succumbed	VBD	O
to	TO	O
the	DT	O
initial	JJ	O
experimental	JJ	O
challenge	NN	O
,	,	O
onward	RB	O
transmission	NN	O
to	TO	O
both	DT	O
transgenic	JJ	O
and	CC	O
nontransgenic	JJ	O
birds	NNS	O
was	VBD	O
prevented	VBN	B-REL
...	:	O

...	:	O
chickens	NNS	O
genetically	RB	O
modified	VBN	O
to	TO	B-REL
prevent	VB	I-REL
them	PRP	O
spreading	VBG	O
bird	NN	O
flu	NN	O
have	VBP	O
been	VBN	O
produced	VBN	O
...	:	O

...	:	O
a	DT	O
genetically	RB	O
modified	VBN	O
`	``	O
superchicken	NN	O
'	''	O
that	WDT	B-REL
does	VBZ	I-REL
n't	RB	I-REL
spread	VBN	O
deadly	JJ	O
bird	NN	O
flu	NN	O
...	:	O

...	:	O
GM	NNP	O
chickens	NNS	O
created	VBD	O
that	DT	B-REL
could	MD	I-REL
prevent	VB	I-REL
the	DT	O
spread	NN	O
of	IN	O
bird	NN	O
flu	NN	O
...	:	O

...	:	O
Chickens	NNS	O
genetically	RB	O
modified	VBN	O
to	TO	B-REL
stop	VB	I-REL
bird	NN	O
flu	NN	O
...	:	O

...	:	O
the	DT	B-REL
chickens	NNS	O
have	VBP	O
an	DT	O
extra	JJ	O
piece	NN	O
of	IN	B-REL
DNA	NN	O
inserted	VBN	O
into	IN	O
their	PRP$	O
genomes	NNS	O
which	WDT	O
produces	VBZ	O
a	DT	O
``	``	O
decoy	NN	O
''	''	O
molecule	NN	O
that	WDT	B-REL
blocks	VBZ	I-REL
the	DT	O
replication	NN	B-REL
of	IN	O
the	DT	O
influenza	NN	B-REL
virus	NN	I-REL
and	CC	I-REL
prevents	VBZ	I-REL
transmission	NN	O
to	TO	O
the	DT	O
rest	NN	O
of	IN	O
the	DT	O
flock	NN	O
...	:	O

...	:	O
UK	NNP	O
scientists	NNS	O
have	VBP	O
created	VBN	O
the	DT	O
world	NN	O
's	POS	O
first	JJ	O
genetically	RB	O
modified	VBN	O
chickens	NNS	O
that	WDT	O
do	VBP	B-REL
not	RB	I-REL
spread	VBN	I-REL
bird	NN	O
flu	NN	O
...	:	O

scientists	NNS	O
make	VBP	O
chickens	NNS	O
that	WDT	B-REL
do	VBP	I-REL
n't	RB	I-REL
spread	VBN	I-REL
bird	NN	O
flu	NN	O
...	:	O

...	:	O
Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
nontranscriptional	JJ	O
mechanisms	NNS	O
are	VBP	O
sufficient	JJ	B-REL
to	TO	I-REL
sustain	VB	I-REL
circadian	JJ	O
timekeeping	NN	O
in	IN	O
the	DT	O
eukaryotic	JJ	O
lineage	NN	O
,	,	O
though	IN	O
they	PRP	O
normally	RB	O
function	VBP	O
in	IN	O
conjunction	NN	O
with	IN	O
transcriptional	JJ	O
components	NNS	O
...	:	O

...	:	O
this	DT	O
study	NN	O
of	IN	O
severe	JJ	O
gram-negative	JJ	O
sepsis	NN	O
has	VBZ	O
demonstrated	VBN	O
a	DT	O
clear	JJ	B-REL
association	NN	I-REL
between	IN	O
glyburide	NN	O
and	CC	O
a	DT	O
survival	NN	O
benefit	NN	O
...	:	O

...	:	O
survival	NN	O
was	VBD	B-REL
greater	JJR	I-REL
in	IN	I-REL
diabetics	NNS	O
than	IN	O
in	IN	O
nondiabetics	NNS	O
...	:	O

...	:	O
scientists	NNS	O
have	VBP	O
identified	VBN	O
a	DT	O
diabetes	NN	O
drug	NN	O
which	WDT	B-REL
halves	VBZ	I-REL
the	DT	I-REL
mortality	NN	I-REL
rate	NN	I-REL
of	IN	O
a	DT	O
deadly	JJ	O
infectious	JJ	O
disease	NN	O
found	VBD	O
throughout	IN	O
Southeast	NNP	O
Asia	NNP	O
and	CC	O
Northern	NNP	O
Australia	NNP	O
...	:	O

...	:	O
in	IN	O
this	DT	O
longitudinal	JJ	O
population-based	JJ	O
cohort	NN	O
study	NN	O
,	,	O
children	NNS	O
who	WP	O
were	VBD	O
rated	VBN	O
by	IN	O
teachers	NNS	O
as	IN	O
being	VBG	O
`	``	O
positive	JJ	O
'	''	O
at	IN	O
ages	NNS	O
13	CD	O
or	CC	O
15	CD	O
years	NNS	O
,	,	O
were	VBD	O
significantly	RB	B-REL
more	RBR	I-REL
likely	JJ	I-REL
than	IN	O
those	DT	O
who	WP	O
received	VBD	O
no	DT	O
positive	JJ	O
ratings	NNS	O
to	TO	O
report	VB	O
satisfaction	NN	O
with	IN	O
their	PRP$	O
work	NN	O
in	IN	O
midlife	NN	O
,	,	O
have	VBP	O
regular	JJ	O
contact	NN	O
with	IN	O
friends	NNS	O
and	CC	O
family	NN	O
,	,	O
and	CC	O
engage	VB	O
in	IN	O
regular	JJ	O
social	JJ	O
activities	NNS	O
...	:	O

...	:	O
prospectively	RB	O
rated	VBN	O
childhood	NN	O
wellbeing	NN	O
has	VBZ	B-REL
long-term	JJ	I-REL
beneficial	JJ	I-REL
links	NNS	I-REL
to	TO	I-REL
adult	JJ	O
functioning	VBG	O
...	:	O

...	:	O
happy	JJ	O
children	NNS	O
make	VBP	B-REL
happy	JJ	O
adults	NNS	O
...	:	O

...	:	O
diabetes	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
substantial	JJ	O
premature	JJ	O
death	NN	O
from	IN	O
several	JJ	O
cancers	NNS	O
,	,	O
infectious	JJ	O
diseases	NNS	O
,	,	O
external	JJ	O
causes	NNS	O
,	,	O
intentional	JJ	O
self-harm	NN	O
,	,	O
and	CC	O
degenerative	JJ	O
disorders	NNS	O
,	,	O
independent	JJ	O
of	IN	O
major	JJ	O
risk	NN	O
factors	NNS	O
...	:	O

...	:	O
diabetes	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
substantial	JJ	O
premature	JJ	O
death	NN	O
from	IN	O
several	JJ	O
cancers	NNS	O
,	,	O
infectious	JJ	O
diseases	NNS	O
,	,	O
external	JJ	O
causes	NNS	O
,	,	O
intentional	JJ	O
self-harm	NN	O
,	,	O
and	CC	O
degenerative	JJ	O
disorders	NNS	O
,	,	O
independent	JJ	O
of	IN	O
several	JJ	O
major	JJ	O
risk	NN	O
factors	NNS	O
...	:	O

...	:	O
middle	JJ	O
aged	JJ	O
diabetics	NNS	O
can	MD	B-REL
die	VB	I-REL
six	CD	O
years	NNS	O
earlier	RBR	O
...	:	O

...	:	O
diabetes	NN	O
in	IN	O
middle	JJ	O
age	NN	O
will	MD	B-REL
cut	VB	I-REL
your	PRP$	I-REL
life	NN	I-REL
short	JJ	I-REL
by	IN	O
an	DT	O
average	NN	O
of	IN	O
six	CD	O
years	NNS	O
,	,	O
say	VBP	O
researchers	NNS	O
...	:	O

...	:	O
a	DT	O
50-year-old	JJ	O
with	IN	O
diabetes	NN	O
dies	VBZ	B-REL
six	CD	I-REL
years	NNS	I-REL
sooner	RBR	I-REL
than	IN	I-REL
someone	NN	O
without	IN	O
the	DT	O
disease	NN	O
,	,	O
and	CC	O
not	RB	O
just	RB	O
from	IN	O
a	DT	O
heart	NN	O
attack	NN	O
or	CC	O
a	DT	O
stroke	NN	O
...	:	O

...	:	O
having	VBG	O
diabetes	NN	O
also	RB	O
ups	NNS	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
dying	VBG	O
from	IN	O
many	JJ	O
cancers	NNS	O
and	CC	O
other	JJ	O
diseases	NNS	O
...	:	O

...	:	O
our	PRP$	O
study	NN	O
demonstrates	VBZ	O
that	IN	O
Hnf4a	NN	O
expression	NN	O
in	IN	O
islets	NNS	O
is	VBZ	O
under	IN	O
tight	JJ	O
epigenetic	JJ	O
control	NN	O
that	WDT	O
is	VBZ	O
dynamically	RB	B-REL
modulated	VBN	I-REL
by	IN	O
maternal	JJ	O
diet	NN	O
during	IN	O
early	JJ	O
development	NN	O
and	CC	O
by	IN	O
aging	VBG	O
...	:	O

...	:	O
exposure	NN	O
to	TO	B-REL
suboptimal	JJ	O
nutrition	NN	O
during	IN	O
early	JJ	O
development	NN	O
leads	VBZ	B-REL
to	TO	O
epigenetic	JJ	O
silencing	NN	O
at	IN	O
the	DT	O
enhancer	NN	O
region	NN	O
,	,	O
which	WDT	O
weakens	VBZ	O
the	DT	O
P2	NN	O
promoter-enhancer	JJ	O
interaction	NN	O
and	CC	O
results	VBZ	O
in	IN	O
a	DT	O
permanent	JJ	O
reduction	NN	O
in	IN	O
Hnf4a	NN	O
expression	NN	O
...	:	O

...	:	O
research	NN	O
provides	VBZ	O
new	JJ	O
insight	NN	O
into	IN	O
why	WRB	O
poor	JJ	O
diet	NN	O
during	IN	O
pregnancy	NN	O
negatively	RB	B-REL
affects	VBZ	I-REL
offspring	NN	O
's	POS	O
long	JJ	O
term	NN	O
health	NN	O
...	:	O

...	:	O
poor	JJ	O
diet	NN	O
during	IN	O
pregnancy	NN	O
can	MD	B-REL
give	VB	I-REL
your	PRP$	O
future	JJ	O
grandchildren	NNS	O
diabetes	NN	O
...	:	O

...	:	O
an	DT	O
unbalanced	JJ	O
diet	NN	O
in	IN	O
pregnancy	NN	O
can	MD	B-REL
increase	VB	I-REL
children	NNS	O
's	POS	O
odds	NNS	O
of	IN	O
getting	VBG	O
ageing-related	JJ	O
illnesses	NNS	O
like	IN	O
type	NN	O
2	CD	O
diabetes	NN	O
in	IN	O
later	JJ	O
life	NN	O
...	:	O

...	:	O
scientists	NNS	O
say	VBP	O
they	PRP	O
have	VBP	O
found	VBN	O
a	DT	O
mechanism	NN	O
which	WDT	O
may	MD	O
explain	VB	O
why	WRB	O
a	DT	O
poor	JJ	O
diet	NN	O
during	IN	O
pregnancy	NN	O
can	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
offspring	NN	O
developing	VBG	O
diabetes	NNS	O
...	:	O

...	:	O
closed	VBD	O
loop	NN	O
delivery	NN	O
of	IN	B-REL
insulin	NN	O
can	MD	B-REL
significantly	RB	I-REL
improve	VB	I-REL
the	DT	I-REL
control	NN	I-REL
of	IN	O
glucose	NN	O
levels	NNS	O
overnight	JJ	O
and	CC	O
reduce	VB	O
the	DT	O
risk	NN	O
of	IN	O
nocturnal	JJ	O
hypoglycaemia	NN	O
in	IN	O
adults	NNS	O
with	IN	O
type	NN	O
1	CD	O
diabetes	NN	O
...	:	O

...	:	O
closed	VBD	O
loop	NN	O
delivery	NN	O
of	IN	O
insulin	NN	O
may	MD	B-REL
improve	VB	I-REL
overnight	JJ	O
control	NN	O
of	IN	O
glucose	NN	O
levels	NNS	O
...	:	O

...	:	O
research	NN	O
funded	VBN	O
by	IN	O
the	DT	O
health	NN	O
charity	NN	O
Diabetes	NNP	O
UK	NNP	O
has	VBZ	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
successfully	RB	O
demonstrated	VBD	O
the	DT	O
potential	NN	B-REL
of	IN	I-REL
an	DT	I-REL
`	``	O
artificial	JJ	O
pancreas	NN	O
'	''	O
in	IN	B-REL
preventing	VBG	I-REL
night-time	JJ	O
hypoglycaemia	NN	O
in	IN	O
adults	NNS	O
with	IN	O
Type	NN	O
1	CD	O
diabetes	NN	O
...	:	O

...	:	O
Trials	NNS	O
of	IN	O
an	DT	O
artificial	JJ	O
pancreas	NN	O
that	WDT	O
can	MD	B-REL
monitor	VB	I-REL
the	DT	O
blood	NN	O
sugar	NN	O
levels	NNS	O
of	IN	O
people	NNS	O
with	IN	O
diabetes	NN	O
and	CC	O
then	RB	O
deliver	VB	O
insulin	NN	O
more	RBR	O
accurately	RB	O
should	MD	O
move	VB	O
out	IN	O
of	IN	O
hospital	NN	O
into	IN	O
the	DT	O
home	NN	O
...	:	O

...	:	O
MCI	NNP	O
patients	NNS	O
performing	VBG	O
the	DT	O
task	NN	O
exhibited	VBD	B-REL
both	CC	O
hyper-activation	NN	O
and	CC	O
hypo-activation	NN	O
of	IN	O
the	DT	O
hippocampus	NN	O
as	IN	O
a	DT	O
function	NN	O
of	IN	O
memory	NN	O
load	NN	O
during	IN	O
encoding	VBG	O
...	:	O

...	:	O
MCI	NNP	O
patients	NNS	O
activating	VBG	O
significantly	RB	B-REL
more	JJR	I-REL
than	IN	I-REL
controls	NNS	O
at	IN	O
low	JJ	O
loads	NNS	O
and	CC	O
significantly	RB	O
less	RBR	O
at	IN	O
higher	JJR	O
loads	NNS	O
...	:	O

...	:	O
these	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
patients	NNS	O
'	POS	O
performance	NN	O
depended	VBD	B-REL
more	RBR	I-REL
strongly	RB	I-REL
on	IN	I-REL
habitual	JJ	O
control	NN	O
at	IN	O
the	DT	O
expense	NN	O
of	IN	O
goal-directed	JJ	O
control	NN	O
...	:	O

...	:	O
compulsions	NNS	O
lead	VBP	B-REL
to	TO	I-REL
obsessions	NNS	I-REL
,	,	O
and	CC	O
not	RB	O
the	DT	O
other	JJ	O
way	NN	O
around	IN	O
...	:	O

...	:	O
As	IN	O
predicted	VBN	O
,	,	O
this	DT	O
estimate	NN	O
of	IN	O
the	DT	O
prevalence	NN	O
of	IN	O
school-aged	JJ	O
children	NNS	O
with	IN	O
a	DT	O
formal	JJ	O
ASC	NN	O
diagnosis	NN	O
was	VBD	O
significantly	RB	B-REL
higher	JJR	I-REL
in	IN	O
the	DT	O
Eindhoven	NNP	O
region	NN	O
...	:	O

...	:	O
The	DT	O
prevalence	NN	O
estimates	NNS	O
of	IN	O
ASC	NNP	O
in	IN	O
Eindhoven	NNP	O
was	VBD	O
229	CD	O
per	IN	O
10,000	CD	O
,	,	O
significantly	RB	B-REL
higher	JJR	I-REL
than	IN	O
in	IN	O
Haarlem	NNP	O
...	:	O

...	:	O
diagnosed	VBD	O
autism	NN	O
is	VBZ	O
more	RBR	B-REL
common	JJ	I-REL
in	IN	O
an	DT	O
IT-rich	JJ	O
region	NN	O
...	:	O

...	:	O
we	PRP	O
identified	VBD	O
extensive	JJ	O
significantly	RB	B-REL
decreased	VBD	I-REL
grey	JJ	O
matter	NN	O
volume	NN	O
in	IN	O
orbitofrontal	NN	O
and	CC	O
other	JJ	O
cortical	JJ	O
regions	NNS	O
,	,	O
and	CC	O
a	DT	O
significant	JJ	O
increase	NN	O
in	IN	O
grey	JJ	O
matter	NN	O
volume	NN	O
of	IN	O
the	DT	O
basal	JJ	O
ganglia	NN	O
,	,	O
in	IN	O
cocaine-dependent	JJ	O
individuals	NNS	O
...	:	O

...	:	O
greater	JJR	O
impairment	NN	O
of	IN	O
attentional	JJ	O
control	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
reduced	VBN	O
volume	NN	O
in	IN	O
insular	JJ	O
cortex	NN	O
and	CC	O
increased	VBD	O
volume	NN	O
of	IN	O
caudate	NN	O
nucleus	NN	O
...	:	O

...	:	O
abnormal	JJ	O
brain	NN	O
structure	NN	O
linked	VBN	B-REL
to	TO	I-REL
chronic	JJ	O
cocaine	NN	O
abuse	NN	O
...	:	O

...	:	O
Brain	NN	O
abnormalities	NNS	O
mean	VBP	O
some	DT	O
people	NNS	O
are	VBP	B-REL
predisposed	VBN	I-REL
to	TO	I-REL
being	VBG	I-REL
cocaine	NN	O
addicts	NNS	O
,	,	O
claim	NN	O
researchers	NNS	O
at	IN	O
Cambridge	NNP	O
University	NNP	O
...	:	O

...	:	O
this	DT	O
large	JJ	O
population-based	JJ	O
study	NN	O
showed	VBD	O
that	IN	O
the	DT	B-REL
use	NN	O
of	IN	B-REL
medications	NNS	O
with	IN	O
anticholinergic	JJ	O
activity	NN	O
increased	VBD	B-REL
the	DT	O
risk	NN	B-REL
of	IN	O
cognitive	JJ	O
decline	NN	O
...	:	O

...	:	O
the	DT	B-REL
use	NN	O
of	IN	O
medications	NNS	O
with	IN	O
anticholinergic	JJ	O
activity	NN	O
increases	VBZ	B-REL
the	DT	O
cumulative	JJ	B-REL
risk	NN	I-REL
of	IN	O
cognitive	JJ	O
impairment	NN	O
and	CC	O
mortality	NN	O
...	:	O

...	:	O
drug	NN	O
side	NN	O
effect	NN	O
linked	VBN	O
with	IN	B-REL
increased	VBN	I-REL
health	NN	O
risks	NNS	O
for	IN	O
over	IN	O
65s	NNS	O
...	:	O

...	:	O
they	PRP	O
blocked	VBD	O
a	DT	O
chemical	NN	O
in	IN	O
the	DT	O
nervous	JJ	O
system	NN	O
called	VBN	O
acetylcholine	NN	O
-	:	O
was	VBD	B-REL
linked	VBN	I-REL
with	IN	I-REL
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
both	CC	O
mental	JJ	O
impairment	NN	O
and	CC	O
death	NN	O
...	:	O

...	:	O
common	JJ	O
drug	NN	O
effect	NN	O
ups	NNS	B-REL
elderly	JJ	I-REL
death	NN	I-REL
risk	NN	I-REL
:	:	O
study	NN	O
...	:	O

a	DT	O
relationship	NN	B-REL
between	IN	O
impulsive	JJ	O
choice	NN	O
on	IN	O
the	DT	O
delay	NN	O
discounting	VBG	O
task	NN	O
and	CC	O
the	DT	O
level	NN	O
of	IN	O
gambling-related	JJ	O
cognitive	JJ	O
distortions	NNS	O

Impulsive	JJ	O
choice	NN	O
in	IN	O
the	DT	O
gamblers	NNS	O
was	VBD	O
correlated	VBN	B-REL
with	IN	O
the	DT	O
level	NN	O
of	IN	O
gambling	VBG	O
distortions	NNS	O

research	NN	O
finds	VBZ	O
a	DT	B-REL
connection	NN	I-REL
between	IN	O
inpulsivity	NN	O
and	CC	O
superstitions	NNS	O
.	.	O

...	:	O
we	PRP	O
have	VBP	O
shown	VBN	O
that	IN	O
activation	NN	O
in	IN	O
a	DT	O
range	NN	O
of	IN	O
brain	NN	O
areas	NNS	O
,	,	O
including	VBG	O
the	DT	O
FFA	NNP	O
,	,	O
is	VBZ	B-REL
significantly	RB	O
reduced	VBN	O
in	IN	O
autism	NN	O
compared	VBN	O
with	IN	O
controls	NNS	O
in	IN	O
response	NN	O
to	TO	O
emotional	JJ	O
versus	CC	O
neutral	JJ	O
faces	NNS	O
...	:	O

...	:	O
the	DT	O
response	NN	O
in	IN	O
unaffected	JJ	O
siblings	NNS	O
did	VBD	B-REL
not	RB	I-REL
differ	VB	I-REL
significantly	RB	I-REL
from	IN	O
the	DT	O
response	NN	O
in	IN	O
autism	NN	O
...	:	O

...	:	O
siblings	NNS	O
of	IN	O
people	NNS	O
with	IN	O
autism	NN	O
show	VBP	O
a	DT	O
similar	JJ	B-REL
pattern	NN	I-REL
of	IN	O
brain	NN	O
activity	NN	O
...	:	O

...	:	O
brothers	NNS	O
and	CC	O
sisters	NNS	O
of	IN	O
autistic	JJ	O
people	NNS	O
have	VBP	B-REL
a	DT	I-REL
marker	NN	I-REL
in	IN	O
their	PRP$	O
brain	NN	O
...	:	O

...	:	O
their	PRP$	O
brothers	NNS	O
and	CC	O
sisters	NNS	O
also	RB	B-REL
have	VBP	I-REL
a	DT	I-REL
lower	JJR	I-REL
brain	NN	O
reaction	NN	O
...	:	O

...	:	O
siblings	NNS	O
of	IN	O
those	DT	O
with	IN	O
autism	NN	O
show	NN	B-REL
similar	JJ	I-REL
brain	NN	O
patterns	NNS	O
...	:	O

...	:	O
siblings	NNS	O
of	IN	O
those	DT	O
with	IN	O
autism	NN	O
show	NN	B-REL
similar	JJ	I-REL
brain	NN	O
patterns	NNS	O
...	:	O

...	:	O
homotypic	JJ	O
fusion	NN	O
of	IN	O
Atg16-positive	JJ	O
,	,	O
LC3-negative	JJ	O
autophagosome	JJ	O
precursors	NNS	O
is	VBZ	B-REL
a	DT	I-REL
critical	JJ	I-REL
regulatory	JJ	I-REL
step	NN	I-REL
in	IN	O
autophagosome	JJ	O
biogenesis	NN	O
...	:	O

maturation	NN	O
of	IN	O
the	DT	O
early	JJ	O
Atg16L1	NN	O
precursors	NNS	O
requires	VBZ	O
homotypic	JJ	O
fusion	NN	O
,	,	O
which	WDT	O
is	VBZ	B-REL
essential	JJ	I-REL
for	IN	I-REL
subsequent	JJ	O
autophagosome	NN	O
formation	NN	O

...	:	O
The	DT	O
ensuing	VBG	O
movements	NNS	O
have	VBP	B-REL
a	DT	I-REL
pattern	NN	I-REL
and	CC	I-REL
timing	NN	I-REL
that	WDT	O
provides	VBZ	O
a	DT	O
powerful	JJ	O
method	NN	O
of	IN	O
assessing	VBG	O
an	DT	O
egg	NN	O
's	POS	O
ability	NN	O
to	TO	O
achieve	VB	O
its	PRP$	O
full	JJ	O
developmental	JJ	O
potential	NN	O
...	:	O

...	:	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
movements	NNS	O
and	CC	O
the	DT	O
events	NNS	O
of	IN	O
egg	NN	O
activation	NN	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	B-REL
use	VB	O
the	DT	O
movements	NNS	O
alone	RB	O
to	TO	O
predict	VB	B-REL
developmental	JJ	O
potential	NN	O
of	IN	O
the	DT	O
zygote	NN	O
...	:	O

...	:	O
a	DT	O
series	NN	O
of	IN	O
movements	NNS	O
in	IN	O
the	DT	O
egg	NN	O
in	IN	O
the	DT	O
first	JJ	O
hours	NNS	O
after	IN	O
fertilisation	NN	O
can	MD	O
be	VB	O
used	VBN	B-REL
to	TO	I-REL
predict	VB	I-REL
which	WDT	O
embryos	NNS	O
have	VBP	O
the	DT	O
best	JJS	O
chance	NN	O
of	IN	O
survival	NN	O
...	:	O

...	:	O
the	DT	O
success	NN	O
of	IN	O
IVF	NN	O
pregnancies	NNS	O
could	MD	B-REL
be	VB	I-REL
significantly	RB	I-REL
improved	VBN	I-REL
by	IN	O
a	DT	O
technique	NN	O
...	:	O
that	WDT	O
looks	VBZ	O
for	IN	O
tell-tale	NN	O
movenments	NNS	O
...	:	O

...	:	O
robust	JJ	O
organism	NN	O
to	TO	O
implant	VB	O
into	IN	O
a	DT	B-REL
woman	NN	O
will	MD	O
ensure	VB	O
a	DT	O
better	JJR	B-REL
chance	NN	I-REL
of	IN	O
a	DT	O
successful	JJ	O
live	JJ	O
birth	NN	O
...	:	O

...	:	O
thiostrepton	NN	O
directly	RB	B-REL
binds	VBZ	I-REL
to	TO	O
the	DT	O
FOXM1	NN	O
protein	NN	O
,	,	O
which	WDT	O
in	IN	O
turn	NN	O
prevents	VBZ	O
the	DT	O
interaction	NN	O
of	IN	O
the	DT	O
transcription	NN	O
factor	NN	O
with	IN	O
several	JJ	O
gene	NN	O
promoters	NNS	O
...	:	O

...	:	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
thiostrepton	NN	O
can	MD	B-REL
inhibit	VB	I-REL
the	DT	O
binding	NN	O
of	IN	O
FOXM1	NN	O
to	TO	O
genomic	JJ	O
target	NN	O
sites	NNS	O
...	:	O

...	:	O
a	DT	B-REL
molecule	NN	O
that	WDT	O
was	VBD	O
first	JJ	O
discovered	VBN	O
in	IN	O
bacteria	NNS	O
blocks	VBZ	B-REL
a	DT	O
protein	NN	O
which	WDT	O
causes	VBZ	O
breast	NN	O
cancer	NN	O
...	:	O

...	:	O
a	DT	O
molecule	NN	O
which	WDT	O
blocks	VBZ	B-REL
the	DT	I-REL
development	NN	I-REL
and	CC	O
spread	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
has	VBZ	O
been	VBN	O
discovered	VBN	O
...	:	O

...	:	O
Thiostrepton	NNP	O
,	,	O
which	WDT	O
occurs	VBZ	O
naturally	RB	O
,	,	O
blocks	VBZ	B-REL
a	DT	I-REL
key	JJ	O
protein	NN	O
...	:	O

...	:	O
thiostrepton	NN	O
,	,	O
clamps	VBZ	B-REL
FOXM1	NN	O
,	,	O
...	:	O

higher	JJR	O
levels	NNS	O
of	IN	O
chocolate	NN	O
consumption	NN	O
might	MD	B-REL
be	VB	I-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
one	CD	O
third	JJ	O
reduction	NN	O
in	IN	O
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
cardiovascular	JJ	O
disease	NN	O

levels	NNS	O
of	IN	O
chocolate	NN	O
consumption	NN	O
seem	VBP	B-REL
to	TO	I-REL
be	VB	I-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
substantial	JJ	O
reduction	NN	O
in	IN	O
the	DT	O
risk	NN	O
of	IN	O
cardiometabolic	JJ	O
disorders	NNS	O

Eating	NNP	O
chocolate	NN	O
cuts	NNS	B-REL
risk	NN	O
of	IN	O
heart	NN	O
disease	NN	O

TWO	CD	O
PIECES	NNS	O
OF	IN	O
CHOCOLATE	NNP	O
A	NNP	O
WEEK	NNP	O
`	``	O
CUT	NNP	B-REL
HEART	NN	O
DISEASE	NN	O
RISK	NN	O

CHOCS	NNP	O
REDUCE	VB	B-REL
HEART	NN	O
ATTACK	NN	O
RISK	NN	O
BY	IN	O
1/3	CD	O

Daily	NNP	O
dose	NN	O
of	IN	O
chocolate	NN	O
`	``	O
cuts	NNS	B-REL
heart	NN	O
disease	NN	O
risk	NN	O
by	IN	O
a	DT	O
third	JJ	O
'	''	O

Chocolate	NN	O
seems	VBZ	B-REL
to	TO	I-REL
cut	VB	I-REL
the	DT	O
risk	NN	O
of	IN	O
heart	NN	O
disease	NN	O
and	CC	O
stroke	NN	O

Chocolate	NN	O
may	MD	B-REL
be	VB	I-REL
good	JJ	I-REL
for	IN	O
the	DT	O
heart	NN	O

Chocolate	NNP	O
`	``	O
cuts	NNS	B-REL
heart	NN	O
risk	NN	O
by	IN	O
a	DT	O
third	JJ	O
'	''	O

Chocolate-lovers	NNS	O
could	MD	B-REL
be	VB	I-REL
cutting	VBG	I-REL
their	PRP$	O
risk	NN	O
of	IN	O
diabetes	NN	O
,	,	O
stroke	NN	O
and	CC	O
heart	NN	O
disease	NN	O

Chocolate	VB	O
every	DT	O
day	NN	O
can	MD	B-REL
reduce	VB	I-REL
risk	NN	O
of	IN	O
heart	NN	O
disease	NN	O

Eating	NNP	O
high	JJ	O
levels	NNS	O
of	IN	O
chocolate	NN	O
could	MD	B-REL
reduce	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
coronary	JJ	O
heart	NN	O
disease	NN	O
and	CC	O
stroke	NN	O

chocolate	NN	O
consumption	NN	O
might	MD	B-REL
be	VB	I-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
one	CD	O
third	JJ	O
reduction	NN	O
in	IN	O
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
heart	NN	O
disease	NN	O

chocolate-lovers	NNS	O
may	MD	B-REL
be	VB	I-REL
cutting	VBG	I-REL
their	PRP$	O
risk	NN	O
of	IN	O
heart	NN	O
disease	NN	O
,	,	O
diabetes	NN	O
and	CC	O
stroke	NN	O

It	PRP	O
also	RB	O
provides	VBZ	O
indirect	JJ	O
evidence	NN	O
that	IN	O
many	JJ	O
more	JJR	O
common	JJ	O
variants	NNS	O
of	IN	O
small	JJ	O
effect	NN	O
contribute	VBP	O
to	TO	B-REL
genetic	JJ	I-REL
susceptibility	NN	O
for	IN	O
multiple	JJ	O
sclerosis	NN	O

...	:	O
we	PRP	O
have	VBP	O
replicated	VBN	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
previously	RB	O
suggested	VBN	O
associations	NNS	B-REL
and	CC	I-REL
identified	VBN	I-REL
at	IN	O
least	JJS	O
a	DT	O
further	JJ	O
29	CD	O
novel	JJ	O
susceptibility	NN	O
loci	NNS	O
...	:	O

...	:	O
scientists	NNS	O
have	VBP	O
identified	VBN	O
29	CD	O
new	JJ	O
genetic	JJ	O
variants	NNS	O
linked	VBN	B-REL
to	TO	I-REL
multiple	JJ	O
sclerosis	NN	O
...	:	O

...	:	O
genetic	JJ	O
variants	NNS	O
that	WDT	B-REL
raise	VBP	I-REL
a	DT	I-REL
person	NN	I-REL
's	POS	I-REL
risk	NN	I-REL
of	IN	O
multiple	JJ	O
sclerosis	NN	O
...	:	O

...	:	O
Scientists	NNS	O
have	VBP	O
discovered	VBN	O
29	CD	O
new	JJ	O
gene	NN	O
variants	NNS	O
that	WDT	O
are	VBP	O
implicated	VBN	B-REL
in	IN	I-REL
multiple	JJ	O
sclerosis	NN	O
...	:	O

...	:	O
identified	VBN	O
29	CD	O
new	JJ	O
genetic	JJ	O
factors	NNS	O
that	WDT	O
are	VBP	O
implicated	VBN	B-REL
in	IN	I-REL
the	DT	I-REL
development	NN	O
of	IN	O
the	DT	O
disease	NN	O
...	:	O

...	:	O
a	DT	O
GENETIC	NNP	O
``	``	O
map	NN	O
''	''	O
setting	VBG	O
out	RP	O
all	PDT	O
the	DT	O
genes	NNS	O
involved	VBN	B-REL
in	IN	I-REL
multiple	JJ	O
...	:	O

...	:	O
around	IN	O
30	CD	O
genetic	JJ	O
risk	NN	B-REL
factors	NNS	I-REL
fro	NN	I-REL
developing	VBG	I-REL
multiple	JJ	O
sclerosis	NN	O
ha	NN	O
been	VBN	O
discovered	VBN	O
...	:	O

...	:	O
scientists	NNS	O
have	VBP	O
found	VBN	O
29	CD	O
new	JJ	O
genetic	JJ	O
variants	NNS	O
linked	VBN	B-REL
to	TO	I-REL
multiple	JJ	O
sclerosis	NN	O
...	:	O

...	:	O
The	DT	O
effects	NNS	O
of	IN	O
HCN2	NN	O
deletion	NN	O
on	IN	O
action	NN	O
potential	JJ	O
firing	NN	O
in	IN	B-REL
small	JJ	O
sensory	JJ	O
neurons	NNS	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
are	VBP	O
nociceptors	NNS	O
,	,	O
suggest	VBP	O
that	IN	O
HCN2	NN	O
may	MD	B-REL
be	VB	I-REL
important	JJ	I-REL
in	IN	O
inflammatory	JJ	B-REL
pain	NN	I-REL
,	,	O
where	WRB	O
the	DT	O
firing	NN	O
of	IN	O
action	NN	O
potentials	NNS	O
in	IN	O
response	NN	O
to	TO	O
a	DT	O
noxious	JJ	O
stimulus	NN	O
is	VBZ	O
enhanced	VBN	O
by	IN	O
inflammatory	JJ	O
mediators	NNS	O
such	JJ	O
as	IN	O
prostaglandin	NN	O
E2	NN	O
...	:	O

...	:	O
Mice	NNS	O
in	IN	O
which	WDT	O
HCN2	NN	O
was	VBD	O
specifically	RB	O
deleted	VBN	O
in	IN	O
nociceptors	NNS	O
expressing	VBG	O
NaV1	NN	O
.8	CD	O
had	VBD	B-REL
normal	JJ	I-REL
pain	NN	I-REL
thresholds	NNS	I-REL
,	,	O
but	CC	O
inflammation	NN	O
did	VBD	O
not	RB	O
cause	VB	O
hyperalgesia	NN	O
to	TO	O
heat	NN	O
stimuli	NNS	O
...	:	O

...	:	O
a	DT	O
gene	NN	O
responsible	JJ	B-REL
for	IN	I-REL
regulating	VBG	I-REL
chronic	JJ	O
pain	NN	O
...	:	O

...	:	O
identified	VBD	O
the	DT	O
gene	NN	O
behind	IN	B-REL
back	JJ	O
pain	NN	O
...	:	O

...	:	O
they	PRP	O
have	VBP	O
discovered	VBN	O
a	DT	O
gene	NN	O
,	,	O
HCN2	NN	O
,	,	O
that	WDT	B-REL
controls	VBZ	I-REL
chronic	JJ	O
pain	NN	O
...	:	O

...	:	O
scientists	NNS	O
have	VBP	O
discovered	VBN	O
the	DT	B-REL
role	NN	I-REL
of	IN	I-REL
a	DT	O
rogue	NN	O
gene	NN	O
behind	IN	O
the	DT	O
condition	NN	O
...	:	O

...	:	O
a	DT	O
gene	NN	O
responsible	JJ	B-REL
for	IN	I-REL
chronic	JJ	O
pain	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
...	:	O

...	:	O
a	DT	O
genes	NNS	O
responsible	JJ	O
for	IN	B-REL
regulating	VBG	I-REL
chronic	JJ	O
pain	NN	O
...	:	O

...	:	O
ATD	NN	O
significantly	RB	B-REL
altered	VBD	I-REL
the	DT	O
functional	JJ	O
connectivity	NN	O
between	IN	O
the	DT	O
amygdala	NN	O
and	CC	O
right	JJ	O
vACC	NN	O
and	CC	O
VLPFC	NN	O
when	WRB	O
processing	VBG	O
angry	JJ	O
compared	VBN	O
with	IN	O
neutral	JJ	O
faces	NNS	O
...	:	O

...	:	O
5-HT	NN	O
significantly	RB	O
influences	VBZ	O
PFC-amygdala	JJ	O
circuits	NNS	O
implicated	VBN	B-REL
in	IN	I-REL
aggression	NN	O
and	CC	O
other	JJ	O
affective	JJ	O
behaviors	NNS	O
.	.	O

...	:	O
serotonin	NN	O
levels	NNS	O
affect	VBP	B-REL
the	DT	I-REL
brain	NN	O
's	POS	O
response	NN	O
to	TO	O
anger	NN	O
...	:	O

...	:	O
levels	NNS	O
of	IN	O
the	DT	O
brain	NN	O
chemical	NN	O
serotonin	NN	O
,	,	O
often	RB	O
brought	VBN	O
on	RP	O
when	WRB	O
someone	NN	O
has	VBZ	O
n't	RB	O
eaten	VBN	O
or	CC	O
is	VBZ	O
stressed	JJ	O
,	,	O
affect	VB	B-REL
brain	NN	O
regions	NNS	O
that	WDT	O
enable	VBP	O
people	NNS	O
to	TO	O
regulate	VB	O
anger	NN	O
...	:	O

entertainment	NN	O
preferences	NNS	O
are	VBP	O
more	RBR	O
a	DT	B-REL
function	NN	I-REL
of	IN	I-REL
substance	NN	O
than	IN	O
style	NN	O

our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
perturbing	VBG	O
the	DT	O
interaction	NN	O
of	IN	B-REL
BET	NN	O
proteins	NNS	O
with	IN	O
chromatin	NN	O
using	VBG	O
I-BET151	NN	O
may	MD	B-REL
be	VB	I-REL
of	IN	O
great	JJ	B-REL
therapeutic	JJ	I-REL
value	NN	I-REL
in	IN	O
humanMLL-fusion	JJ	O
leukaemias	NNS	O

the	DT	O
displacement	NN	O
of	IN	O
BET	NN	O
proteins	NNS	O
from	IN	O
chromatin	NN	O
as	IN	B-REL
a	DT	I-REL
promising	JJ	I-REL
epigenetic	JJ	I-REL
therapy	NN	I-REL
for	IN	O
these	DT	O
aggressive	JJ	O
leukaemias	NNS	O

potential	JJ	O
new	JJ	O
drug	NN	O
could	MD	B-REL
treat	VB	I-REL
mixed-lineage	JJ	O
leukaemia	NN	O

chemical	NN	O
agent	NN	O
L-BET151	NN	O
acts	VBZ	B-REL
on	IN	O
the	DT	O
protein	NN	O
and	CC	O
DNA	NN	O
``	``	O
packaging	NN	O
''	''	O
in	IN	O
cells	NNS	O
called	VBN	O
chromatin	NN	O

the	DT	O
drug	NN	O
appears	VBZ	B-REL
to	TO	I-REL
block	VB	I-REL
a	DT	O
key	JJ	O
stage	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
mixed	JJ	O
lineage	NN	O
leukaemia	NN	O
-LRB-	-LRB-	O
MLL	NN	O
-RRB-	-RRB-	O

that	IN	O
the	DT	O
experimental	JJ	O
drug	NN	O
,	,	O
called	VBN	O
I-BET151	NN	O
,	,	O
mimics	VBZ	O
a	DT	O
chemical	NN	O
tag	NN	O
which	WDT	O
is	VBZ	B-REL
key	JJ	I-REL
to	TO	I-REL
preventing	VBG	I-REL
the	DT	O
process	NN	O
of	IN	O
activating	VBG	O
the	DT	O
leukaemia	NN	O
genes	NNS	O

the	DT	O
variability	NN	O
in	IN	B-REL
introspective	JJ	O
abilities	NNS	O
like	IN	O
reality	NN	O
monitoring	NN	O
typically	RB	O
seen	VBN	O
in	IN	O
the	DT	O
healthy	JJ	O
population	NN	O
may	MD	B-REL
have	VB	I-REL
a	DT	I-REL
specific	JJ	I-REL
structural	JJ	I-REL
basis	NN	I-REL
in	IN	O
the	DT	O
PCS	NN	O

individual	JJ	O
differences	NNS	O
in	IN	O
introspective	JJ	O
abilities	NNS	O
like	IN	O
reality	NN	O
monitoring	NN	O
may	MD	B-REL
be	VB	I-REL
associated	VBN	I-REL
with	IN	I-REL
specific	JJ	O
structural	JJ	O
variability	NN	O
in	IN	O
the	DT	O
PFC	NN	O

A	DT	O
structural	JJ	O
variation	NN	O
in	IN	O
a	DT	O
part	NN	O
of	IN	O
the	DT	O
brain	NN	O
may	MD	B-REL
explain	VB	I-REL
why	WRB	I-REL
some	DT	O
people	NNS	O
are	VBP	O
better	JJR	O
than	IN	O
others	NNS	O
at	IN	O
distinguishing	VBG	O
real	JJ	O
events	NNS	O
from	IN	O
those	DT	O
they	PRP	O
might	MD	O
have	VB	O
imagined	VBN	O
or	CC	O
been	VBN	O
told	VBN	O
about	IN	O

Blame	VB	B-REL
their	PRP$	O
paracingulate	JJ	O
sulcus	NN	O

A	DT	O
variation	NN	O
in	IN	O
a	DT	O
part	NN	O
of	IN	O
the	DT	O
brain	NN	O
may	MD	B-REL
explain	VB	I-REL
why	WRB	I-REL
some	DT	O
people	NNS	O
have	VBP	O
a	DT	O
better	JJR	O
memory	NN	O
of	IN	O
reality	NN	O
than	IN	O
others	NNS	O

The	DT	O
D2/3	NN	O
/	:	O
receptor	NN	O
agonist	NN	O
pramipexole	NN	O
reversed	VBD	B-REL
this	DT	O
perseverative	JJ	O
behaviour	NN	O
in	IN	O
the	DT	O
SDI	NNP	O
group	NN	O

The	DT	O
beneficial	JJ	O
effects	NNS	O
of	IN	O
a	DT	O
dopamine	NN	O
agonist	NN	O
drug	NN	O
challenge	NN	O
on	IN	O
both	DT	O
behavior	NN	O
and	CC	O
associated	VBN	O
brain	NN	O
activation	NN	O
in	IN	O
stimulant	NN	O
dependent	JJ	O
individuals	NNS	O
may	MD	B-REL
indicate	VB	I-REL
new	JJ	O
avenues	NNS	O
for	IN	O
pharmacologic	JJ	O
treatment	NN	O

Medicine	NN	O
which	WDT	O
increase	VBP	O
levels	NNS	O
f	LS	O
the	DT	B-REL
brain	NN	O
chemical	NN	O
dopamine	NN	O
may	MD	B-REL
hold	VB	I-REL
the	DT	O
key	NN	B-REL
to	TO	O
helping	VBG	O
those	DT	O
addicted	VBN	O
to	TO	O
cocaine	NN	O

The	DT	O
mutant	JJ	O
AKT2	NN	O
was	VBD	O
constitutively	RB	O
recruited	VBN	O
to	TO	O
the	DT	O
plasma	NN	O
membrane	NN	O
,	,	O
leading	VBG	B-REL
to	TO	O
insulin-independent	JJ	O
activation	NN	O
of	IN	O
downstream	JJ	O
signalling	NN	O

Scientists	NNS	O
identify	VBP	O
cause	NN	B-REL
of	IN	O
severe	JJ	O
hypoglycaemia	NN	O

Severe	JJ	O
hypoglycaemia	NN	O
cause	NN	B-REL
found	VBD	O

in	IN	O
an	DT	O
eff	NN	O
ort	NN	O
to	TO	O
fi	VB	O
nance	JJ	O
debts	NNS	O
,	,	O
ordinary	JJ	O
people	NNS	O
are	VBP	O
paying	VBG	O
the	DT	O
ultimate	JJ	O
price	NN	O
:	:	O
losing	VBG	B-REL
access	NN	O
to	TO	O
care	VB	O
and	CC	O
preventive	JJ	O
services	NNS	O
,	,	O
facing	VBG	O
higher	JJR	O
risks	NNS	O
of	IN	O
HIV	NN	O
and	CC	O
sexually	RB	O
transmitted	JJ	O
diseases	NNS	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
worst	JJS	O
cases	NNS	O
losing	VBG	O
their	PRP$	O
lives	NNS	O

The	DT	O
Greek	JJ	O
debt	NN	O
crisis	NN	O
threatens	VBZ	B-REL
not	RB	O
just	RB	O
its	PRP$	O
economy	NN	O
,	,	O
but	CC	O
the	DT	O
health	NN	O
of	IN	O
its	PRP$	O
people	NNS	O

Greeks	NNS	O
pay	VBP	O
for	IN	O
the	DT	O
debt	NN	O
crisis	NN	O
with	IN	O
their	PRP$	O
health	NN	O
:	:	O
Demand	NN	O
for	IN	O
services	NNS	O
rises	VBZ	B-REL
steeply	RB	O

Swingeing	VBG	O
budget	NN	O
cuts	NNS	O
and	CC	O
growing	VBG	O
unemployment	NN	O
are	VBP	B-REL
pushing	VBG	I-REL
more	JJR	O
people	NNS	O
into	IN	O
severe	JJ	O
depression	NN	O
and	CC	O
drug-dependence	NN	O

...	:	O
unique	JJ	O
mechanism	NN	O
of	IN	O
antimicrobial	JJ	O
resistance	NN	O
involving	VBG	B-REL
the	DT	I-REL
entire	JJ	I-REL
deletion	NN	O
of	IN	O
a	DT	O
PBP	NN	O
3	CD	O
gene	NN	O
in	IN	O
B.	NNP	O
pseudomallei	NNS	O
...	:	O

...	:	O
B.	NNP	O
pseudomallei	NNP	O
demonstrated	VBD	O
that	IN	O
ceftazidime	NN	O
resistance	NN	O
was	VBD	B-REL
due	JJ	I-REL
to	TO	I-REL
deletion	NN	I-REL
of	IN	I-REL
a	DT	O
gene	NN	O
encoding	VBG	O
a	DT	O
penicillin-binding	JJ	O
protein	NN	O
3	CD	O
...	:	O

...	:	O
scientists	NNS	O
find	VBP	O
mechanism	NN	O
that	WDT	O
leads	VBZ	B-REL
to	TO	I-REL
drug	NN	I-REL
resistance	NN	O
in	IN	O
bacteria	NNS	O
causing	VBG	O
melioidosis	NN	O
...	:	O

iPSCs	NNS	O
derived	VBN	O
from	IN	O
different	JJ	O
patients	NNS	O
were	VBD	O
effectively	RB	B-REL
corrected	VBN	I-REL
...	:	O

Genetic	JJ	O
correction	NN	B-REL
of	IN	O
human	JJ	O
iPSCs	NNS	O
restored	VBD	O
the	DT	O
structure	NN	O
and	CC	O
function	NN	O
of	IN	O
A1AT	NN	O
in	IN	O
subsequently	RB	O
derived	VBN	O
liver	NN	O
cells	NNS	O
in	FW	O
vitro	FW	O
and	CC	O
in	FW	O
vivo	FW	O

...	:	O
New	NNP	O
gene	NN	O
therapy	NN	O
methods	NNS	O
accurately	RB	B-REL
correct	JJ	I-REL
mutation	NN	O
in	IN	O
patient	NN	O
's	POS	O
stem	NN	O
cells	NNS	O
...	:	O

...	:	O
a	DT	O
genetic	JJ	O
fault	NN	O
responsible	JJ	O
for	IN	O
a	DT	O
fatal	JJ	O
liver	NN	O
condition	NN	O
has	VBZ	O
been	VBN	O
completely	RB	B-REL
corrected	VBN	I-REL
by	IN	O
Cambridge	NNP	O
scientists	NNS	O
in	IN	O
a	DT	O
stem	NN	O
cell	NN	O
experiment	NN	O
which	WDT	O
could	MD	O
bring	VB	O
patient-specific	JJ	O
treatments	NNS	O
closer	RBR	O
to	TO	O
reality	NN	O
...	:	O

Article	NNP	O
use	NN	O
correlated	VBD	B-REL
with	IN	I-REL
noun	NN	O
animacy	NN	O

It	PRP	O
is	VBZ	O
concluded	VBN	O
that	IN	O
grammatical	JJ	O
form-meaning	NN	O
connections	NNS	O
may	MD	B-REL
be	VB	I-REL
learned	VBN	I-REL
implicitly	RB	I-REL

Unconscious	JJ	O
learning	NN	O
could	MD	B-REL
be	VB	I-REL
the	DT	I-REL
secret	NN	I-REL
to	TO	I-REL
speeding	VBG	O
up	IN	O
learning	VBG	O

the	DT	O
activity	NN	O
in	IN	O
the	DT	O
orx/hcrt	NN	O
system	NN	O
is	VBZ	B-REL
regulated	VBN	I-REL
by	IN	I-REL
macronutrient	JJ	O
balance	NN	O

Physiological	JJ	O
mixtures	NNS	O
of	IN	O
AAs	NNS	O
electrically	RB	O
excited	VBN	B-REL
orx/hcrt	NN	O
cells	NNS	O

protein	NN	O
and	CC	O
not	RB	O
sugar	NN	O
activates	VBZ	B-REL
the	DT	O
cells	NNS	O
responsible	JJ	O
for	IN	O
keeping	VBG	O
us	PRP	O
awake	RB	O
and	CC	O
burning	VBG	O
calories	NNS	O

egg	NN	O
proteins	NNS	O
,	,	O
specifically	RB	O
those	DT	O
found	VBN	O
in	IN	O
the	DT	O
white	JJ	O
,	,	O
help	VB	B-REL
us	PRP	O
stay	VB	O
awake	RB	O
and	CC	O
feel	VB	O
alert	JJ	O

protein	NN	O
and	CC	O
not	RB	O
sugar	NN	O
that	WDT	O
activates	VBZ	B-REL
the	DT	O
cells	NNS	O
responsible	JJ	O
for	IN	O
keeping	VBG	O
us	PRP	O
awake	RB	O
and	CC	O
burning	VBG	O
calories	NNS	O

EGG	NN	O
`	``	O
KEEPS	VBZ	B-REL
YOU	PRP	O
ALERT	NN	O
'	''	O
;	:	O

...	:	O
uncovered	JJ	O
distinct	JJ	B-REL
differences	NNS	I-REL
in	IN	I-REL
important	JJ	O
elements	NNS	O
of	IN	O
the	DT	O
cardiac	JJ	O
genome	NN	O
...	:	O

...	:	O
distinct	JJ	B-REL
epigenomic	JJ	I-REL
patterns	NNS	I-REL
exist	VBP	I-REL
in	IN	I-REL
important	JJ	O
DNA	NN	O
elements	NNS	O
of	IN	O
the	DT	O
cardiac	JJ	O
genome	NN	O
in	IN	O
human	JJ	O
end-stage	JJ	O
cardiomyopathy	NN	O
...	:	O

C-metomidate	JJ	O
PET-CT	NN	O
be	VB	O
considered	VBN	O
an	DT	O
accurate	JJ	B-REL
,	,	I-REL
noninvasive	JJ	O
alternative	NN	O
to	TO	O
AVS	NNP	O
in	IN	O
the	DT	O
management	NN	O
of	IN	O
patients	NNS	O
with	IN	O
PHA	NN	O
and	CC	O
adrenal	JJ	O
adenoma	NN	O

C-metomidate	JJ	O
PET-CT	NN	O
is	VBZ	O
a	DT	O
sensitive	JJ	B-REL
and	CC	I-REL
specific	JJ	I-REL
noninvasive	JJ	O
alternative	NN	O
to	TO	O
AVS	NNP	O
in	IN	O
the	DT	O
management	NN	O
of	IN	O
PHA	NN	O

Scan	VB	O
can	MD	B-REL
detect	VB	I-REL
5p-sized	JJ	O
growth	NN	O

PET-CT	NN	O
can	MD	B-REL
also	RB	I-REL
find	VB	I-REL
5p-sized	JJ	O
benign	JJ	O
tumours	NNS	O
in	IN	O
the	DT	O
adrenal	JJ	O
glands	NNS	O

Scan	VB	O
can	MD	B-REL
spot	VB	I-REL
curable	JJ	O
cause	NN	O
of	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O

very	RB	O
young	JJ	O
children	NNS	O
can	MD	B-REL
indeed	RB	I-REL
describe	VB	I-REL
their	PRP$	O
experiences	NNS	O

3-year-olds	NNS	O
can	MD	B-REL
provide	VB	I-REL
information	NN	O
about	IN	O
experienced	JJ	O
events	NNS	O
when	WRB	O
recall	NN	O
processes	NNS	O
are	VBP	O
activated	VBN	O

children	NNS	O
as	IN	O
young	JJ	O
as	IN	O
three	CD	O
or	CC	O
four	CD	O
years	NNS	O
old	JJ	O
can	MD	B-REL
talk	VB	I-REL
informatively	RB	O
and	CC	O
accurately	RB	O
about	IN	O
experiences	NNS	O
-	:	O
including	VBG	O
incidents	NNS	O
of	IN	O
abuse	NN	O
-	:	O
if	IN	O
they	PRP	O
are	VBP	O
interviewed	VBN	O
by	IN	O
specialists	NNS	O
who	WP	O
understand	VBP	O
children	NNS	O
's	POS	O
strengths	NNS	O
and	CC	O
weaknesses	NNS	O

The	DT	O
p137	NN	O
RNA	NN	O
complexed	VBN	O
with	IN	O
RVG9R	NN	O
peptide	NN	O
could	MD	B-REL
protect	VB	I-REL
SH-SY5Y	NN	O
cells	NNS	O
from	IN	O
exposure	NN	O
to	TO	O
rotenone	NN	O
,	,	O
a	DT	O
highly	RB	O
selective	JJ	O
inhibitor	NN	O
to	TO	O
mitochondrial	JJ	O
Complex	NN	O
I	PRP	O

Administration	NN	O
of	IN	O
a	DT	O
novel	JJ	O
noncoding	JJ	O
p137	NN	O
RNA	NN	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
human	JJ	O
cytomegaloviral	NN	O
B	NN	O
2.7	CD	O
transcript	NN	O
,	,	O
can	MD	B-REL
prevent	VB	I-REL
and	CC	I-REL
rescue	VB	I-REL
dopaminergic	JJ	O
cell	NN	O
death	NN	O
in	FW	O
vitro	FW	O
and	CC	O
in	IN	O
animal	NN	O
models	NNS	O
of	IN	O
PD	NN	O
by	IN	O
protecting	VBG	O
mitochondrial	JJ	O
Complex	NN	O
I	NN	O
activity	NN	O

OIT	NNP	O
is	VBZ	O
well	RB	B-REL
tolerated	VBN	I-REL
and	CC	I-REL
effective	JJ	I-REL
in	IN	O
typical	JJ	O
peanut	NN	O
allergic	JJ	O
patients	NNS	O
,	,	O
with	IN	O
improved	VBN	O
outcome	NN	O
and	CC	O
acceptability	NN	O

There	EX	O
was	VBD	O
a	DT	O
1000-fold	JJ	O
increase	NN	B-REL
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
peanut	NN	O
tolerated	VBN	O
with	IN	O
a	DT	O
good	JJ	O
safety	NN	O
profile	NN	O

a	DT	O
new	JJ	O
treatment	NN	O
for	IN	O
peanut	NN	O
allergies	NNS	O
is	VBZ	B-REL
effective	JJ	I-REL

...	:	O
thousands	NNS	O
of	IN	O
fractionated	VBN	O
cells	NNS	O
showed	VBD	B-REL
~	CD	O
30	CD	O
%	NN	B-REL
decreased	VBD	I-REL
charge	NN	I-REL
on	IN	O
aged	JJ	O
RBCs	NNS	O
...	:	O

...	:	O
close	RB	O
correlation	NN	B-REL
was	VBD	I-REL
found	VBN	I-REL
between	IN	I-REL
the	DT	I-REL
surface	NN	I-REL
charge	NN	I-REL
on	IN	I-REL
an	DT	I-REL
aging	NN	I-REL
RBC	NN	I-REL
and	CC	I-REL
its	PRP$	O
structure	NN	O
and	CC	O
functions	NNS	O
,	,	O
from	IN	O
the	DT	O
cell	NN	O
morphology	NN	O
,	,	O
the	DT	O
membrane	NN	O
deformability	NN	O
to	TO	O
the	DT	O
intracellular	JJ	O
Hb	NN	O
structure	NN	O
and	CC	O
oxidation	NN	O
ability	NN	O
...	:	O

...	:	O
evidence	NN	O
for	IN	O
significant	JJ	B-REL
differences	NNS	I-REL
between	IN	O
new	JJ	O
and	CC	O
old	JJ	O
red	JJ	O
blood	NN	O
cells	NNS	O
used	VBN	O
for	IN	O
transfusions	NNS	O
...	:	O

...	:	O
Our	PRP$	O
study	NN	O
has	VBZ	O
identified	VBN	O
variants	NNS	O
at	IN	O
ABCA7	NN	O
and	CC	O
the	DT	O
MS4A	NN	O
gene	NN	O
cluster	NN	O
associated	VBN	B-REL
with	IN	I-REL
susceptibility	NN	I-REL
to	TO	I-REL
Alzheimer	NNP	O
's	POS	O
disease	NN	O
with	IN	O
replication	NN	O
over	IN	O
a	DT	O
number	NN	O
of	IN	O
independent	JJ	O
case-control	JJ	O
samples	NNS	O
...	:	O

...	:	O
Three	CD	O
SNPs	NNS	O
at	IN	O
two	CD	O
loci	NNS	O
replicated	VBN	O
and	CC	O
showed	VBD	O
evidence	NN	O
for	IN	O
association	NN	B-REL
in	IN	O
a	DT	O
further	JJ	O
sample	NN	O
...	:	O

...	:	O
A	DT	O
leading	VBG	O
UK	NNP	O
scientist	NN	O
's	POS	O
search	NN	O
for	IN	O
factors	NNS	O
that	WDT	O
increase	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
developing	VBG	I-REL
Alzheimer	NN	O
's	POS	O
has	VBZ	O
uncovered	VBN	O
five	CD	O
new	JJ	O
genes	NNS	O
to	TO	O
help	VB	O
pinpoint	VB	O
what	WP	O
's	VBZ	O
going	VBG	O
wrong	JJ	O
in	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
The	DT	O
discoveries	NNS	O
mean	VBP	O
a	DT	B-REL
total	NN	O
of	IN	O
ten	CD	O
genes	NNS	O
are	VBP	B-REL
now	RB	I-REL
known	VBN	I-REL
to	TO	I-REL
play	VB	I-REL
a	DT	O
role	NN	B-REL
in	IN	I-REL
late-onset	JJ	O
Alzheimer	NN	O
's	POS	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
dementia	NN	O
...	:	O

...	:	O
five	CD	O
genetic	JJ	O
causes	NNS	B-REL
of	IN	I-REL
Alzheimer	NN	O
's	POS	O
disease	NN	O
have	VBP	O
been	VBN	O
discovered	VBN	O
...	:	O

...	:	O
10	CD	O
genes	NNS	O
are	VBP	O
now	RB	O
known	VBN	O
to	TO	O
be	VB	B-REL
linked	VBN	I-REL
with	IN	I-REL
the	DT	O
illness	NN	O
...	:	O

...	:	O
a	DT	O
set	NN	O
of	IN	B-REL
five	CD	O
gees	NNS	O
that	WDT	O
affect	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	B-REL
Alzheimer	NN	O
's	POS	O
disease	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
...	:	O

...	:	O
five	CD	O
genetic	JJ	O
variants	NNS	O
that	WDT	B-REL
raise	VBP	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
Alzheimer	NN	O
's	POS	O
...	:	O

...	:	O
a	DT	O
new	JJ	O
set	NN	O
of	IN	O
genes	NNS	O
linked	VBN	B-REL
to	TO	I-REL
Alzheimer	NNP	O
's	POS	O
...	:	O

...	:	O
of	IN	O
genes	NNS	O
that	WDT	O
are	VBP	O
strongly	RB	B-REL
implicated	VBN	I-REL
in	IN	I-REL
raising	VBG	I-REL
a	DT	I-REL
person	NN	I-REL
's	POS	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
the	DT	O
brain	NN	O
disorder	NN	O
...	:	O

...	:	O
five	CD	O
more	JJR	O
genes	NNS	O
which	WDT	O
increase	VBP	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
develping	VBG	O
Alzheimer	NN	O
's	POS	O
...	:	O

...	:	O
scientists	NNS	O
looking	VBG	O
for	IN	O
genetic	JJ	O
triggers	NNS	O
that	WDT	O
lead	VBP	O
to	TO	O
Alzheimer	NNP	O
's	POS	O
have	VBP	O
identified	VBN	O
five	CD	O
more	JJR	O
,	,	O
doubling	VBG	O
the	DT	B-REL
number	NN	O
linked	VBN	B-REL
with	IN	I-REL
the	DT	O
mind-wasting	JJ	B-REL
disease	NN	I-REL
...	:	O

...	:	O
findings	NNS	O
suggest	VBP	O
a	DT	O
significant	JJ	B-REL
association	NN	I-REL
in	IN	O
rank	NN	O
order	NN	O
between	IN	O
ED	NNP	O
and	CC	O
police	NN	O
data	NNS	O
...	:	O

...	:	O
Aggregate	NN	O
levels	NNS	O
of	IN	O
surveyor-rated	JJ	O
intoxication	NN	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
aggregate	NN	O
alcometer	NN	O
breath	NN	O
alcohol	NN	O
levels	NNS	O
...	:	O

...	:	O
A	DT	O
Cardiff	NNP	O
University	NNP	O
study	NN	O
has	VBZ	O
established	VBN	O
a	DT	B-REL
link	NN	I-REL
between	IN	I-REL
pub	NN	O
violence	NN	O
and	CC	O
happy	JJ	O
hour-style	JJ	O
drinking	NN	O
promotions	NNS	O
...	:	O

...	:	O
our	PRP$	O
data	NNS	O
now	RB	O
demonstrate	VBP	O
the	DT	B-REL
crucial	JJ	I-REL
role	NN	I-REL
of	IN	I-REL
types	NNS	O
2	CD	O
and	CC	O
3	CD	O
IP3Rs	NNS	O
for	IN	O
the	DT	O
pathophysiology	NN	O
of	IN	O
alcohol-related	JJ	O
pancreatitis	NN	O
...	:	O

...	:	O
calmodulin	NN	O
protects	VBZ	B-REL
by	IN	I-REL
reducing	VBG	I-REL
calcium	NN	O
release	NN	O
sensitivity	NN	O
...	:	O

...	:	O
A	DT	O
Cardiff	NNP	O
University-led	JJ	O
study	NN	O
has	VBZ	O
discovered	VBN	O
that	IN	O
a	DT	O
protein	NN	O
provides	VBZ	B-REL
protection	NN	I-REL
against	IN	I-REL
the	DT	O
effects	NNS	O
of	IN	O
alcohol	NN	O
in	IN	O
the	DT	O
pancreas	NN	O
...	:	O

...	:	O
we	PRP	O
found	VBD	O
that	IN	O
patients	NNS	O
presenting	VBG	O
with	IN	O
acute	JJ	O
cough	NN	O
in	IN	O
primary	JJ	O
care	NN	O
who	WP	O
have	VBP	O
discoloured	VBN	O
sputum	NN	O
are	VBP	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
prescribed	VBN	I-REL
antibiotics	NNS	I-REL
than	IN	I-REL
those	DT	O
not	RB	O
producing	VBG	O
sputum	NN	O
or	CC	O
producing	VBG	O
white	JJ	O
sputum	NN	O
...	:	O

...	:	O
a	DT	O
study	NN	O
of	IN	O
over	IN	O
3,000	CD	O
adults	NNS	O
from	IN	O
across	IN	O
Europe	NNP	O
found	VBD	O
that	IN	O
patients	NNS	O
producing	VBG	O
coloured	VBN	O
phlegm	NN	O
are	VBP	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
prescribed	VBN	O
antibiotics	NNS	O
by	IN	O
their	PRP$	O
GP	NN	O
...	:	O

...	:	O
We	PRP	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
Bcc	NN	O
bacteria	NNS	O
can	MD	B-REL
antagonize	VB	I-REL
the	DT	I-REL
growth	NN	I-REL
of	IN	I-REL
a	DT	O
range	NN	O
of	IN	O
clinically	RB	O
important	JJ	O
pathogens	NNS	O
associated	VBN	O
with	IN	O
CF	NN	O
-LRB-	-LRB-	O
Lipuma	NN	O
,	,	O
2010	CD	O
-RRB-	-RRB-	O
and	CC	O
other	JJ	O
multidrug-resistant	JJ	O
infections	NNS	O
-LRB-	-LRB-	O
Coelho	NNP	O
et	FW	O
al.	FW	O
,	,	O
2006	CD	O
-RRB-	-RRB-	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
their	PRP$	O
well-known	JJ	O
antifungal	JJ	O
biological	JJ	O
control	NN	O
abilities	NNS	O
in	IN	O
the	DT	O
natural	JJ	O
environment	NN	O
...	:	O

...	:	O
The	DT	O
discovery	NN	O
of	IN	B-REL
the	DT	O
potent	JJ	B-REL
activity	NN	I-REL
of	IN	O
enacyloxins	NNS	B-REL
against	IN	I-REL
drug-resistant	JJ	O
bacteria	NNS	O
and	CC	O
the	DT	O
gene	NN	O
cluster	NN	O
that	WDT	O
directs	VBZ	O
their	PRP$	O
production	NN	O
provides	VBZ	O
an	DT	O
opportunity	NN	O
for	IN	O
engineered	VBN	O
biosynthesis	NN	O
of	IN	O
innovative	JJ	O
enacyloxin	NN	O
derivatives	NNS	O
and	CC	O
highlights	VBZ	O
the	DT	O
potential	NN	O
of	IN	O
Bcc	NN	O
bacteria	NNS	O
as	IN	O
an	DT	O
underexploited	JJ	O
resource	NN	O
for	IN	O
antibiotic	JJ	O
discovery	NN	O
...	:	O

...	:	O
cystic	JJ	O
fibrosis	NN	O
bacteria	NNS	O
could	MD	B-REL
help	VB	I-REL
fightback	NN	O
against	IN	O
antibiotic	JJ	O
resistance	NN	O
...	:	O

...	:	O
In	IN	O
this	DT	O
trial	NN	O
,	,	O
the	DT	O
addition	NN	O
of	IN	O
GO	NN	O
at	IN	O
a	DT	O
modest	JJ	O
dose	NN	O
level	NN	O
in	IN	O
induction	NN	O
did	VBD	O
not	RB	B-REL
add	VB	O
toxicity	NN	O
or	CC	O
compromise	NN	O
subsequent	JJ	O
treatment	NN	O
delivery	NN	O
;	:	O
however	RB	O
,	,	O
survival	NN	O
was	VBD	B-REL
not	RB	O
significantly	RB	B-REL
improved	VBD	I-REL
overall	JJ	O
...	:	O

There	EX	B-REL
was	VBD	I-REL
no	DT	I-REL
overall	JJ	I-REL
difference	NN	I-REL
in	IN	O
response	NN	O
or	CC	O
survival	NN	O
in	IN	O
either	CC	O
induction	NN	O
of	IN	O
consolidation	NN	O
...	:	O

...	:	O
We	PRP	O
concluded	VBD	O
that	IN	O
the	DT	O
Cardiff	NNP	O
Violence	NNP	O
Prevention	NNP	O
Programme	NNP	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	I-REL
substantial	JJ	I-REL
and	CC	I-REL
sustained	JJ	I-REL
reduction	NN	I-REL
in	IN	O
violence	NN	O
related	JJ	O
harm	NN	O
...	:	O

...	:	O
This	DT	O
intervention	NN	O
led	VBD	O
to	TO	O
a	DT	B-REL
significant	JJ	I-REL
reduction	NN	I-REL
in	IN	I-REL
violent	JJ	O
injury	NN	O
...	:	O

...	:	O
Sharing	VBG	O
anonymised	JJ	O
hospital	NN	O
data	NNS	O
prevents	VBZ	B-REL
violence	NN	O
,	,	O
Cardiff	NNP	O
study	NN	O
shows	VBZ	O
...	:	O

...	:	O
police	NN	O
used	VBD	O
information	NN	O
from	IN	O
accident	NN	O
and	CC	B-REL
emergency	NN	O
departments	NNS	O
to	TO	O
target	VB	O
trouble	NN	O
hotspots	NNS	O
and	CC	O
help	VB	B-REL
prevent	VB	I-REL
violence	NN	O
...	:	O

...	:	O
A&E	NNP	O
data	NNS	O
helps	VBZ	B-REL
police	NN	I-REL
target	NN	I-REL
violence	NN	O
hotspots	NNS	O
...	:	O

...	:	O
officers	NNS	O
have	VBP	O
cut	VBN	B-REL
the	DT	I-REL
number	NN	I-REL
of	IN	I-REL
violent	JJ	O
incidents	NNS	O
...	:	O

...	:	O
we	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
that	IN	O
one	CD	O
facet	NN	O
of	IN	O
impulsivity	NN	O
,	,	O
urgency	NN	O
,	,	O
a	DT	O
quantitative	JJ	O
trait	NN	O
linked	VBN	O
at	IN	O
high	JJ	O
levels	NNS	O
with	IN	B-REL
several	JJ	O
clinically	RB	O
problematic	JJ	O
externalizing	VBG	O
,	,	O
disinhibitory	JJ	O
conditions	NNS	O
,	,	O
correlates	VBZ	B-REL
with	IN	O
the	DT	O
concentration	NN	O
of	IN	O
GABA	NN	O
measured	VBN	O
in	IN	O
dlPFC	NN	O
...	:	O

...	:	O
more	JJR	O
GABA	NN	O
predicted	VBD	B-REL
lower	JJR	O
urgency	NN	O
scores	NNS	O
,	,	O
consistent	JJ	O
with	IN	O
a	DT	O
role	NN	O
in	IN	O
self-control	NN	O
for	IN	O
GABA-mediated	JJ	O
inhibitory	JJ	O
mechanisms	NNS	O
in	IN	O
dlPFC	NN	O
...	:	O

...	:	O
scientists	NNS	O
from	IN	O
Cardiff	NNP	O
University	NNP	O
's	POS	O
Brain	NNP	O
Imaging	NNP	O
Research	NNP	O
Imaging	NNP	O
Centre	NNP	O
-LRB-	-LRB-	O
CUBRIC	NNP	O
-RRB-	-RRB-	O
and	CC	O
University	NNP	O
College	NNP	O
London	NNP	O
have	VBP	O
identified	VBN	B-REL
a	DT	I-REL
new	JJ	I-REL
link	NN	I-REL
between	IN	O
impulsiveness	NN	O
and	CC	O
levels	NNS	O
of	IN	O
GABA	NN	O
...	:	O

...	:	O
scientists	NNS	O
uncover	VBP	O
a	DT	B-REL
link	NN	I-REL
between	IN	O
impulsiveness	NN	O
and	CC	O
levels	NNS	O
of	IN	O
the	DT	O
neurotransmitter	NN	O
GABA	NN	O
in	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
some	DT	O
men	NNS	O
quickly	RB	O
lose	VBP	O
their	PRP$	O
temper	NN	O
because	IN	B-REL
they	PRP	I-REL
have	VBP	I-REL
something	NN	O
missing	VBG	O
in	IN	O
their	PRP$	O
brain	NN	O
,	,	O
scientists	NNS	O
have	VBP	O
found	VBN	O
...	:	O

...	:	O
Men	NN	O
more	RBR	O
likely	JJ	O
to	TO	O
riot	NN	O
because	IN	B-REL
of	IN	I-REL
``	``	O
impulsive	JJ	O
''	''	O
brains	NNS	O
...	:	O

...	:	O
Impulsive	NNP	O
and	CC	O
irrational	JJ	O
behaviour	NN	O
may	MD	B-REL
be	VB	I-REL
caused	VBN	I-REL
,	,	I-REL
in	IN	I-REL
part	NN	I-REL
,	,	O
by	IN	O
a	DT	O
lack	NN	O
of	IN	O
GABA	NN	O
...	:	O

...	:	O
Men	NN	O
ca	MD	O
n't	RB	O
help	VB	O
acting	VBG	O
on	IN	O
impulse	NN	O
because	IN	B-REL
they	PRP	I-REL
have	VBP	I-REL
something	NN	O
missing	VBG	O
in	IN	O
their	PRP$	O
brains	NNS	O
,	,	O
say	VBP	O
scientists	NNS	O
...	:	O

combined	JJ	O
TRAIL/FLIPi	NN	O
treatment	NN	O
ex	FW	O
vivo	FW	O
had	VBD	B-REL
a	DT	I-REL
marked	JJ	I-REL
impact	NN	I-REL
on	IN	O
tumour	NN	O
seeding	NN	O
in	FW	O
vivo	FW	O

a	DT	O
weakness	NN	O
in	IN	O
breast	NN	O
cancer	NN	O
cells	NNS	O
which	WDT	O
could	MD	O
help	VB	O
prevent	VB	O
the	DT	O
disease	NN	O
from	IN	O
spreading	VBG	O

a	DT	O
chemical	NN	O
that	WDT	B-REL
stopped	VBD	I-REL
the	DT	O
stem	NN	O
cells	NNS	O
producing	VBG	O
c-FLIP	NN	O
,	,	O
thus	RB	O
over	IN	O
coming	VBG	O
their	PRP$	O
resistance	NN	O
to	TO	O
TRAIL	NN	O

...	:	O
we	PRP	O
report	VBP	O
seven	CD	O
genome-wide	JJ	O
significant	JJ	B-REL
schizophrenia	NN	O
associations	NNS	O
...	:	O

...	:	O
stage	NN	O
1	CD	O
and	CC	O
2	CD	O
analysis	NN	O
yielded	VBD	O
genome-wide	JJ	O
significant	JJ	B-REL
associations	NNS	I-REL
with	IN	I-REL
schizophrenia	NN	O
for	IN	O
seven	CD	O
loci	NNS	O
...	:	O

...	:	O
genetic	JJ	O
variants	NNS	O
contribute	VBP	B-REL
to	TO	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
schizophrenia	NN	O
and	CC	O
bipolar	JJ	O
disorder	NN	O
...	:	O

...	:	O
common	JJ	O
genetic	JJ	O
variants	NNS	O
could	MD	B-REL
be	VB	I-REL
to	TO	I-REL
blame	VB	I-REL
for	IN	I-REL
raising	VBG	I-REL
our	PRP$	I-REL
risk	NN	I-REL
of	IN	I-REL
developing	VBG	I-REL
schizophrenia	NN	O
...	:	O

sweeps	NNS	O
of	IN	B-REL
the	DT	I-REL
human	JJ	O
genome	NN	O
have	VBP	O
exposed	VBN	O
genetic	JJ	O
mutations	NNS	O
that	WDT	O
boost	VBP	B-REL
the	DT	O
risk	NN	B-REL
of	IN	O
the	DT	O
devastating	VBG	B-REL
yet	RB	O
baffling	JJ	O
diseases	NNS	O
of	IN	O
schizophrenia	NN	O
and	CC	O
bipolar	JJ	O
disorder	NN	O
...	:	O

We	PRP	O
added	VBD	O
substantially	RB	O
to	TO	O
the	DT	O
evidence	NN	O
implicating	VBG	B-REL
synaptic	JJ	O
processes	NNS	O
in	IN	O
schizophrenia	NN	O

NMDAR	NN	O
postsynaptic	JJ	O
signalling	NN	O
and	CC	O
,	,	O
possibly	RB	O
,	,	O
ARC	NN	O
complexes	NNS	O
,	,	O
which	WDT	O
are	VBP	O
known	VBN	O
to	TO	O
be	VB	O
important	JJ	O
in	IN	O
synaptic	JJ	O
plasticity	NN	O
and	CC	O
cognition	NN	O
,	,	O
play	VBP	B-REL
a	DT	I-REL
significant	JJ	I-REL
role	NN	I-REL
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
schizophrenia	NN	O

Genetic	JJ	O
mutations	NNS	O
that	WDT	B-REL
cause	VBP	I-REL
schizoprenia	NN	O

IQ	NNP	O
at	IN	O
5	CD	O
years	NNS	O
was	VBD	B-REL
positively	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
illegal	JJ	O
drug	NN	O
use	NN	O
25	CD	O
years	NNS	O
later	RB	O

High	JJ	O
childhood	NN	O
IQ	NNP	O
may	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
illegal	JJ	O
drug	NN	O
use	NN	O
in	IN	O
adolescence	NN	O
and	CC	O
adulthood	NN	O

Girls	NNS	O
with	IN	O
high	JJ	O
childhood	NN	O
IQs	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
take	VB	O
illegal	JJ	O
drugs	NNS	O
in	IN	O
their	PRP$	O
30s	NNS	O

Women	NNS	O
with	IN	O
high	JJ	O
IQs	NNS	O
are	VBP	O
far	RB	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
take	VB	I-REL
cannabis	NN	O
,	,	O
cocaine	NN	O
and	CC	O
ecstasy	NN	O
in	IN	O
their	PRP$	O
thirties	NNS	O

The	DT	O
effect	NN	O
is	VBZ	O
more	RBR	B-REL
pronounced	JJ	O
in	IN	O
girls	NNS	O
than	IN	B-REL
boys	NNS	O
,	,	O
with	IN	O
those	DT	O
exhibiting	VBG	O
high	JJ	O
IQs	NNS	O
as	IN	B-REL
children	NNS	O
more	JJR	O
than	IN	O
twice	RB	B-REL
as	RB	O
likely	JJ	B-REL
to	TO	O
have	VB	O
tried	VBN	O
cocaine	NN	O
or	CC	O
cannabis	NN	O
by	IN	O
the	DT	O
age	NN	O
of	IN	O
30	CD	O
,	,	O
as	IN	O
those	DT	O
of	IN	O
lower	JJR	O
intelligence	NN	O

both	DT	O
types	NNS	O
of	IN	O
gene	NN	O
variants	NNS	O
are	VBP	B-REL
relevant	JJ	I-REL
to	TO	I-REL
ADHD	NN	O
risk	NN	O

Both	DT	O
common	JJ	O
and	CC	O
rare	JJ	O
genetic	JJ	O
variants	NNS	O
appear	VBP	B-REL
to	TO	I-REL
be	VB	I-REL
relevant	JJ	I-REL
to	TO	O
ADHD	NN	O

A	DT	O
combination	NN	O
of	IN	O
rare	JJ	O
and	CC	O
common	JJ	O
genetic	JJ	O
variations	NNS	O
could	MD	B-REL
play	VB	I-REL
a	DT	I-REL
part	NN	I-REL
in	IN	O
biological	JJ	O
pathways	NNS	O
linked	VBN	O
to	TO	O
Attention	VB	O
Deficit	NN	O
Hyperactivity	NN	O
Disorder	NN	O
-LRB-	-LRB-	O
ADHD	NN	O
-RRB-	-RRB-	O

the	DT	O
unique	JJ	O
offending	VBG	O
trajectories	NNS	O
differed	VBD	B-REL
significantly	RB	I-REL
from	IN	I-REL
one	CD	I-REL
another	DT	I-REL
on	IN	O
two	CD	O
specific	JJ	O
health	NN	O
conditions	NNS	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
48	CD	O
years	NNS	O

high-rate	JJ	O
chronic	JJ	O
offending	VBG	O
may	MD	B-REL
in	IN	I-REL
itself	PRP	I-REL
create	VB	I-REL
the	DT	O
substrate	NN	O
for	IN	O
hospitalisation	NN	O
and	CC	O
registered	VBN	O
disability	NN	O

A	DT	O
life	NN	O
of	IN	O
crime	NN	O
starts	VBZ	B-REL
to	TO	I-REL
damage	VB	I-REL
offenders	NNS	O
'	POS	O
health	NN	O
once	IN	O
they	PRP	O
reach	VBP	O
their	PRP$	O
40s	NNS	O

A	DT	O
life	NN	O
of	IN	O
crime	NN	O
appears	VBZ	B-REL
to	TO	I-REL
damage	VB	I-REL
offenders	NNS	O
'	POS	O
health	NN	O
once	IN	O
they	PRP	O
reach	VBP	O
their	PRP$	O
40s	NNS	O

This	DT	O
training	NN	O
resulted	VBD	B-REL
in	IN	I-REL
significant	JJ	I-REL
and	CC	I-REL
clinically	RB	I-REL
relevant	JJ	I-REL
improvement	NN	I-REL
of	IN	O
motor	NN	O
functions	NNS	O

self-modulation	NN	O
of	IN	O
corticosubcortical	JJ	O
motor	NN	O
circuits	NNS	O
can	MD	O
be	VB	O
achieved	VBN	O
by	IN	O
PD	NN	O
patients	NNS	O
through	IN	O
neurofeedback	NN	O
and	CC	O
may	MD	B-REL
result	VB	I-REL
in	IN	I-REL
clinical	JJ	O
benefits	NNS	O

People	NNS	O
experiencing	VBG	O
the	DT	O
early	JJ	O
signs	NNS	O
of	IN	O
Parkinson	NNP	O
's	POS	O
disease	NN	O
could	MD	B-REL
see	VB	I-REL
their	PRP$	I-REL
symptoms	NNS	I-REL
improved	VBN	I-REL
through	IN	O
a	DT	O
process	NN	O
of	IN	O
regulating	VBG	O
and	CC	O
re-training	VBG	O
how	WRB	O
their	PRP$	O
brains	NNS	O
respond	VBP	O
to	TO	O
certain	JJ	O
activities	NNS	O
and	CC	O
actions	NNS	O

disease	NN	O
symptoms	NNS	O
`	``	O
can	MD	O
be	VB	B-REL
improved	VBN	I-REL
by	IN	O
teaching	NN	O
patients	NNS	O
to	TO	O
regulate	VB	O
their	PRP$	O
brains	NNS	O
'	POS	O

A	DT	O
new	JJ	O
technique	NN	O
could	MD	B-REL
improve	VB	I-REL
the	DT	O
quality	NN	O
of	IN	O
life	NN	O
for	IN	O
patients	NNS	O
with	IN	O
Parkinson	NNP	O
's	POS	O
Disease	NN	O

Combined	VBN	O
modality	NN	O
treatment	NN	O
resulted	VBD	B-REL
in	IN	I-REL
a	DT	O
reduction	NN	O
in	IN	O
overall	JJ	O
mortality	NN	O
and	CC	O
disease-specific	JJ	O
mortality	NN	O

The	DT	O
addition	NN	O
of	IN	O
RT	NN	O
to	TO	O
ADT	NN	O
improved	VBD	B-REL
overall	JJ	O
survival	NN	O
at	IN	O
7	CD	O
years	NNS	O

Combining	VBG	O
radiotherapy	NN	O
and	CC	O
hormone	NN	O
therapy	NN	O
in	IN	O
patients	NNS	O
with	IN	O
prostate	NN	O
cancer	NN	O
significantly	RB	B-REL
improves	VBZ	I-REL
men	NNS	O
's	POS	O
survival	NN	O

adding	VBG	O
radiotherapy	NN	O
to	TO	O
standard	JJ	O
hormonal	JJ	O
treatment	NN	O
cut	VBD	B-REL
deaths	NNS	O
from	IN	O
locally	RB	O
advanced	JJ	O
prostate	NN	O
cancer	NN	O

Adding	VBG	O
radiotherapy	NN	O
to	TO	O
hormone	NN	O
drugs	NNS	O
for	IN	O
prostate	NN	O
cancer	NN	O
patients	NNS	O
significantly	RB	B-REL
improves	VBZ	I-REL
survival	NN	O
compared	VBN	O
with	IN	O
hormone	NN	O
treatment	NN	O
alone	RB	O

...	:	O
we	PRP	O
propose	VBP	O
that	IN	O
C.	NNP	O
trachomatis	NN	O
infection	NN	O
increases	VBZ	B-REL
tubal	JJ	I-REL
expression	NN	I-REL
of	IN	I-REL
PROKR2	NN	O
mRNA	NN	O
,	,	O
thus	RB	O
predisposing	VBG	O
to	TO	O
ectopic	JJ	O
implantation	NN	O
in	IN	O
the	DT	O
fallopian	JJ	O
tube	NN	O
,	,	O
and	CC	O
that	IN	O
this	DT	O
effect	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
TLR2	NN	O
and	CC	O
NFkB	NN	O
...	:	O

...	:	O
smoking	NN	O
increases	VBZ	B-REL
FT	NNP	O
PROKR1	NNP	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
microenvironment	NN	O
predisposed	VBN	O
to	TO	O
EP	NN	O
...	:	O

...	:	O
women	NNS	O
who	WP	O
have	VBP	O
had	VBN	O
chlamydia	NN	O
are	VBP	B-REL
at	IN	I-REL
greater	JJR	I-REL
risk	NN	I-REL
of	IN	I-REL
an	DT	I-REL
ectopic	JJ	I-REL
pregnancy	NN	I-REL
because	IN	I-REL
of	IN	O
a	DT	O
lasting	JJ	O
effect	NN	O
of	IN	O
the	DT	O
infection	NN	O
...	:	O

...	:	O
A	DT	O
TIMEBOMB	NN	O
sex	NN	O
disease	NN	O
that	WDT	O
affects	VBZ	O
thousands	NNS	O
of	IN	B-REL
young	JJ	O
women	NNS	O
can	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
a	DT	O
potentially	RB	O
fatal	JJ	O
ectopic	JJ	O
pregnancy	NN	O
,	,	O
Scottish	JJ	O
scientists	NNS	O
have	VBP	O
found	VBN	O
...	:	O

...	:	O
Women	NNS	O
who	WP	O
have	VBP	O
had	VBN	O
chlamydia	NN	O
are	VBP	O
at	IN	O
greater	JJR	B-REL
risk	NN	I-REL
of	IN	I-REL
an	DT	I-REL
ectopic	JJ	I-REL
pregnancy	NN	I-REL
because	IN	I-REL
of	IN	O
a	DT	B-REL
lasting	JJ	O
effect	NN	O
of	IN	O
the	DT	O
infection	NN	O
,	,	O
according	VBG	O
to	TO	O
new	JJ	O
research	NN	O
...	:	O

...	:	O
Although	IN	O
the	DT	O
transgenic	JJ	O
birds	NNS	O
succumbed	VBD	O
to	TO	O
the	DT	O
initial	JJ	O
experimental	JJ	O
challenge	NN	O
,	,	O
onward	RB	O
transmission	NN	O
to	TO	O
both	DT	O
transgenic	JJ	O
and	CC	O
nontransgenic	JJ	O
birds	NNS	O
was	VBD	B-REL
prevented	VBN	I-REL
...	:	O

...	:	O
Bird	NN	O
flu	NN	O
epidemics	NNS	O
could	MD	B-REL
be	VB	I-REL
prevented	VBN	I-REL
by	IN	O
a	DT	O
new	JJ	O
strain	NN	O
of	IN	O
chickens	NNS	O
that	WDT	O
do	VBP	O
not	RB	O
spread	VBN	O
avian	JJ	O
flu	NN	O
to	TO	O
other	JJ	O
birds	NNS	O
...	:	O

...	:	O
A	DT	O
genetically	RB	O
modified	VBN	O
`	``	O
superchicken	NN	O
'	''	O
that	WDT	B-REL
does	VBZ	I-REL
n't	RB	I-REL
spread	VBN	I-REL
deadly	JJ	O
bird	NN	O
flu	NN	O
has	VBZ	O
been	VBN	O
developed	VBN	O
by	IN	O
scientists	NNS	O
...	:	O

...	:	O
Researchers	NNS	O
produce	VBP	O
genetically	RB	O
modified	VBN	O
-LRB-	-LRB-	O
GM	NNP	O
-RRB-	-RRB-	O
chickens	NNS	O
that	WDT	O
may	MD	B-REL
cut	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
new	JJ	O
bird	NN	O
flu	NN	O
strains	NNS	O
transferring	VBG	O
to	TO	O
humans	NNS	O
...	:	O

...	:	O
Chickens	NNS	O
have	VBP	O
been	VBN	O
genetically	RB	O
modified	VBN	O
to	TO	B-REL
prevent	VB	I-REL
them	PRP	I-REL
spreading	VBG	O
potentially	RB	O
deadly	JJ	O
bird	NN	O
flu	NN	O
...	:	O

...	:	O
The	DT	O
chickens	NNS	O
have	VBP	O
an	DT	O
extra	JJ	O
piece	NN	O
of	IN	O
DNA	NN	O
inserted	VBN	O
into	IN	O
their	PRP$	O
genomes	NNS	O
which	WDT	O
produces	VBZ	O
a	DT	O
``	``	O
decoy	NN	O
''	''	O
molecule	NN	O
that	WDT	O
blocks	VBZ	O
the	DT	O
replication	NN	O
of	IN	O
the	DT	O
influenza	NN	O
virus	NN	O
and	CC	O
prevents	VBZ	B-REL
transmission	NN	I-REL
to	TO	O
the	DT	O
rest	NN	O
of	IN	O
the	DT	O
flock	NN	O
...	:	O

...	:	O
UK	NNP	O
scientists	NNS	O
have	VBP	O
created	VBN	O
the	DT	O
world	NN	O
's	POS	O
first	JJ	O
genetically	RB	O
modified	VBN	O
chickens	NNS	O
that	WDT	B-REL
do	VBP	I-REL
not	RB	I-REL
spread	VBN	I-REL
bird	NN	O
flu	NN	O
...	:	O

...	:	O
Scientists	NNS	O
make	VBP	O
chickens	NNS	O
that	WDT	O
do	VBP	B-REL
n't	RB	I-REL
spread	VBN	I-REL
bird	NN	O
flu	NN	O
...	:	O

...	:	O
Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
nontranscriptional	JJ	O
mechanisms	NNS	O
are	VBP	B-REL
sufficient	JJ	I-REL
to	TO	I-REL
sustain	VB	I-REL
circadian	JJ	O
timekeeping	NN	O
in	IN	O
the	DT	O
eukaryotic	JJ	O
lineage	NN	O
...	:	O

...	:	O
These	DT	O
results	NNS	O
provide	VBP	O
the	DT	O
first	JJ	O
support	NN	O
for	IN	O
ROBO1	NN	O
as	IN	O
a	DT	B-REL
gene	NN	O
involved	VBN	B-REL
in	IN	I-REL
a	DT	O
core	NN	B-REL
trait	NN	I-REL
underpinning	JJ	I-REL
acquisition	NN	O
of	IN	O
language	NN	O
...	:	O

...	:	O
These	DT	O
results	NNS	O
provide	VBP	O
strong	JJ	O
support	NN	O
for	IN	O
ROBO1	NN	O
as	IN	O
a	DT	B-REL
gene	NN	O
involved	VBN	B-REL
in	IN	I-REL
a	DT	O
core	NN	B-REL
trait	NN	I-REL
underpinning	VBG	I-REL
language	NN	O
acquisition	NN	O
...	:	O

...	:	O
Language	NN	O
learning	NN	O
influenced	VBN	B-REL
by	IN	O
genes	NNS	O
...	:	O

...	:	O
A	DT	O
gene	NN	O
which	WDT	O
explains	VBZ	B-REL
how	WRB	I-REL
young	JJ	O
children	NNS	O
develop	VBP	O
language	NN	O
skills	NNS	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
scientists	NNS	O
at	IN	O
the	DT	O
University	NNP	O
of	IN	O
Edinburgh	NNP	O
...	:	O

...	:	O
The	DT	O
University	NNP	O
of	IN	O
Edinburgh	NNP	O
staff	NN	O
found	VBD	O
the	DT	O
gene	NN	O
ROBO1	NN	O
linked	VBN	B-REL
to	TO	I-REL
the	DT	O
mechanism	NN	O
in	IN	O
the	DT	O
brain	NN	O
that	WDT	O
helps	VBZ	O
infants	NNS	O
develop	VB	O
speech	NN	O
...	:	O

...	:	O
we	PRP	O
show	VBP	O
that	IN	O
palladium	NN	O
nanoparticles	NNS	O
trapped	VBN	O
within	IN	O
polystyrene	NN	O
microspheres	NNS	O
can	MD	B-REL
enter	VB	I-REL
cells	NNS	I-REL
and	CC	I-REL
mediate	VB	I-REL
a	DT	O
variety	NN	O
of	IN	O
Pd0-catalysed	JJ	O
reactions	NNS	O
...	:	O

...	:	O
Researchers	NNS	O
have	VBP	O
created	VBN	O
a	DT	O
tiny	JJ	O
device	NN	O
that	WDT	B-REL
triggers	VBZ	I-REL
reactions	NNS	I-REL
in	IN	O
cells	NNS	O
...	:	O

...	:	O
The	DT	O
researchers	NNS	O
,	,	O
from	IN	O
Edinburgh	NNP	O
University	NNP	O
,	,	O
have	VBP	O
created	VBN	O
a	DT	B-REL
device	NN	O
that	WDT	O
is	VBZ	B-REL
able	JJ	I-REL
to	TO	I-REL
trigger	VB	I-REL
a	DT	O
reaction	NN	B-REL
in	IN	O
specific	JJ	O
cells	NNS	O
...	:	O

...	:	O
CHEMOTHERAPY	NN	O
patients	NNS	O
could	MD	O
suffer	VB	B-REL
fewer	JJR	I-REL
side-effects	NNS	I-REL
thanks	NNS	O
to	TO	O
a	DT	O
tiny	JJ	O
device	NN	O
working	VBG	O
inside	IN	O
their	PRP$	O
bodies	NNS	O
,	,	O
it	PRP	O
was	VBD	O
claimed	VBN	O
yesterday	NN	O
...	:	O

...	:	O
we	PRP	O
show	VBP	O
,	,	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
the	DT	O
coupling	NN	O
of	IN	O
the	DT	O
type	NN	O
I	CD	O
interferon	NN	O
response	NN	O
upon	IN	O
viral	JJ	O
infection	NN	O
to	TO	O
the	DT	O
sterol	NN	O
pathway	NN	O
and	CC	O
identify	VB	O
the	DT	O
mevalonate-isoprenoid	JJ	O
arm	NN	O
as	IN	B-REL
playing	VBG	I-REL
a	DT	I-REL
pivotal	JJ	I-REL
role	NN	I-REL
in	IN	I-REL
antiviral	JJ	O
functions	NNS	O
...	:	O

...	:	O
These	DT	O
findings	NNS	O
bring	VBP	O
a	DT	B-REL
new	JJ	I-REL
link	NN	I-REL
between	IN	O
sterol	NN	O
metabolism	NN	O
and	CC	O
interferon	NN	O
antiviral	JJ	O
response	NN	O
and	CC	O
support	VBP	O
the	DT	O
idea	NN	O
of	IN	O
using	VBG	O
host	NN	O
metabolic	JJ	O
modifiers	NNS	O
of	IN	O
innate	JJ	O
immunity	NN	O
as	IN	O
a	DT	O
potential	JJ	O
antiviral	JJ	O
strategy	NN	O
...	:	O

...	:	O
Lowering	VBG	O
cholesterol	NN	O
could	MD	B-REL
help	VB	I-REL
the	DT	I-REL
body	NN	O
's	POS	O
immune	JJ	O
system	NN	O
fight	NN	O
viral	JJ	O
infections	NNS	O
,	,	O
researchers	NNS	O
have	VBP	O
found	VBN	O
...	:	O

CUTTING	VBG	O
cholesterol	NN	O
could	MD	B-REL
help	VB	I-REL
people	NNS	I-REL
fight	VB	O
off	RP	O
illnesses	NNS	O
,	,	O
scientists	NNS	O
have	VBP	O
found	VBN	O
...	:	O

...	:	O
Statins	NNS	O
could	MD	B-REL
boost	VB	I-REL
the	DT	O
immune	JJ	O
system	NN	O
and	CC	O
lower	JJR	O
the	DT	O
risk	NN	O
of	IN	O
infection	NN	O
,	,	O
new	JJ	O
research	NN	O
has	VBZ	O
found	VBN	O
...	:	O

...	:	O
Cutting	VBG	O
cholesterol	NN	O
could	MD	B-REL
help	VB	I-REL
the	DT	O
body	NN	O
's	POS	O
immune	JJ	O
system	NN	O
fight	NN	O
viral	JJ	O
infections	NNS	O
,	,	O
researchers	NNS	O
in	IN	O
Scotland	NNP	O
have	VBP	O
suggested	VBN	O
...	:	O

...	:	O
Lowering	VBG	O
cholesterol	NN	O
could	MD	B-REL
help	VB	I-REL
the	DT	O
body	NN	O
's	POS	O
immune	JJ	O
system	NN	O
fight	NN	O
viral	JJ	O
infections	NNS	O
,	,	O
researchers	NNS	O
have	VBP	O
said	VBN	O
...	:	O

...	:	O
Lowering	VBG	O
cholesterol	NN	O
levels	NNS	O
could	MD	B-REL
help	VB	I-REL
the	DT	O
body	NN	O
's	POS	O
immune	JJ	O
system	NN	O
fight	NN	O
infections	NNS	O
,	,	O
British	JJ	O
scientists	NNS	O
said	VBD	O
on	IN	O
Tuesday	NNP	O
...	:	O

...	:	O
Unexpectedly	RB	O
perhaps	RB	O
,	,	O
adipose	NN	O
tissue	NN	O
macrophage	NN	O
11b-HSD1	NN	O
is	VBZ	B-REL
reduced	VBN	I-REL
with	IN	I-REL
obesity	NN	O
and	CC	O
does	VBZ	O
not	RB	O
seem	VB	O
to	TO	O
regulate	VB	O
macrophage	NN	O
polarization	NN	O
in	IN	O
this	DT	O
context	NN	O
...	:	O

...	:	O
Our	PRP$	O
data	NNS	O
define	VBP	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
the	DT	O
novel	JJ	O
and	CC	O
distinct	JJ	O
depot-specific	JJ	O
mechanisms	NNS	O
driving	VBG	O
healthier	JJR	O
fat	JJ	O
patterning	NN	O
and	CC	O
function	NN	O
as	IN	O
a	DT	O
result	NN	O
of	IN	B-REL
reduced	VBN	I-REL
intra-adipose	JJ	O
glucocorticoid	NN	O
levels	NNS	O
...	:	O

...	:	O
Researchers	NNS	O
at	IN	O
the	DT	O
University	NNP	O
of	IN	O
Edinburgh	NNP	O
have	VBP	O
pinpointed	VBN	O
a	DT	B-REL
protein	NN	O
that	WDT	B-REL
plays	VBZ	I-REL
a	DT	O
part	NN	B-REL
in	IN	O
how	WRB	O
fat	JJ	O
is	VBZ	O
stored	VBN	O
in	IN	O
the	DT	O
body	NN	O
...	:	O

...	:	O
The	DT	O
protein	NN	O
plays	VBZ	B-REL
a	DT	I-REL
part	NN	I-REL
in	IN	I-REL
how	WRB	O
and	CC	O
where	WRB	O
fat	JJ	O
is	VBZ	O
stored	VBN	O
in	IN	O
the	DT	O
body	NN	O
-	:	O
around	IN	O
the	DT	O
hips	NNS	O
or	CC	O
on	IN	O
the	DT	O
tummy	NN	O
...	:	O

...	:	O
Researchers	NNS	O
believe	VBP	O
apple-shaped	JJ	O
people	NNS	O
with	IN	O
large	JJ	O
tummies	NNS	O
have	VBP	O
a	DT	O
protein	NN	O
known	VBN	O
as	IN	O
11BetaHSD1	NN	O
which	WDT	B-REL
makes	VBZ	I-REL
them	PRP	I-REL
store	NN	I-REL
fat	JJ	O
around	IN	O
vital	JJ	O
organs	NNS	O
...	:	O

...	:	O
we	PRP	O
find	VBP	O
that	IN	O
following	VBG	O
assembly	NN	O
of	IN	O
the	DT	O
AIS	NNP	O
,	,	O
Nfasc186	NN	O
appears	VBZ	O
to	TO	B-REL
act	VB	I-REL
as	IN	I-REL
an	DT	I-REL
anchor	NN	I-REL
that	WDT	O
maintains	VBZ	O
the	DT	O
appropriate	JJ	O
localization	NN	O
of	IN	O
critical	JJ	O
components	NNS	O
including	VBG	O
AnkryinG	NN	O
and	CC	O
sodium	NN	O
channels	NNS	O
...	:	O

...	:	O
This	DT	O
causes	VBZ	B-REL
AIS	NNP	O
disintegration	NN	O
,	,	O
impairment	NN	O
of	IN	O
motor	NN	O
learning	NN	O
and	CC	O
the	DT	O
abolition	NN	O
of	IN	O
the	DT	O
spontaneous	JJ	O
tonic	JJ	O
discharge	NN	O
typical	JJ	O
of	IN	O
Purkinje	NN	O
cells	NNS	O
...	:	O

...	:	O
University	NNP	O
scientists	NNS	O
have	VBP	O
identified	VBN	O
a	DT	O
protein	NN	O
crucial	JJ	B-REL
for	IN	I-REL
maintaining	VBG	O
the	DT	O
health	NN	O
and	CC	O
function	NN	O
of	IN	O
the	DT	O
segment	NN	O
of	IN	O
nerve	NN	O
fibres	NNS	O
...	:	O

...	:	O
The	DT	O
University	NNP	O
of	IN	O
Edinburgh	NNP	O
team	NN	O
said	VBD	O
the	DT	O
protein	NN	O
,	,	O
neurofacin	NN	O
,	,	O
is	VBZ	B-REL
crucial	JJ	I-REL
for	IN	I-REL
maintaining	VBG	O
the	DT	O
health	NN	O
and	CC	O
function	NN	O
of	IN	O
the	DT	O
segment	NN	O
of	IN	O
nerve	NN	O
fibres	NNS	O
that	WDT	O
controls	VBZ	O
transmission	NN	O
of	IN	O
messages	NNS	O
within	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
Scientists	NNS	O
at	IN	O
the	DT	O
University	NNP	O
of	IN	O
Edinburgh	NNP	O
said	VBD	O
the	DT	O
protein	NN	O
,	,	O
called	VBN	O
neurofacin	NN	O
,	,	O
is	VBZ	B-REL
crucial	JJ	I-REL
for	IN	I-REL
maintaining	VBG	O
the	DT	O
health	NN	O
and	CC	O
function	NN	O
of	IN	O
nerve	NN	O
fibres	NNS	O
...	:	O

...	:	O
Scientists	NNS	O
say	VBP	O
they	PRP	O
have	VBP	O
discovered	VBN	O
a	DT	O
``	``	O
maintenance	NN	O
''	''	O
protein	NN	O
that	WDT	B-REL
helps	VBZ	I-REL
keep	VB	I-REL
nerve	NN	O
fibres	NNS	O
that	WDT	O
transmit	VBP	O
messages	NNS	O
in	IN	O
the	DT	O
brain	NN	O
operating	NN	O
smoothly	RB	O
...	:	O

...	:	O
Edinburgh	NNP	O
University	NNP	O
researchers	NNS	O
say	VBP	O
the	DT	O
substance	NN	O
,	,	O
named	VBN	O
neurfacin	NN	O
,	,	O
is	VBZ	B-REL
crucial	JJ	I-REL
for	IN	I-REL
maintaining	VBG	O
the	DT	O
health	NN	O
and	CC	O
function	NN	O
of	IN	O
nerve	NN	O
fibres	NNS	O
...	:	O

...	:	O
the	DT	B-REL
use	NN	O
of	IN	O
a	DT	O
sensitive	JJ	O
troponin	NN	O
assay	NN	O
in	IN	O
patients	NNS	O
with	IN	O
suspected	VBN	O
ACS	NNP	O
increased	VBD	B-REL
the	DT	O
rate	NN	B-REL
of	IN	O
diagnosis	NN	O
of	IN	O
MI	NNP	O
and	CC	O
identified	VBD	O
a	DT	O
high-risk	JJ	O
group	NN	O
of	IN	O
patients	NNS	O
...	:	O

...	:	O
In	IN	O
patients	NNS	O
with	IN	O
suspected	VBN	O
ACS	NNP	O
,	,	O
implementation	NN	O
of	IN	O
a	DT	O
sensitive	JJ	O
troponin	NN	O
assay	NN	O
increased	VBD	B-REL
the	DT	I-REL
diagnosis	NN	O
of	IN	O
MI	NNP	O
and	CC	O
identified	VBN	O
patients	NNS	O
at	IN	O
high	JJ	O
risk	NN	O
of	IN	O
recurrent	JJ	O
MI	NNP	O
and	CC	O
death	NN	O
...	:	O

...	:	O
Blood	NN	O
test	NN	O
identifies	VBZ	O
more	JJR	B-REL
heart	NN	O
attacks	NNS	O
...	:	O

...	:	O
A	DT	O
BLOOD	NN	O
test	NN	O
that	WDT	B-REL
detects	VBZ	I-REL
heart	NN	O
attacks	NNS	O
that	WDT	O
would	MD	O
otherwise	RB	O
have	VB	O
gone	VBN	O
undiagnosed	JJ	O
has	VBZ	O
been	VBN	O
hailed	VBN	O
as	IN	O
a	DT	O
potential	JJ	O
lifesaver	NN	O
by	IN	O
scientists	NNS	O
...	:	O

...	:	O
New	NNP	O
test	NN	O
shows	VBZ	B-REL
rise	NN	I-REL
in	IN	I-REL
heart	NN	O
attack	NN	O
rates	NNS	O
...	:	O

...	:	O
The	DT	O
team	NN	O
at	IN	O
the	DT	B-REL
University	NNP	O
of	IN	B-REL
Edinburgh	NNP	O
found	VBD	O
that	IN	O
in	IN	O
patients	NNS	B-REL
admitted	VBN	O
to	TO	O
hospital	NN	O
with	IN	O
chest	NN	O
pains	NNS	O
,	,	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
more	RBR	O
sensitive	JJ	O
blood	NN	O
test	NN	O
to	TO	O
identify	VB	O
heart	NN	O
muscle	NN	O
damage	NN	O
increased	VBD	B-REL
the	DT	O
number	NN	B-REL
of	IN	O
patients	NNS	O
diagnosed	VBN	B-REL
with	IN	O
a	DT	O
heart	NN	O
attack	NN	O
by	IN	O
a	DT	O
third	JJ	O
...	:	O

...	:	O
Heart	NNP	O
attack	NN	O
test	NN	O
`	``	O
detects	VBZ	B-REL
more	JJR	I-REL
'	''	O
...	:	O

...	:	O
A	DT	O
BLOOD	NN	O
test	NN	O
found	VBN	B-REL
to	TO	I-REL
better	JJR	I-REL
detect	VB	I-REL
heart-attack	NN	O
risk	NN	O
should	MD	O
replace	VB	O
`	``	O
outdated	VBN	O
'	''	O
NHS	NN	O
tests	NNS	O
to	TO	O
save	VB	O
thousands	NNS	O
of	IN	O
lives	NNS	O
...	:	O

spatial	JJ	O
memory	NN	O
deficits	NNS	O
in	IN	O
aged	JJ	O
mice	NNS	O
are	VBP	O
ameliorated	VBN	O
by	IN	B-REL
central	JJ	O
GR	NN	O
antagonism	NN	O

plays	VBZ	B-REL
a	DT	I-REL
pivotal	JJ	I-REL
role	NN	I-REL
in	IN	I-REL
age-related	JJ	O
memory	NN	O
deficits	NNS	O

stress	NN	O
contributes	VBZ	O
to	TO	B-REL
memory	NN	O
loss	NN	O

...	:	O
SCIENTISTS	NNS	O
claim	VBP	O
they	PRP	O
have	VBP	O
discovered	VBN	O
how	WRB	O
stress	NN	O
can	MD	B-REL
contribute	VB	I-REL
to	TO	I-REL
forgetfulness	NN	O
in	IN	O
old	JJ	O
age	NN	O
...	:	O

stress	NN	O
could	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
memory	NN	O
loss	NN	O

...	:	O
Scientists	NNS	O
claim	VBP	O
to	TO	B-REL
have	VB	O
discovered	VBN	O
how	WRB	O
stress	NN	O
can	MD	B-REL
contribute	VB	I-REL
to	TO	O
memory	NN	O
loss	NN	O
in	IN	O
old	JJ	O
age	NN	O
...	:	O

how	WRB	O
stress	NN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
memory	NN	O
loss	NN	O
in	IN	O
old	JJ	O
age	NN	O
.	.	O

...	:	O
Our	PRP$	O
proteomics	NNS	O
experiments	NNS	O
also	RB	O
revealed	VBD	O
a	DT	O
significant	JJ	B-REL
influence	NN	I-REL
of	IN	O
apoE	NNP	O
genotype	NN	O
on	IN	O
the	DT	O
expression	NN	O
levels	NNS	O
of	IN	O
proteins	NNS	O
associated	VBN	O
with	IN	O
haematological	JJ	O
regulation	NN	O
...	:	O

...	:	O
these	DT	O
findings	NNS	O
have	VBP	O
identified	VBN	O
isoform-specific	JJ	O
roles	NNS	B-REL
for	IN	I-REL
apoE	NN	I-REL
in	IN	I-REL
determining	VBG	I-REL
the	DT	O
protein	NN	O
composition	NN	O
of	IN	O
peripheral	JJ	O
nerve	NN	O
as	RB	O
well	RB	O
as	IN	O
regulating	VBG	O
nerve	NN	O
regeneration	NN	O
pathways	NNS	O
in	FW	O
vivo	FW	O
...	:	O

...	:	O
Scientists	NNS	O
have	VBP	O
pinpointed	VBN	O
a	DT	O
gene	NN	O
that	WDT	O
controls	VBZ	B-REL
how	WRB	O
quickly	RB	O
a	DT	O
person	NN	O
's	POS	O
nerves	NNS	O
can	MD	O
regenerate	VB	O
after	IN	O
injury	NN	O
or	CC	O
disease	NN	O
...	:	O

...	:	O
Scientists	NNS	O
have	VBP	O
found	VBN	O
a	DT	O
gene	NN	O
which	WDT	B-REL
controls	VBZ	I-REL
how	WRB	O
quickly	RB	O
a	DT	O
person	NN	O
's	POS	O
nerves	NNS	O
can	MD	O
regenerate	VB	O
after	IN	O
injury	NN	O
or	CC	O
disease	NN	O
...	:	O

...	:	O
With	IN	O
the	DT	O
use	NN	O
of	IN	O
several	JJ	O
surrogate	JJ	O
measures	NNS	O
,	,	O
a	DT	O
range	NN	O
of	IN	O
adverse	JJ	O
cardiovascular	JJ	O
effects	NNS	O
of	IN	O
diesel	NN	O
exhaust	NN	O
inhalation	NN	O
in	IN	O
men	NNS	O
appears	VBZ	B-REL
to	TO	I-REL
be	VB	I-REL
prevented	VBN	I-REL
by	IN	I-REL
the	DT	O
introduction	NN	O
of	IN	O
a	DT	O
particle	NN	O
trap	NN	O
...	:	O

...	:	O
With	IN	O
a	DT	O
range	NN	O
of	IN	O
surrogate	JJ	O
measures	NNS	O
,	,	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
particle	NN	O
trap	NN	O
prevents	VBZ	B-REL
several	JJ	O
adverse	JJ	O
cardiovascular	JJ	O
effects	NNS	O
of	IN	O
exhaust	NN	O
inhalation	NN	O
in	IN	O
men	NNS	O
...	:	O

...	:	O
University	NNP	O
scientists	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
`	``	O
particle	NN	O
traps	NNS	O
'	POS	O
dramatically	RB	B-REL
reduce	VB	I-REL
the	DT	O
negative	JJ	O
effects	NNS	O
of	IN	O
diesel	NN	O
fumes	VBZ	O
on	IN	O
the	DT	O
heart	NN	O
and	CC	O
circulation	NN	O
and	CC	O
might	MD	O
reduce	VB	O
heart	NN	O
attack	NN	O
risk	NN	O
...	:	O

...	:	O
Our	PRP$	O
study	NN	O
has	VBZ	O
provided	VBN	O
the	DT	O
experimental	JJ	O
framework	NN	O
for	IN	O
dissecting	VBG	O
the	DT	O
contribution	NN	B-REL
of	IN	I-REL
transmission	NN	I-REL
stages	NNS	I-REL
to	TO	I-REL
the	DT	O
within-host	JJ	O
dynamics	NNS	O
of	IN	O
trypanosome	NN	O
infection	NN	O
,	,	O
which	WDT	O
in	IN	O
future	NN	O
must	MD	O
integrate	VB	O
with	IN	O
similarly	RB	O
detailed	JJ	O
analyses	NNS	O
of	IN	O
antigen	NN	O
switching	NN	O
and	CC	O
immune	JJ	O
responses	NNS	O
to	TO	O
provide	VB	O
a	DT	O
comprehensive	JJ	O
understanding	NN	O
of	IN	O
infection	NN	O
chronicity	NN	O
...	:	O

...	:	O
Our	PRP$	O
data	NNS	O
reveal	VBP	O
the	DT	O
dominance	NN	B-REL
of	IN	I-REL
transmission	NN	I-REL
stages	NNS	I-REL
throughout	IN	I-REL
infection	NN	I-REL
,	,	O
a	DT	O
consequence	NN	O
being	VBG	O
austere	JJ	O
use	NN	O
of	IN	O
the	DT	O
parasite	NN	O
's	POS	O
antigen	NN	O
repertoire	NN	O
...	:	O

...	:	O
This	DT	O
would	MD	O
be	VB	O
of	IN	O
particular	JJ	O
benefit	NN	O
during	IN	O
wound	NN	O
healing	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
where	WRB	O
type	NN	O
2-activated	JJ	O
macrophages	NNS	O
accelerate	VBP	B-REL
repair	NN	I-REL
...	:	O

...	:	O
Thus	RB	O
,	,	O
expansion	NN	O
of	IN	O
innate	JJ	O
cells	NNS	O
necessary	JJ	O
for	IN	O
pathogen	NN	O
control	NN	O
or	CC	O
wound	NN	O
repair	NN	O
can	MD	B-REL
occur	VB	I-REL
without	IN	O
recruitment	NN	O
of	IN	O
potentially	RB	O
tissue-destructive	JJ	O
inflammatory	JJ	O
cells	NNS	O
...	:	O

...	:	O
In	IN	O
conclusion	NN	O
,	,	O
both	CC	O
socioeconomic	JJ	O
deprivation	NN	O
and	CC	O
type	NN	O
2	CD	O
diabetes	NNS	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
increased	VBN	O
absolute	JJ	O
mortality	NN	O
risk	NN	O
,	,	O
but	CC	O
relative	JJ	O
mortality	NN	O
associated	VBN	O
with	IN	O
type	NN	O
2	CD	O
diabetes	NN	O
was	VBD	O
lower	JJR	O
among	IN	O
deprived	VBN	O
than	IN	O
affluent	JJ	O
populations	NNS	O
...	:	O

...	:	O
SES	NNP	O
modifies	VBZ	B-REL
the	DT	I-REL
association	NN	I-REL
between	IN	O
type	NN	O
2	CD	O
diabetes	NN	O
and	CC	O
mortality	NN	O
so	RB	O
that	IN	O
Relative	JJ	O
Risks	NNS	O
for	IN	O
mortality	NN	O
is	VBZ	O
lower	JJR	O
among	IN	O
more	JJR	O
deprived	VBN	O
populations	NNS	O
...	:	O

...	:	O
University	NNP	O
researchers	NNS	O
have	VBP	O
found	VBN	O
that	IN	O
people	NNS	O
with	IN	O
Type	NN	O
2	CD	O
diabetes	NN	O
from	IN	O
an	DT	O
affluent	JJ	O
background	NN	O
had	VBD	B-REL
the	DT	I-REL
same	JJ	I-REL
risk	NN	I-REL
of	IN	I-REL
dying	VBG	I-REL
as	IN	O
someone	NN	O
without	IN	O
the	DT	O
condition	NN	O
from	IN	O
a	DT	O
deprived	VBN	O
area	NN	O
...	:	O

...	:	O
our	PRP$	O
findings	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	B-REL
the	DT	O
notion	NN	O
that	IN	O
the	DT	O
mammalian	JJ	O
brain	NN	O
may	MD	B-REL
code	VB	I-REL
for	IN	O
spatial	JJ	O
information	NN	O
in	IN	O
a	DT	O
format	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
tied	VBN	O
to	TO	O
a	DT	O
specific	JJ	O
sensory	JJ	O
modality	NN	O
...	:	O

...	:	O
these	DT	O
findings	NNS	O
establish	VBP	O
the	DT	O
PPA/RSC	NN	O
network	NN	O
as	IN	O
critical	JJ	B-REL
in	IN	I-REL
modality-independent	JJ	O
spatial	JJ	O
computations	NNS	O
and	CC	O
provide	VBP	O
important	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
theory	NN	O
of	IN	O
high-level	JJ	O
abstract	JJ	O
spatial	JJ	O
information	NN	O
processing	NN	O
in	IN	O
the	DT	O
human	JJ	O
brain	NN	O
...	:	O

...	:	O
University	NNP	O
researchers	NNS	O
have	VBP	O
found	VBN	O
that	IN	O
our	PRP$	O
brain	NN	O
can	MD	B-REL
use	VB	I-REL
other	JJ	O
senses	NNS	O
-	:	O
such	JJ	O
as	IN	O
touch	NN	O
-	:	O
to	TO	O
help	VB	O
us	PRP	O
understand	VB	O
spatial	JJ	O
awareness	NN	O
...	:	O

...	:	O
we	PRP	O
report	VBP	O
a	DT	O
clear	JJ	B-REL
length-dependent	JJ	I-REL
inflammogenicity	NN	I-REL
for	IN	O
CNTs	NNS	O
when	WRB	O
injected	VBN	O
directly	RB	O
into	IN	O
the	DT	O
pleural	JJ	O
space	NN	O
of	IN	O
mice	NNS	O
...	:	O

...	:	O
Our	PRP$	O
data	NNS	O
confirm	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
,	,	O
although	IN	O
a	DT	B-REL
proportion	NN	O
of	IN	B-REL
all	DT	O
deposited	VBN	O
particles	NNS	O
passes	VBZ	O
through	IN	O
the	DT	O
pleura	NN	O
,	,	O
the	DT	O
pathogenicity	NN	O
of	IN	O
long	JJ	O
CNTs	NNS	O
and	CC	O
other	JJ	O
fibers	NNS	O
arises	VBZ	O
as	IN	B-REL
a	DT	O
result	NN	B-REL
of	IN	O
length-dependent	JJ	B-REL
retention	NN	I-REL
at	IN	O
the	DT	O
stomata	NN	O
on	IN	O
the	DT	O
parietal	JJ	O
pleura	NN	O
...	:	O

...	:	O
Nanotubes	NNS	O
pose	VBP	B-REL
health	NN	O
risk	NN	O
...	:	O

...	:	O
there	EX	O
was	VBD	O
an	DT	O
immediate	JJ	B-REL
up-regualtion	NN	I-REL
of	IN	O
the	DT	O
two	CD	O
IEGs	NNS	O
...	:	O

...	:	O
learning	NN	O
of	IN	O
new	JJ	O
paired	JJ	O
associates	NNS	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
striking	JJ	O
...	:	O

...	:	O
building	NN	O
on	IN	O
existing	VBG	O
knowledge	NN	O
activates	VBZ	B-REL
a	DT	O
key	JJ	O
set	NN	O
of	IN	O
genes	NNS	O
...	:	O

...	:	O
building	NN	O
on	IN	O
knowledge	NN	O
already	RB	O
possessed	VBD	O
activated	VBN	B-REL
a	DT	O
key	JJ	O
set	NN	O
of	IN	O
genes	NNS	O
...	:	O

...	:	O
Inhalation	NN	O
of	IN	O
dilute	VB	O
diesel	JJ	O
exhaust	NN	O
-LRB-	-LRB-	O
but	CC	O
not	RB	O
the	DT	O
associated	VBN	O
gaseous	JJ	O
pollutants	NNS	O
or	CC	O
carbon	NN	O
nanoparticles	NNS	O
alone	RB	O
-RRB-	-RRB-	O
impairs	VBZ	B-REL
vascular	JJ	O
function	NN	O
in	IN	O
man	NN	O
.	.	O

...	:	O
Combustion-derived	JJ	O
nanoparticulate	JJ	O
appears	VBZ	B-REL
to	TO	I-REL
predominately	RB	I-REL
mediate	VB	I-REL
the	DT	O
adverse	JJ	O
vascular	JJ	O
effects	NNS	O
of	IN	O
diesel	NN	O
exhaust	NN	O
inhalation	NN	O
...	:	O

...	:	O
ultrafine	NN	O
particles	NNS	O
produced	VBD	O
when	WRB	O
diesel	NN	O
burns	NNS	O
are	VBP	B-REL
harmful	JJ	I-REL
to	TO	I-REL
blood	NN	O
vessels	NNS	O
...	:	O

...	:	O
tiny	JJ	O
particles	NNS	O
produced	VBN	O
when	WRB	O
diesel	NN	O
burns	NNS	O
are	VBP	B-REL
harmful	JJ	I-REL
to	TO	I-REL
blood	NN	O
vessels	NNS	O
...	:	O

...	:	O
INVISIBLE	JJ	O
chemicals	NNS	O
in	IN	O
diesel	NN	O
fumes	VBZ	O
are	VBP	B-REL
triggering	VBG	I-REL
heart	NN	O
attacks	NNS	O
and	CC	O
strokes	NNS	O
...	:	O

...	:	O
minuscule	JJ	O
particles	NNS	O
produced	VBN	O
by	IN	O
burning	VBG	O
diesel	NN	O
can	MD	B-REL
increase	VB	I-REL
the	DT	O
chance	NN	O
of	IN	O
blood	NN	O
clots	NNS	O
forming	VBG	O
in	IN	O
arteries	NNS	O
...	:	O

...	:	O
that	IN	O
chemical	NN	O
particles	NNS	O
emitted	VBN	O
by	IN	O
diesel	NN	O
exhaust	NN	O
fumes	VBZ	O
significantly	RB	B-REL
increase	VB	I-REL
the	DT	O
risk	NN	O
of	IN	O
heart	NN	O
attack	NN	O
...	:	O

It	PRP	O
is	VBZ	O
noteworthy	JJ	O
that	IN	O
although	IN	O
both	CC	O
human	JJ	O
and	CC	O
trypanosomal	JJ	O
PYKs	NNS	O
are	VBP	O
inhibited	VBN	B-REL
by	IN	I-REL
suramin	NN	O
,	,	O
a	DT	O
clear	JJ	O
cell	NN	O
uptake/entry	NN	O
mechanism	NN	O
for	IN	O
this	DT	O
highly	RB	O
charged	VBN	O
molecule	NN	O
remains	VBZ	O
controversial	JJ	O

large	JJ	O
proportion	NN	O
of	IN	O
the	DT	O
heritability	NN	O
estimate	NN	O
of	IN	O
intelligence	NN	O
in	IN	O
middle	JJ	O
to	TO	O
older	JJR	O
adulthood	NN	O
can	MD	B-REL
be	VB	I-REL
traced	VBN	O
to	TO	O
biological	JJ	O
variation	NN	O
using	VBG	O
SNP	NN	O
data	NNS	O

a	DT	O
substantial	JJ	O
proportion	NN	O
of	IN	O
individual	JJ	O
differences	NNS	O
in	IN	O
human	JJ	O
intelligence	NN	O
is	VBZ	B-REL
due	JJ	I-REL
to	TO	I-REL
genetic	JJ	O
variation	NN	O

Scientists	NNS	O
have	VBP	O
provided	VBN	O
the	DT	O
first	JJ	O
direct	JJ	O
biological	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
genetic	JJ	O
contribution	NN	O
to	TO	B-REL
people	NNS	O
's	POS	O
intelligence	NN	O

HALF	NN	O
OF	IN	O
YOUR	JJ	O
INTELLIGENCE	NN	O
COMES	VBZ	B-REL
FROM	IN	I-REL
YOUR	JJ	O
PARENTS	NNS	O

Genetic	JJ	O
factors	NNS	O
explain	VBP	B-REL
about	IN	O
half	PDT	O
the	DT	O
differences	NNS	O
between	IN	O
individual	JJ	O
people	NNS	O
's	POS	O
intelligence	NN	O

Genetic	JJ	O
differences	NNS	O
between	IN	O
people	NNS	O
account	VBP	B-REL
for	IN	I-REL
up	RB	O
to	TO	O
half	NN	O
of	IN	O
the	DT	O
variation	NN	O
in	IN	O
intelligence	NN	O

...	:	O
rivaroxaban	NN	O
was	VBD	O
noninferior	JJ	B-REL
to	TO	I-REL
warfarin	NN	O
in	IN	O
the	DT	O
prevention	NN	O
of	IN	O
subsequent	JJ	O
stroke	NN	O
or	CC	O
systematic	JJ	O
embolism	NN	O
...	:	O

...	:	O
in	IN	O
patients	NNS	O
with	IN	O
atrial	JJ	O
fibrillation	NN	O
,	,	O
rivaroxaban	NN	O
was	VBD	B-REL
noninferior	JJ	I-REL
to	TO	I-REL
wararin	VB	O
for	IN	O
the	DT	O
prevention	NN	O
of	IN	O
stroke	NN	O
or	CC	O
systemic	JJ	O
embolism	NN	O
...	:	O

...	:	O
rivaroxaban	NN	O
is	VBZ	O
twice	RB	B-REL
as	RB	I-REL
effective	JJ	I-REL
at	IN	I-REL
blocking	VBG	I-REL
fatal	JJ	O
brain	NN	O
bleeds	NNS	O
...	:	O

...	:	O
the	DT	O
new	JJ	O
treatment	NN	O
was	VBD	O
found	VBN	B-REL
to	TO	I-REL
be	VB	I-REL
as	RB	I-REL
effective	JJ	I-REL
as	IN	O
warfarin	NN	O
...	:	O

...	:	O
rivaroxaban	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	B-REL
as	RB	I-REL
effective	JJ	I-REL
as	IN	O
warfarin	NN	O
...	:	O

...	:	O
an	DT	O
anti-clotting	JJ	O
pill	NN	O
from	IN	O
Bayer	NNP	O
-LRB-	-LRB-	O
BAYGn.DE	NNP	O
-RRB-	-RRB-	O
and	CC	O
Johnson	NNP	O
&	CC	O
Johnson	NNP	O
offers	VBZ	O
a	DT	O
new	JJ	B-REL
way	NN	I-REL
of	IN	I-REL
preventing	VBG	I-REL
stroke	NN	O
...	:	O

...	:	O
a	DT	O
focussed	JJ	O
candidate	NN	O
gene	NN	O
enrichment	NN	O
strategy	NN	O
in	IN	O
the	DT	O
unique	JJ	O
F	NN	O
and	CC	O
L	NN	O
model	NN	O
has	VBZ	O
identified	VBN	O
novel	JJ	O
adipose	NN	O
tissue-enriched	JJ	O
genes	NNS	O
contributing	VBG	B-REL
to	TO	O
obesity	NN	O
...	:	O

...	:	O
has	VBZ	O
identified	VBN	O
novel	JJ	O
adipose	NN	O
tissue-enriched	JJ	O
genes	NNS	O
contributing	VBG	B-REL
to	TO	I-REL
obesity	NN	O
...	:	O

...	:	O
have	VBP	O
identified	VBN	O
a	DT	O
number	NN	O
of	IN	O
genes	NNS	O
in	IN	O
fat	JJ	O
tissue	NN	O
that	WDT	B-REL
may	MD	I-REL
lead	VB	I-REL
us	PRP	O
to	TO	O
retain	VB	O
fat	JJ	O
unnecessarily	RB	O
in	IN	O
the	DT	O
body	NN	O
...	:	O

...	:	O
fat	JJ	O
genes	NNS	O
that	WDT	B-REL
make	VBP	I-REL
some	DT	I-REL
pile	NN	I-REL
on	IN	I-REL
the	DT	I-REL
pounds	NNS	I-REL
...	:	O

...	:	O
being	VBG	O
fat	JJ	O
is	VBZ	B-REL
all	DT	I-REL
in	IN	I-REL
the	DT	I-REL
genes	NNS	O
...	:	O

overconfidence	NN	O
maximizes	VBZ	B-REL
individual	JJ	O
fitness	NN	O

Why	WRB	O
self-delusion	NN	O
produces	VBZ	B-REL
winners	NNS	O

COCKY	JJ	O
people	NNS	O
are	VBP	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	I-REL
succeed	VB	I-REL
in	IN	O
life	NN	O

The	DT	O
ability	NN	O
of	IN	O
three	CD	O
sigma	NN	O
viruses	NNS	O
to	TO	O
persist	VB	O
and	CC	O
replicate	VB	O
in	IN	O
51	CD	O
different	JJ	O
species	NNS	O
of	IN	O
Drosophilia	NNP	O
is	VBZ	O
largely	RB	B-REL
explained	VBN	I-REL
by	IN	O
the	DT	O
host	NN	O
phylogeny	NN	O

Most	JJS	O
of	IN	O
this	DT	O
effect	NN	O
could	MD	B-REL
be	VB	I-REL
explained	VBN	I-REL
by	IN	O
variation	NN	O
in	IN	O
general	JJ	O
susceptibility	NN	O
to	TO	O
all	DT	O
three	CD	O
sigma	NN	O
viruses	NNS	O
,	,	O
as	IN	O
there	EX	O
is	VBZ	O
a	DT	O
strong	JJ	O
phylogenetic	JJ	O
correlation	NN	O
in	IN	O
the	DT	O
titres	NNS	O
of	IN	O
the	DT	O
three	CD	O
viruses	NNS	O

...	:	O
a	DT	O
toxin	NN	O
released	VBN	B-REL
by	IN	I-REL
virtually	RB	I-REL
all	DT	I-REL
strains	NNS	I-REL
of	IN	I-REL
MRSA	NNP	O
...	:	O

...	:	O
virtually	RB	O
all	DT	O
strand	NN	O
of	IN	O
bacterium	NN	O
release	VBP	B-REL
the	DT	I-REL
poison	NN	I-REL
SEIX	NNP	O
...	:	O

...	:	O
a	DT	O
toxin	NN	O
released	VBN	B-REL
by	IN	I-REL
virtually	RB	I-REL
all	DT	I-REL
strains	NNS	I-REL
of	IN	I-REL
MRSA	NNP	O
...	:	O

...	:	O
a	DT	O
toxin	NN	O
released	VBN	O
by	IN	B-REL
virtually	RB	I-REL
all	DT	I-REL
strains	NNS	I-REL
of	IN	I-REL
MRSA	NNP	I-REL
could	MD	O
help	VB	O
scientists	NNS	O
develop	VB	O
drugs	NNS	O
that	WDT	O
can	MD	O
fight	VB	O
the	DT	O
superbug	NN	O
...	:	O

Three	CD	O
doses	NNS	O
of	IN	O
MSP-1	NN	O
hybrid	NN	O
formulated	VBN	O
in	IN	O
CoVaccine	NNP	O
HT	NNP	O
elicited	VBD	B-REL
potent	JJ	O
immunogenicity	NN	O
in	IN	O
Rhesus	NNP	O
monkeys	NNS	O

MSP-1	NN	O
hybrid	NN	O
...	:	O
eliciting	VBG	B-REL
antibodies	NNS	O
against	IN	O
epitopes	NNS	O
from	IN	O
all	DT	O
three	CD	O
Block	NNP	O
2	CD	O
serotypes	NNS	O

A	DT	O
new	JJ	O
malaria	NN	O
vaccine	NN	O
has	VBZ	O
been	VBN	O
created	VBN	O
to	TO	O
target	VB	B-REL
different	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O

The	DT	O
vaccine	NN	O
is	VBZ	O
designed	VBN	O
to	TO	B-REL
trigger	VB	I-REL
production	NN	O
of	IN	O
a	DT	O
range	NN	O
of	IN	O
antibodies	NNS	O

SCIENTISTS	NNS	O
have	VBP	O
developed	VBN	O
a	DT	O
malaria	NN	O
vaccine	NN	O
to	TO	B-REL
tackle	VB	I-REL
different	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O

All	DT	O
aspects	NNS	O
of	IN	O
the	DT	O
near-death	JJ	O
experience	NN	O
have	VBP	B-REL
a	DT	I-REL
neurophysiological	JJ	O
or	CC	O
psychological	JJ	O
basis	NN	O

Near-death	JJ	O
experiences	NNS	O
are	VBP	B-REL
the	DT	O
manifestation	NN	O
of	IN	O
normal	JJ	O
brain	NN	O
function	NN	O
gone	VBN	O
awry	RB	O

Near-death	JJ	O
experiences	NNS	O
are	VBP	O
not	RB	O
paranormal	JJ	O
but	CC	O
triggered	VBN	B-REL
by	IN	I-REL
a	DT	O
change	NN	O
in	IN	O
normal	JJ	O
brain	NN	O
function	NN	O

It	PRP	B-REL
's	VBZ	I-REL
your	PRP$	O
brian	NN	O
playing	VBG	O
tricks	NNS	O

are	VBP	B-REL
triggered	VBN	I-REL
by	IN	I-REL
a	DT	O
change	NN	O
in	IN	O
normal	JJ	O
brain	NN	O
function	NN	O

Near-death	JJ	O
experiences	NNS	O
are	VBP	B-REL
simply	RB	O
manifestations	NNS	O
of	IN	O
normal	JJ	O
brain	NN	O
functions	NNS	O
gone	VBN	O
awry	RB	O

Near-death	JJ	O
experiences	NNS	O
are	VBP	O
not	RB	O
paranormal	JJ	O
but	CC	O
triggered	VBN	B-REL
by	IN	I-REL
a	DT	O
change	NN	O
in	IN	O
normal	JJ	O
brain	NN	O
function	NN	O

at	IN	O
least	JJS	O
50	CD	O
%	NN	O
of	IN	O
the	DT	O
case	NN	O
de	IN	O
novos	NNS	O
are	VBP	B-REL
relevant	JJ	I-REL
to	TO	I-REL
the	DT	O
pathophysiology	NN	O
of	IN	O
schizophrenia	NN	O

confirming	VBG	O
the	DT	B-REL
involvement	NN	I-REL
of	IN	O
de	FW	O
novo	FW	O
CNVs	FW	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
schizophrenia	NN	O

Genetic	JJ	O
mutations	NNS	O
that	WDT	O
cause	VBP	B-REL
schizophrenia	NN	O

...	:	O
IRG1	NN	O
has	VBZ	O
a	DT	B-REL
role	NN	I-REL
in	IN	I-REL
the	DT	I-REL
apoptosis	NN	O
pathway	NN	O
.	.	O

...	:	O
One	CD	O
of	IN	O
these	DT	O
genes	NNS	O
,	,	O
IRG1	NN	O
,	,	O
was	VBD	O
confirmed	VBN	O
by	IN	O
single	JJ	O
nucleotide	NN	O
polymorphism	NN	O
analysis	NN	O
to	TO	B-REL
be	VB	I-REL
involved	VBN	I-REL
in	IN	I-REL
susceptibility	NN	O
...	:	O

Following	VBG	O
peripheral	JJ	O
exposure	NN	O
PrPc-expressing	JJ	O
FDC	NN	O
alone	RB	O
are	VBP	O
sufficient	JJ	B-REL
to	TO	I-REL
sustain	VB	I-REL
high	JJ	O
levels	NNS	O
of	IN	O
prion	NN	O
replication	NN	O
in	IN	O
the	DT	O
spleen	NN	O

PrPc	NN	O
expression	NN	O
only	RB	O
on	IN	O
FDC	NN	O
is	VBZ	O
sufficient	JJ	B-REL
to	TO	I-REL
sustain	VB	I-REL
prion	NN	O
replication	NN	O
in	IN	O
the	DT	O
spleen	NN	O

A	DT	O
protein	NN	O
linked	VBN	O
to	TO	O
the	DT	O
immune	JJ	O
system	NN	O
could	MD	B-REL
play	VB	I-REL
a	DT	I-REL
key	JJ	I-REL
role	NN	I-REL
in	IN	O
helping	VBG	O
scientists	NNS	O
understand	VB	O
how	WRB	O
vCJD	NNP	O
spread	VBD	O
throughout	IN	O
the	DT	O
body	NN	O

Blocking	VBG	O
the	DT	O
production	NN	O
of	IN	O
proteins	NNS	O
in	IN	O
the	DT	O
immune	JJ	O
system	NN	O
could	MD	B-REL
prevent	VB	I-REL
the	DT	O
spread	NN	O
of	IN	O
a	DT	O
disease	NN	O
that	WDT	O
destroys	VBZ	O
nerve	NN	O
cells	NNS	O

The	DT	O
knockdown	NN	O
of	IN	O
its	PRP$	O
-LRB-	-LRB-	O
single	JJ	O
-RRB-	-RRB-	O
homologue	NN	O
in	IN	O
flies	NNS	O
shortens	VBZ	B-REL
sleep	NN	O
duration	NN	O

RNA	NN	O
interference	NN	O
knockdown	NN	O
experiments	NNS	O
of	IN	O
the	DT	O
conserved	VBN	O
ABCC9	NN	O
homologue	NN	O
in	IN	O
Drosophila	FW	O
neurons	NNS	O
renders	VBZ	B-REL
flies	NNS	O
sleepless	JJ	O
during	IN	O
the	DT	O
first	JJ	O
3	CD	O
h	NN	O
of	IN	O
the	DT	O
night	NN	O

Need	VBN	O
for	IN	O
sleep	NN	O
lies	VBZ	B-REL
in	IN	O
our	PRP$	O
genes	NNS	O

Blame	VB	B-REL
your	PRP$	O
genes	NNS	O
...	:	O

Mutant	JJ	O
gene	NN	O
'	''	O
to	TO	O
blame	VB	B-REL
for	IN	O
laziness	NN	O

SOME	NNP	O
people	NNS	O
may	MD	O
need	VB	O
more	JJR	O
sleep	NN	O
than	IN	O
others	NNS	O
because	IN	B-REL
they	PRP	O
carry	VBP	O
a	DT	O
certain	JJ	O
gene	NN	O
variant	NN	O

Blame	VB	B-REL
your	PRP$	O
parents	NNS	O

People	NNS	O
who	WP	O
like	VBP	O
a	DT	O
lie-in	NN	O
may	MD	O
now	RB	O
have	VB	O
an	DT	O
excuse	NN	O
-	:	O
it	PRP	O
is	VBZ	O
at	IN	O
least	JJS	O
partly	RB	O
down	IN	B-REL
to	TO	I-REL
their	PRP$	O
genes	NNS	O

some	DT	O
people	NNS	O
may	MD	O
need	VB	O
more	JJR	O
sleep	NN	O
than	IN	O
others	NNS	O
because	IN	B-REL
they	PRP	O
carry	VBP	O
a	DT	O
certain	JJ	O
gene	NN	O
variant	NN	O

...	:	O
the	DT	O
evaluation	NN	O
of	IN	O
aortic	JJ	O
stenosis	NN	O
using	VBG	O
PET	NN	O
is	VBZ	B-REL
feasible	JJ	I-REL
and	CC	I-REL
highly	RB	I-REL
reproducible	JJ	I-REL
...	:	O

...	:	O
positron	NN	O
emission	NN	O
tomography	NN	O
is	VBZ	O
a	DT	O
novel	JJ	B-REL
,	,	I-REL
feasible	JJ	I-REL
and	CC	I-REL
repeatable	JJ	I-REL
approach	NN	I-REL
to	TO	O
the	DT	O
evaluation	NN	O
of	IN	O
valvular	JJ	O
calcification	NN	O
and	CC	O
inflammation	NN	O
in	IN	O
patients	NNS	O
with	IN	O
aortic	JJ	O
stenosis	NN	O
...	:	O

...	:	O
Patients	NNS	O
with	IN	O
life-threatening	JJ	O
heart	NN	O
valve	NN	O
disease	NN	O
could	MD	O
be	VB	O
helped	VBN	O
with	IN	O
alternative	JJ	O
scanning	NN	O
techniques	NNS	O
that	WDT	B-REL
provide	VBP	I-REL
greater	JJR	I-REL
insight	NN	I-REL
into	IN	I-REL
the	DT	O
condition	NN	O
...	:	O

...	:	O
Using	VBG	O
this	DT	O
novel	JJ	O
model	NN	O
we	PRP	O
can	MD	B-REL
statistically	RB	I-REL
significantly	RB	I-REL
improve	VB	I-REL
the	DT	I-REL
overall	JJ	I-REL
prediction	NN	I-REL
of	IN	I-REL
live	JJ	O
birth	NN	O
as	IN	O
assessed	VBN	O
by	IN	O
area	NN	O
under	IN	O
the	DT	O
curve	NN	O
and	CC	O
attain	VB	O
excellent	JJ	O
calibration	NN	O
with	IN	O
accurate	JJ	O
identification	NN	O
of	IN	O
couples	NNS	O
with	IN	O
a	DT	O
poor	JJ	O
,	,	O
moderate	JJ	O
,	,	O
or	CC	O
good	JJ	O
prognosis	NN	O
...	:	O

...	:	O
our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
couple	NN	O
-	:	O
and	CC	O
treatment-specific	JJ	O
factors	NNS	O
can	MD	B-REL
be	VB	I-REL
used	VBN	I-REL
to	TO	O
provide	VB	O
infertile	JJ	O
couples	NNS	O
with	IN	O
an	DT	O
accurate	JJ	O
assessment	NN	O
of	IN	O
whether	IN	O
they	PRP	O
have	VBP	O
low	JJ	O
or	CC	O
high	JJ	O
risk	NN	O
of	IN	O
a	DT	O
successful	JJ	O
outcome	NN	O
following	VBG	O
IVF	NN	O
...	:	O

...	:	O
Researchers	NNS	O
have	VBP	O
produced	VBN	O
a	DT	O
calculator	NN	O
which	WDT	O
gives	VBZ	B-REL
the	DT	I-REL
most	RBS	I-REL
accurate	JJ	I-REL
reading	NN	I-REL
yet	RB	I-REL
on	IN	I-REL
the	DT	O
potential	JJ	B-REL
success	NN	I-REL
of	IN	O
IVF	NN	O
treatment	NN	O
...	:	O

...	:	O
A	DT	O
60-SECOND	JJ	O
test	NN	O
which	WDT	O
predicts	VBZ	B-REL
couples	NNS	I-REL
'	POS	I-REL
chances	NNS	I-REL
of	IN	O
having	VBG	O
a	DT	O
baby	NN	O
through	IN	O
IVF	NNP	O
has	VBZ	O
been	VBN	O
created	VBN	O
by	IN	O
scientists	NNS	O
...	:	O

...	:	O
The	DT	O
most	RBS	O
accurate	JJ	O
test	NN	O
to	TO	O
tell	VB	O
infertile	JJ	O
couples	NNS	O
whether	IN	O
they	PRP	O
will	MD	O
conceive	VB	O
has	VBZ	B-REL
a	DT	I-REL
99	CD	I-REL
%	NN	I-REL
success	NN	I-REL
rate	NN	I-REL
for	IN	I-REL
predictions	NNS	I-REL
...	:	O

...	:	O
AN	DT	O
IVF	NN	O
calculator	NN	O
that	WDT	O
can	MD	B-REL
predict	VB	I-REL
in	IN	O
just	RB	O
60	CD	O
seconds	NNS	O
a	DT	O
couple	NN	O
's	POS	O
chances	NNS	O
of	IN	O
conceiving	VBG	O
through	IN	O
treatment	NN	O
was	VBD	O
unveiled	VBN	O
yesterday	NN	O
...	:	O

...	:	O
IVF	NN	O
calculator	NN	O
aims	VBZ	O
to	TO	O
give	VB	B-REL
99	CD	I-REL
%	NN	I-REL
accurate	JJ	I-REL
pregnancy	NN	I-REL
predictions	NNS	I-REL
...	:	O

...	:	O
TMS	NN	O
bursts	NNS	O
did	VBD	O
not	RB	O
impair	VB	O
but	CC	B-REL
rather	RB	I-REL
enhanced	VBD	I-REL
performance	NN	I-REL
in	IN	O
a	DT	O
frequency-dependent	JJ	O
way	NN	O
...	:	O

...	:	O
we	PRP	O
show	VBP	O
via	IN	O
transcranial	JJ	O
magnetic	JJ	O
stimulation	NN	O
-LRB-	-LRB-	O
TMS	NN	O
-RRB-	-RRB-	O
interventions	NNS	O
that	WDT	O
short	RB	O
rhythmic	JJ	O
bursts	NNS	O
of	IN	O
right-parietal	JJ	O
TMS	NNS	O
at	IN	O
theta	NN	O
or	CC	O
beta	NN	O
frequency	NN	O
can	MD	B-REL
causally	RB	I-REL
benefit	VB	I-REL
processing	NN	O
of	IN	O
global	JJ	O
or	CC	O
local	JJ	O
levels	NNS	O
...	:	O

...	:	O
Researchers	NNS	O
at	IN	O
the	DT	O
University	NNP	O
of	IN	O
Glasgow	NNP	O
and	CC	O
University	NNP	O
College	NNP	O
London	NNP	O
-LRB-	-LRB-	O
UCL	NNP	O
-RRB-	-RRB-	O
have	VBP	O
,	,	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
enhanced	VBD	B-REL
visual	JJ	I-REL
perception	NN	I-REL
through	IN	O
rhythmic	JJ	O
transcranial	JJ	O
magnetic	JJ	O
stimulation	NN	O
-LRB-	-LRB-	O
rTMS	NN	O
-RRB-	-RRB-	O
of	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
from	IN	O
a	DT	B-REL
public	JJ	O
health	NN	O
perspective	NN	O
it	PRP	O
suggests	VBZ	B-REL
a	DT	O
link	NN	B-REL
between	IN	I-REL
perceptions	NNS	O
of	IN	O
parenting	NN	O
and	CC	O
more	JJR	O
general	JJ	O
mental	JJ	O
health	NN	O
...	:	O

...	:	O
children	NNS	O
's	POS	O
perceptions	NNS	O
of	IN	O
neglect	NN	O
and	CC	O
control	NN	O
are	VBP	B-REL
associated	VBN	I-REL
with	IN	I-REL
over	IN	O
twice	RB	O
the	DT	O
odds	NNS	O
of	IN	O
psychiatric	JJ	O
disorder	NN	O
at	IN	O
age	NN	O
15	CD	O
...	:	O

...	:	O
Neglectful	NNP	O
and	CC	O
controlling	VBG	O
parents	NNS	O
linked	VBN	B-REL
to	TO	I-REL
mental	JJ	O
health	NN	O
problems	NNS	O
in	IN	O
children	NNS	O
...	:	O

...	:	O
Taken	VBN	O
together	RB	O
,	,	B-REL
we	PRP	O
believe	VBP	O
that	IN	O
our	PRP$	O
data	NNS	O
demonstrate	VBP	O
the	DT	O
crucial	JJ	O
role	NN	B-REL
of	IN	I-REL
context	NN	I-REL
,	,	O
carried	VBN	O
by	IN	O
the	DT	O
physiological	JJ	O
mechanisms	NNS	O
of	IN	O
feedback	NN	O
and/or	CC	O
lateral	JJ	O
interaction	NN	O
,	,	O
in	IN	O
driving	VBG	O
activity	NN	O
even	RB	O
in	IN	O
nonstimulated	JJ	O
early	JJ	O
visual	JJ	O
areas	NNS	O
...	:	O

...	:	O
We	PRP	O
show	VBP	O
further	RBR	O
that	IN	O
the	DT	O
activity	NN	O
patterns	NNS	O
in	IN	O
these	DT	O
regions	NNS	O
are	VBP	O
significantly	RB	O
related	JJ	B-REL
to	TO	I-REL
those	DT	O
observed	VBN	O
with	IN	O
feed-forward	JJ	O
stimulation	NN	O
and	CC	O
that	IN	O
these	DT	O
effects	NNS	O
are	VBP	O
driven	VBN	O
primarily	RB	O
by	IN	O
V1	NN	O
...	:	O

...	:	O
What	WP	O
our	PRP$	O
eyes	NNS	O
ca	MD	O
n't	RB	O
see	VB	O
,	,	O
the	DT	B-REL
brain	NN	I-REL
fills	VBZ	I-REL
in	IN	I-REL
...	:	O

...	:	O
Taken	VBN	O
together	RB	O
,	,	O
our	PRP$	O
in	FW	O
vitro	FW	O
,	,	O
in	FW	O
vivo	FW	O
and	CC	O
clinical	JJ	O
data	NNS	O
support	VBP	B-REL
an	DT	I-REL
important	JJ	I-REL
role	NN	I-REL
for	IN	I-REL
the	DT	O
MEK5-ERK5	NN	O
signalling	NN	O
pathway	NN	O
in	IN	O
invasive	JJ	O
PCa	NN	O
...	:	O

...	:	O
Our	PRP$	O
in	FW	O
vitro	FW	O
,	,	O
in	FW	O
vivo	FW	O
and	CC	O
clinical	JJ	O
data	NNS	O
support	VBP	O
an	DT	B-REL
important	JJ	I-REL
role	NN	I-REL
for	IN	O
the	DT	O
MEK5-ERK5	NN	O
signalling	NN	O
pathway	NN	O
in	IN	O
invasive	JJ	O
Pca	NN	O
...	:	O

...	:	O
Scientists	NNS	O
at	IN	O
the	DT	O
University	NNP	O
have	VBP	O
discovered	VBN	O
how	WRB	O
a	DT	O
protein	NN	O
present	JJ	O
in	IN	O
prostate	NN	O
cancer	NN	O
cells	NNS	O
drives	VBZ	B-REL
growth	NN	O
of	IN	O
the	DT	O
disease	NN	O
...	:	O

...	:	O
Scientists	NNS	O
at	IN	O
Glasgow	NNP	O
University	NNP	O
believe	VBP	O
they	PRP	O
can	MD	B-REL
cut	VB	I-REL
deaths	NNS	O
from	IN	O
prostate	NN	O
cancer	NN	O
by	IN	O
targeting	VBG	O
a	DT	O
protein	NN	O
that	WDT	O
drives	VBZ	O
the	DT	O
disease	NN	O
...	:	O

diabetes	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
substantial	JJ	O
premature	JJ	O
death	NN	O
from	IN	O
several	JJ	O
cancers	NNS	O
,	,	O
infectious	JJ	O
diseases	NNS	O
,	,	O
external	JJ	O
causes	NNS	O
,	,	O
intentional	JJ	O
self-harm	NN	O
,	,	O
and	CC	O
degenerative	JJ	O
disorders	NNS	O
,	,	O
independent	JJ	O
of	IN	O
major	JJ	O
risk	NN	O
factors	NNS	O

diabetes	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
substantial	JJ	O
premature	JJ	O
death	NN	O
from	IN	O
several	JJ	O
cancers	NNS	O
,	,	O
infectious	JJ	O
diseases	NNS	O
,	,	O
external	JJ	O
causes	NNS	O
,	,	O
intentional	JJ	O
selfharm	NN	O
,	,	O
and	CC	O
degenerative	JJ	O
disorders	NNS	O
,	,	O
independent	JJ	O
of	IN	O
several	JJ	O
major	JJ	O
risk	NN	O
factors	NNS	O

Middle	NNP	O
aged	JJ	O
diabetes	NN	O
patients	NNS	O
can	MD	B-REL
die	VB	I-REL
six	CD	O
years	NNS	O
earlier	RBR	O

HAVING	VBG	O
diabetes	NN	O
in	IN	O
middle	JJ	O
age	NN	O
will	MD	B-REL
cut	VB	I-REL
your	PRP$	I-REL
life	NN	I-REL
short	JJ	O
by	IN	O
an	DT	O
average	NN	O
of	IN	O
six	CD	O
years	NNS	O

the	DT	O
disease	NN	O
also	RB	O
raises	VBZ	B-REL
the	DT	O
risk	NN	O
of	IN	O
dying	VBG	O
prematurely	RB	O
from	IN	O
a	DT	O
host	NN	O
of	IN	O
other	JJ	O
ailments	NNS	O
,	,	O
even	RB	O
breast	NN	O
cancer	NN	O
and	CC	O
pneumonia	NN	O

having	VBG	O
diabetes	NN	O
also	RB	O
ups	NNS	B-REL
the	DT	O
risk	NN	O
of	IN	O
dying	VBG	O
from	IN	O
many	JJ	O
cancers	NNS	O
and	CC	O
other	JJ	O
diseases	NNS	O

...	:	O
Medical	NNP	O
U-turn	NN	O
on	IN	O
`	``	O
apple-shape	NN	O
'	''	O
warnings	NNS	O
:	:	O
It	PRP	B-REL
is	VBZ	O
n't	RB	O
especially	RB	B-REL
dangerous	JJ	I-REL
to	TO	O
the	DT	O
heart	NN	O
...	:	O

...	:	O
OBESE	JJ	O
adults	NNS	O
who	WP	O
carry	VBP	O
fat	JJ	O
around	IN	O
the	DT	O
waist	NN	O
do	VBP	B-REL
n't	RB	I-REL
have	VB	I-REL
an	DT	I-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
heart	NN	O
attacks	NNS	O
or	CC	O
strokes	NNS	O
,	,	O
researchers	NNS	O
said	VBD	O
today	NN	O
...	:	O

...	:	O
Pot	NNP	O
belly	NN	O
may	MD	B-REL
not	RB	I-REL
be	VB	I-REL
a	DT	I-REL
heart	NN	O
risk	NN	O
after	IN	O
all	DT	O
...	:	O

...	:	O
BEING	VBG	O
an	DT	O
``	``	O
apple	NN	O
''	''	O
shape	NN	O
is	VBZ	B-REL
no	DT	I-REL
less	JJR	I-REL
healthy	JJ	I-REL
than	IN	O
being	VBG	O
a	DT	O
``	``	O
pear	NN	O
''	''	O
...	:	O

...	:	O
A	DT	O
study	NN	O
of	IN	O
220,000	CD	O
people	NNS	O
published	VBN	O
Friday	NNP	O
confirmed	VBD	O
that	IN	B-REL
being	VBG	O
obese	JJ	O
--	:	O
having	VBG	O
a	DT	O
body	NN	O
mass	NN	O
index	NN	O
-LRB-	-LRB-	O
BMI	NN	O
-RRB-	-RRB-	O
of	IN	O
30	CD	O
or	CC	O
more	JJR	O
--	:	O
is	VBZ	O
a	DT	O
major	JJ	O
risk	NN	B-REL
factor	NN	O
for	IN	O
heart	NN	O
disease	NN	O
,	,	O
but	CC	O
found	VBD	O
the	DT	O
distribution	NN	O
of	IN	O
fat	NN	O
on	IN	B-REL
the	DT	O
body	NN	O
has	VBZ	O
no	DT	B-REL
impact	NN	I-REL
on	IN	O
that	DT	O
risk	NN	O
...	:	O

...	:	O
our	PRP$	O
pharmacological	JJ	O
and	CC	O
biochemical	JJ	O
data	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
a	DT	O
PAK1-MEK1	NN	O
pathway	NN	O
is	VBZ	B-REL
activated	VBN	I-REL
in	IN	I-REL
malaria	NN	O
parasite-infected	JJ	O
erythrocytes	NNS	O
...	:	O

...	:	O
we	PRP	O
report	VBP	O
that	IN	O
a	DT	O
protein	NN	O
kinase-mediated	JJ	O
signalling	NN	O
pathway	NN	O
involving	VBG	O
host	NN	O
RBC	NNS	O
PAK1	NN	O
and	CC	O
MEK1	NN	O
,	,	O
which	WDT	O
do	VBP	O
not	RB	O
have	VB	O
orthologues	NNS	O
in	IN	O
the	DT	O
Plasmodium	NN	O
kinome	NN	O
,	,	O
is	VBZ	O
selectively	RB	B-REL
stimulated	VBN	I-REL
in	IN	O
Plasmodium	NN	O
falciparum-infected	JJ	O
-LRB-	-LRB-	O
versus	CC	O
uninfected	JJ	O
-RRB-	-RRB-	O
RBCs	NNS	O
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
the	DT	O
use	NN	O
of	IN	O
phospho-specific	JJ	O
antibodies	NNS	O
directed	VBN	O
against	IN	O
the	DT	O
activated	VBN	O
forms	NNS	O
of	IN	O
these	DT	O
enzymes	NNS	O
...	:	O

...	:	O
discovered	VBN	O
that	IN	O
a	DT	O
class	NN	O
of	IN	O
chemotherapy	NN	O
drugs	NNS	O
originally	RB	O
designed	VBN	O
to	TO	O
inhibit	VB	O
key	JJ	O
signaling	NN	O
pathways	NNS	O
in	IN	O
cancer	NN	O
cells	NNS	O
also	RB	O
kills	VBZ	B-REL
the	DT	I-REL
parasite	NN	O
that	WDT	O
causes	VBZ	O
malaria	NN	O
...	:	O

...	:	O
findings	NNS	O
of	IN	O
this	DT	O
study	NN	O
show	VBP	O
that	IN	O
waist	NN	O
circumference	NN	O
and	CC	O
time	NN	O
spent	VBD	O
sitting	VBG	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
2-h	JJ	O
glucose	NN	O
concentrations	NNS	O
in	IN	O
U.K.	NNP	O
.	.	O

...	:	O
These	DT	O
data	NNS	O
highlight	VBP	B-REL
an	DT	I-REL
important	JJ	I-REL
relationship	NN	I-REL
between	IN	O
sitting	VBG	O
time	NN	O
and	CC	O
2-h	JJ	O
glucose	NN	O
levels	NNS	O
in	IN	O
U.K.	NNP	O
.	.	O

...	:	O
A	DT	O
new	JJ	O
study	NN	O
by	IN	O
scientists	NNS	O
has	VBZ	O
revealed	VBN	O
that	IN	O
time	NN	O
spent	VBD	O
sitting	VBG	O
down	RP	O
is	VBZ	B-REL
a	DT	I-REL
diabetes	NN	I-REL
risk	NN	I-REL
factor	NN	I-REL
in	IN	I-REL
South	NNP	O
Asians	NNPS	O
independent	JJ	O
of	IN	O
how	WRB	O
much	JJ	O
they	PRP	O
exercise	VBP	O
...	:	O

...	:	O
acts	VBZ	O
as	IN	O
a	DT	O
molecular	JJ	B-REL
switch	NN	O
between	IN	O
two	CD	O
key	JJ	O
stages	NNS	O
of	IN	O
cortical	JJ	O
development	NN	O
...	:	O

...	:	O
dual	JJ	B-REL
role	NN	I-REL
for	IN	O
DISC1	NN	O
in	IN	O
corticogenesis	NN	O
...	:	O

...	:	O
Researchers	NNS	O
at	IN	O
the	DT	O
University	NNP	O
of	IN	O
Glasgow	NNP	O
have	VBP	O
discovered	VBN	O
how	WRB	O
a	DT	B-REL
protein	NN	O
linked	VBN	O
to	TO	B-REL
the	DT	O
mental	JJ	O
health	NN	O
condition	NN	O
acts	VBZ	B-REL
as	IN	I-REL
a	DT	O
switch	NN	B-REL
to	TO	O
control	VB	B-REL
key	JJ	O
stages	NNS	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
The	DT	O
conjunction	NN	O
of	IN	O
power	NN	O
and	CC	O
phase	NN	O
-LRB-	-LRB-	O
itself	PRP	O
3	CD	O
times	NNS	O
more	RBR	O
informative	JJ	O
than	IN	O
power	NN	O
-RRB-	-RRB-	O
codes	VBZ	O
specific	JJ	O
expressive	JJ	O
features	NNS	O
across	IN	O
different	JJ	O
oscillatory	JJ	O
bands	NNS	O
,	,	O
a	DT	B-REL
multiplexing	VBG	I-REL
that	IN	I-REL
increases	NNS	I-REL
coding	VBG	O
capacity	NN	O
in	IN	O
the	DT	O
brain	NN	O
...	:	O

...	:	O
oscillatory	JJ	O
frequencies	NNS	O
in	IN	O
the	DT	B-REL
brain	NN	O
multiplex	JJ	B-REL
the	DT	O
coding	NN	B-REL
of	IN	I-REL
visual	JJ	I-REL
features	NNS	I-REL
,	,	I-REL
increasing	VBG	I-REL
coding	VBG	O
capacity	NN	O
...	:	O

...	:	O
Researchers	NNS	O
at	IN	O
the	DT	O
Institute	NNP	O
of	IN	O
Neuroscience	NNP	O
&	CC	O
Psychology	NNP	O
have	VBP	B-REL
been	VBN	I-REL
able	JJ	I-REL
to	TO	I-REL
identify	VB	I-REL
the	DT	O
type	NN	O
of	IN	O
information	NN	O
contained	VBD	O
within	IN	O
certain	JJ	O
brainwaves	NNS	O
related	VBN	O
to	TO	O
vision	NN	O
...	:	O

...	:	O
Deprivation	NN	O
has	VBZ	B-REL
become	VBN	I-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
rates	NNS	O
of	IN	O
male	NN	O
,	,	O
but	CC	O
not	RB	O
female	JJ	O
,	,	O
colorectal	JJ	O
cancer	NN	O
with	IN	O
a	DT	O
widening	VBG	O
deprivation	NN	O
gap	NN	O
in	IN	O
male	JJ	O
incidence	NN	O
emerging	VBG	O
in	IN	O
the	DT	O
West	NNP	O
of	IN	O
Scotland	NNP	O
...	:	O

...	:	O
Deprivation	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
incidence	NN	O
rates	NNS	O
of	IN	O
male	NN	O
,	,	O
but	CC	O
not	RB	O
female	JJ	O
,	,	O
colorectal	JJ	O
cancer	NN	O
before	IN	O
the	DT	O
implementation	NN	O
of	IN	O
a	DT	O
national	JJ	O
bowel	NN	O
screening	NN	O
programme	NN	O
...	:	O

...	:	O
Men	NN	O
living	NN	O
in	IN	O
deprived	VBN	O
areas	NNS	O
now	RB	O
suffer	VBP	O
from	IN	B-REL
higher	JJR	I-REL
levels	NNS	I-REL
of	IN	I-REL
bowel	NN	I-REL
cancer	NN	I-REL
than	IN	I-REL
those	DT	O
from	IN	O
more	JJR	O
affluent	JJ	O
areas	NNS	O
Glasgow	NNP	O
...	:	O

NO	NN	O
could	MD	B-REL
effectively	RB	I-REL
inhibit	VB	I-REL
Th17	NN	O
proliferation	NN	O
and	CC	O
function	NN	O

NO	NN	O
may	MD	B-REL
therefore	RB	O
represent	VB	O
an	DT	O
important	JJ	O
endogenous	JJ	O
regulator	NN	O
to	TO	O
prevent	VB	O
overexpansion	NN	O
of	IN	O
Th17	NN	O
cells	NNS	O
and	CC	O
control	NN	O
of	IN	O
autoimmune	JJ	O
diseases	NNS	O

Diseases	NNS	O
of	IN	O
the	DT	O
immune	JJ	O
system	NN	O
...	:	O
could	MD	B-REL
be	VB	I-REL
treated	VBN	I-REL
by	IN	I-REL
a	DT	O
gas	NN	O
produced	VBD	O
naturally	RB	O
by	IN	O
the	DT	O
body	NN	O

...	:	O
increased	VBD	O
incidence	NN	O
of	IN	O
diabetes	NN	O
with	IN	O
statin	NN	O
therapy	NN	O
by	IN	O
providing	VBG	O
evidence	NN	O
of	IN	O
a	DT	O
dose-dependent	JJ	B-REL
association	NN	I-REL
...	:	O

...	:	O
intensive-dose	NN	O
statin	NN	O
therapy	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
new-onset	NN	O
diabetes	NN	O
...	:	O

...	:	O
medication	NN	O
commonly	RB	O
prescribed	VBN	O
for	IN	O
people	NNS	O
with	IN	O
heart	NN	O
problems	NNS	O
can	MD	B-REL
put	VB	I-REL
them	PRP	I-REL
at	IN	I-REL
an	DT	I-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
developing	VBG	O
diabetes	NNS	O
...	:	O

...	:	O
high	JJ	O
doses	NNS	O
of	IN	B-REL
cholesterol-lowering	JJ	O
pills	NNS	O
can	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
type	NN	O
2	CD	O
diabetes	NN	O
...	:	O

...	:	O
cheaper	JJR	O
statins	NNS	O
on	IN	O
NHS	NN	O
can	MD	B-REL
put	VB	I-REL
patients	NNS	O
in	IN	O
danger	NN	O
...	:	O

...	:	O
drugs	NNS	O
aimed	VBN	O
at	IN	O
lowering	VBG	O
cholesterol	NN	O
are	VBP	B-REL
linked	VBN	I-REL
to	TO	I-REL
increasing	VBG	I-REL
numbers	NNS	I-REL
of	IN	I-REL
new	JJ	I-REL
diabetes	NN	O
cases	NNS	O
...	:	O

...	:	O
the	DT	B-REL
women	NNS	O
in	IN	O
the	DT	O
whole	JJ	O
cohort	NN	O
who	WP	O
did	VBD	O
not	RB	O
smoke	VB	O
and	CC	O
were	VBD	O
not	RB	O
obese	JJ	O
had	VBD	B-REL
the	DT	O
lowest	JJS	B-REL
mortality	NN	I-REL
rates	NNS	I-REL
,	,	O
regardless	RB	O
of	IN	O
their	PRP$	O
social	JJ	O
position	NN	O
...	:	O

...	:	O
Women	NNS	O
who	WP	O
had	VBD	B-REL
never	RB	O
smoked	VBN	O
and	CC	O
were	VBD	O
not	RB	O
obese	JJ	O
had	VBD	O
the	DT	B-REL
lowest	JJS	I-REL
mortality	NN	I-REL
rates	NNS	I-REL
,	,	O
regardless	RB	O
of	IN	O
their	PRP$	O
social	JJ	O
position	NN	O
...	:	O

...	:	O
Obesity	NN	O
is	VBZ	O
an	DT	B-REL
important	JJ	I-REL
contributor	NN	I-REL
to	TO	I-REL
premature	JJ	O
death	NN	O
in	IN	O
women	NNS	O
who	WP	O
have	VBP	O
never	RB	O
smoked	VBN	O
...	:	O

...	:	O
Non-smoking	JJ	O
woman	NN	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	O
obese	JJ	O
and	CC	O
die	VB	O
of	IN	O
associated	VBN	O
illnesses	NNS	O
than	IN	O
those	DT	O
who	WP	O
smoke	VBP	O
...	:	O

nanoscale	JJ	O
patterning	NN	O
as	IN	O
a	DT	B-REL
powerful	JJ	I-REL
tool	NN	I-REL
for	IN	O
the	DT	O
non-invasive	JJ	O
manipulation	NN	O
of	IN	O
stem	NN	O
cells	NNS	O

a	DT	O
nanostructured	JJ	O
surface	NN	O
that	WDT	O
retains	VBZ	B-REL
stem-cell	NN	O
phenotype	NN	O
and	CC	O
maintains	VBZ	O
stem-cell	JJ	O
growth	NN	O
over	IN	O
eight	CD	O
weeks	NNS	O

a	DT	B-REL
new	JJ	O
nanoscale	NN	O
plastic	NN	O
can	MD	B-REL
cheaply	RB	I-REL
and	CC	I-REL
easily	RB	I-REL
solve	VB	I-REL
a	DT	O
problem	NN	B-REL
which	WDT	O
has	VBZ	O
previously	RB	O
made	VBN	O
the	DT	O
expansion	NN	O
of	IN	O
stem	NN	O
cells	NNS	O
for	IN	O
therapeutic	JJ	O
purposes	NNS	O
impossible	JJ	O

A	DT	O
new	JJ	O
plastic	NN	O
surface	NN	O
which	WDT	B-REL
overcomes	VBZ	I-REL
the	DT	I-REL
difficulties	NNS	I-REL
associated	VBN	O
with	IN	O
growing	VBG	O
adult	JJ	O
stem	NN	O
cells	NNS	O
has	VBZ	O
been	VBN	O
developed	VBN	O

...	:	O
Voice-selective	JJ	O
areas	NNS	O
in	IN	O
the	DT	O
auditory	JJ	O
cortex	NN	O
become	VB	B-REL
more	RBR	I-REL
activated	VBN	I-REL
during	IN	O
silent	JJ	O
reading	NN	O
of	IN	O
direct	JJ	O
speech	NN	O
as	IN	O
opposed	VBN	O
to	TO	O
meaning-equivalent	JJ	O
indirect	JJ	O
speech	NN	O
statements	NNS	O
...	:	O

...	:	O
silent	JJ	O
reading	NN	O
of	IN	O
direct	JJ	O
versus	CC	O
indirect	JJ	O
speech	NN	O
engenders	VBZ	B-REL
differential	JJ	I-REL
brain	NN	O
activation	NN	O
in	IN	O
voice-selective	JJ	O
areas	NNS	O
of	IN	O
the	DT	O
auditory	JJ	O
cortex	NN	O
...	:	O

...	:	O
when	WRB	O
reading	VBG	O
direct	JJ	O
quotes	NNS	O
,	,	O
the	DT	B-REL
brain	NN	I-REL
hears	VBZ	I-REL
the	DT	O
voice	NN	O
of	IN	O
the	DT	O
speaker	NN	O
...	:	O

We	PRP	O
have	VBP	O
demonstrated	VBN	O
a	DT	O
direct	JJ	B-REL
link	NN	I-REL
between	IN	O
accelerated	VBN	O
biological	JJ	O
ageing	JJ	O
,	,	O
low	JJ	O
income	NN	O
and	CC	O
poor	JJ	O
diet	NN	O
.	.	O

Lower	JJR	O
socio-economic	JJ	O
status	NN	O
and	CC	O
poor	JJ	O
diet	NN	O
are	VBP	O
relevant	JJ	B-REL
to	TO	I-REL
accelerated	VBN	O
biological	JJ	O
ageing	JJ	O

Low	JJ	O
income	NN	O
and	CC	O
poor	JJ	O
diet	NN	O
linked	VBN	B-REL
to	TO	I-REL
accelerated	VBN	O
ageing	IN	O

Scientists	NNS	O
find	VBP	O
low	JJ	O
income	NN	O
link	NN	B-REL
to	TO	O
ageing	JJ	O

Low-earners	NNS	O
with	IN	O
bad	JJ	O
diets	NNS	O
die	VBP	B-REL
younger	JJR	I-REL

Bad	JJ	O
diet	NN	O
and	CC	O
low	JJ	O
income	NN	O
speeds	NNS	B-REL
ageing	IN	O

DNA	NN	O
test	NN	O
developed	VBD	O
in	IN	O
Glasgow	NNP	O
links	NNS	B-REL
ageing	JJ	O
and	CC	O
poverty	NN	O

the	DT	B-REL
linguistic	JJ	O
operations	NNS	O
required	VBN	O
to	TO	O
understand	VB	O
or	CC	O
produce	VB	O
an	DT	O
utterance	NN	O
are	VBP	O
performed	VBN	B-REL
by	IN	I-REL
the	DT	O
same	JJ	B-REL
network	NN	O
of	IN	O
brain	NN	O
areas	NNS	O

the	DT	O
linguistic	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
language	NN	O
system	NN	O
are	VBP	B-REL
used	VBN	I-REL
for	IN	I-REL
both	DT	I-REL
speaking	NN	O
and	CC	O
listening	VBG	O

Speaking	VBG	O
and	CC	O
listening	VBG	O
share	NN	B-REL
large	JJ	O
part	NN	O
of	IN	O
brain	NN	O
infrastructure	NN	O

...	:	O
the	DT	O
substantial	JJ	O
lifespan	NN	O
penalty	NN	O
for	IN	O
the	DT	O
breeding	VBG	O
partners	NNS	O
of	IN	O
such	JJ	O
birds	NNS	O
suggests	VBZ	O
that	IN	O
birds	NNS	O
exposed	VBN	O
to	TO	O
stress	NN	O
in	IN	O
early	JJ	O
life	NN	O
are	VBP	O
discriminated	VBN	O
against	IN	O
as	IN	O
breeding	VBG	O
partners	NNS	O
not	RB	O
simply	RB	O
because	IN	O
,	,	O
as	IN	O
has	VBZ	O
generally	RB	O
been	VBN	O
assumed	VBN	O
,	,	O
they	PRP	B-REL
make	VBP	O
poor	JJ	O
parents	NNS	O
,	,	O
but	CC	O
rather	RB	O
because	IN	O
they	PRP	O
substantially	RB	B-REL
reduce	VB	I-REL
the	DT	O
lifespan	NN	O
of	IN	O
their	PRP$	O
breeding	VBG	O
partners	NNS	O
...	:	O

...	:	O
Our	PRP$	O
results	NNS	O
clearly	RB	O
show	VBP	O
that	IN	O
increased	VBN	O
exposure	NN	O
to	TO	O
glucocorticoids	NNS	O
early	RB	O
in	IN	O
life	NN	O
can	MD	O
markedly	RB	O
reduce	VB	B-REL
adult	JJ	O
life	NN	O
expectancy	NN	O
,	,	O
and	CC	O
that	IN	O
pairing	VBG	O
with	IN	O
such	JJ	O
exposed	VBN	O
partners	NNS	O
carries	VBZ	O
an	DT	O
additional	JJ	O
and	CC	O
substantial	JJ	O
lifespan	NN	O
penalty	NN	O
...	:	O

...	:	O
Stress	NN	O
in	IN	O
early	JJ	O
life	NN	O
reduces	VBZ	B-REL
life	NN	O
expectancy	NN	O
-	:	O
and	CC	O
that	IN	O
of	IN	O
partners	NNS	O
...	:	O

...	:	O
Stressed-out	JJ	O
partner	NN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
early	JJ	O
death	NN	O
...	:	O

...	:	O
our	PRP$	O
data	NNS	O
directly	RB	B-REL
show	VBP	I-REL
,	,	I-REL
for	IN	I-REL
the	DT	I-REL
first	JJ	I-REL
time	NN	I-REL
,	,	O
differences	NNS	B-REL
in	IN	I-REL
the	DT	O
expectations	NNS	O
of	IN	O
facial	JJ	O
expression	NN	O
signals	NNS	O
across	IN	O
diverse	JJ	O
cultures	NNS	O
...	:	O

...	:	O
it	PRP	O
is	VBZ	O
revealed	VBN	B-REL
directly	RB	I-REL
that	IN	O
culture	NN	O
can	MD	O
finely	RB	O
shape	VB	O
the	DT	O
internal	JJ	O
representations	NNS	O
of	IN	O
common	JJ	O
facial	JJ	O
expressions	NNS	O
of	IN	O
emotion	NN	O
...	:	O

...	:	O
people	NNS	O
from	IN	O
different	JJ	O
cultures	NNS	O
perceive	VBP	O
happy	JJ	O
sad	JJ	O
or	CC	O
angry	JJ	O
facial	JJ	O
expressions	NNS	O
in	IN	O
unique	JJ	B-REL
ways	NNS	I-REL
...	:	O

...	:	O
people	NNS	O
from	IN	O
different	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
world	NN	O
vary	VBP	B-REL
in	IN	I-REL
what	WP	I-REL
they	PRP	I-REL
think	VBP	O
...	:	O

melarsoprol	NN	O
with	IN	O
cyclodextrin	NN	O
molecules	NNS	O
does	VBZ	O
not	RB	O
affect	VB	O
the	DT	O
trypanocidal	JJ	O
properties	NNS	O
of	IN	O
the	DT	O
compound	NN	O
and	CC	O
appreciably	RB	B-REL
enhances	VBZ	I-REL
the	DT	O
ability	NN	O
of	IN	O
the	DT	O
drug	NN	O
to	TO	O
cure	VB	O
CNS-stage	NN	O
trypanosome	NN	O
infections	NNS	O

parasite	NN	O
load	NN	O
within	IN	O
the	DT	O
brain	NN	O
was	VBD	O
rapidly	RB	B-REL
reduced	VBN	I-REL
following	VBG	O
treatment	NN	O
onset	NN	O

...	:	O
men	NNS	O
across	IN	O
the	DT	O
age	NN	O
spectrum	NN	O
are	VBP	B-REL
diagnosed	VBN	I-REL
with	IN	I-REL
diabetes	NN	I-REL
at	IN	I-REL
a	DT	I-REL
lower	JJR	I-REL
BMI	NN	I-REL
than	IN	I-REL
women	NNS	O
...	:	O

...	:	O
men	NNS	O
are	VBP	O
diagnosed	VBN	O
with	IN	O
type	NN	O
2	CD	O
diabetes	NN	O
at	IN	O
lower	JJR	B-REL
BMI	NN	I-REL
than	IN	I-REL
women	NNS	O
...	:	O

...	:	O
men	NNS	O
develop	VBP	B-REL
diabetes	NN	O
at	IN	O
lower	JJR	O
BMIS	NNS	O
than	IN	O
women	NNS	O
...	:	O

...	:	O
men	NNS	O
have	VBP	O
to	TO	B-REL
gain	VB	B-REL
less	JJR	I-REL
weight	NN	I-REL
than	IN	I-REL
women	NNS	I-REL
to	TO	O
develop	VB	B-REL
type	NN	O
2	CD	O
diabetes	NN	O
...	:	O

...	:	O
men	NNS	O
may	MD	B-REL
be	VB	I-REL
more	RBR	I-REL
likely	JJ	I-REL
than	IN	I-REL
women	NNS	O
to	TO	O
develop	VB	O
type	NN	O
2	CD	O
diabetes	NN	O
...	:	O

...	:	O
men	NNS	O
have	VBP	O
to	TO	B-REL
gain	VB	B-REL
less	JJR	I-REL
weight	NN	I-REL
than	IN	I-REL
women	NNS	I-REL
to	TO	O
develop	VB	B-REL
type	NN	O
2	CD	O
diabetes	NN	O
...	:	O

...	:	O
a	DT	O
single	JJ	O
serving	VBG	O
of	IN	B-REL
espresso	NN	O
coffee	NN	O
could	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
caffeine	NN	O
toxicity	NN	O
.	.	O

...	:	O
a	DT	O
cup	NN	O
of	IN	O
coffee	NN	O
at	IN	O
a	DT	O
cafe	NN	O
may	MD	O
be	VB	B-REL
relaxing	VBG	O
-	:	O
but	CC	O
it	PRP	O
could	MD	B-REL
be	VB	O
damaging	JJ	B-REL
your	PRP$	I-REL
health	NN	O
...	:	O

7	CD	O
of	IN	O
the	DT	O
sequenced	VBN	O
peptides	NNS	O
were	VBD	B-REL
seen	VBN	I-REL
to	TO	I-REL
be	VB	I-REL
significantly	RB	I-REL
different	JJ	I-REL
with	IN	I-REL
regard	NN	O
to	TO	O
P-R	NN	O
juice	NN	O
drink	NN	O
versus	CC	O
matching	VBG	O
placebo	NN	O

P-R	NN	O
drink	NN	O
may	MD	B-REL
have	VB	I-REL
beneficial	JJ	I-REL
effects	NNS	I-REL
on	IN	I-REL
urinary	JJ	O
biomarkers	NNS	O
of	IN	O
CAD	NN	O

A	DT	O
diet	NN	O
high	JJ	O
in	IN	O
polyphenols	NNS	O
could	MD	B-REL
help	VB	I-REL
reduce	VB	I-REL
the	DT	O
risk	NN	O
of	IN	O
cardiovascular	JJ	O
disease	NN	O
and	CC	O
associated	VBN	O
health	NN	O
risks	NNS	O

120	CD	O
min	NN	O
of	IN	O
brisk	JJ	O
walking	VBG	O
significantly	RB	B-REL
increased	VBD	I-REL
the	DT	O
FCRs	NNS	O
of	IN	O
VLDL	NN	O

Exercise	NN	O
induced	VBD	B-REL
reductions	NNS	I-REL
in	IN	O
VLDL	NN	O
concentrations	NNS	O

Christmas	NNP	O
day	NN	O
stroll	VB	O
could	MD	B-REL
help	VB	I-REL
reduce	VB	I-REL
fat	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
blood	NN	O

improved	VBN	B-REL
outcomes	NNS	O
among	IN	O
patients	NNS	O
with	IN	O
DM	NN	O
or	CC	O
PS	NNP	O

Clot-busting	JJ	O
drugs	NNS	O
given	VBN	O
to	TO	O
patients	NNS	O
who	WP	O
have	VBP	O
diabetes	NN	O
and	CC	O
previously	RB	O
suffered	VBD	O
a	DT	O
stroke	NN	O
aid	NN	B-REL
their	PRP$	O
recovery	NN	O
from	IN	O
a	DT	O
second	JJ	O
stroke	NN	O

IRF5	NN	O
was	VBD	O
indeed	RB	O
a	DT	O
major	JJ	O
factor	NN	O
in	IN	O
defining	VBG	O
macrophage	NN	O
polarization	NN	O
:	:	O
it	PRP	O
had	VBD	O
high	JJ	O
expression	NN	O
in	IN	O
M1	NN	O
macrophages	NNS	O
and	CC	O
induced	VBD	B-REL
a	DT	O
characteristic	JJ	O
gene-expression	NN	O
and	CC	O
cytokine-secretion	JJ	O
profile	NN	O
and	CC	O
promoted	VBD	O
robust	JJ	O
TH1-TH17	NN	O
responses	NNS	O
.	.	O

High	JJ	O
expression	NN	O
of	IN	O
IRF5	NN	O
was	VBD	O
characteristic	JJ	O
of	IN	O
M1	NN	O
macrophages	NNS	O
,	,	O
in	IN	O
which	WDT	O
it	PRP	O
directly	RB	B-REL
activated	VBD	I-REL
transcription	NN	O
of	IN	O
the	DT	O
genes	NNS	O
encoding	VBG	O
interleukin	NN	O
12	CD	O
subunit	NN	O
p40	NN	O
.	.	O

Scientists	NNS	O
have	VBP	O
identified	VBN	O
a	DT	O
protein	NN	O
that	WDT	O
acts	VBZ	O
as	IN	O
a	DT	O
``	``	O
master	NN	O
switch	NN	O
''	''	O
in	IN	O
certain	JJ	O
white	JJ	O
blood	NN	O
cells	NNS	O
,	,	O
determining	VBG	B-REL
whether	IN	O
they	PRP	O
promote	VBP	O
or	CC	O
inhibit	VBP	O
inflammation	NN	O
.	.	O

A	DT	O
``	``	O
master	NN	O
switch	NN	O
''	''	O
which	WDT	O
triggers	VBZ	B-REL
the	DT	O
condition	NN	O
.	.	O

Scientists	NNS	O
have	VBP	O
found	VBN	O
a	DT	O
protein	NN	O
that	WDT	O
acts	VBZ	O
as	IN	O
a	DT	O
``	``	O
master	NN	O
switch	NN	O
''	''	O
to	TO	O
determine	VB	B-REL
whether	IN	O
certain	JJ	O
white	JJ	O
blood	NN	O
cells	NNS	O
will	MD	O
boost	VB	O
or	CC	O
dampen	VB	O
inflammation	NN	O
.	.	O

...	:	O
Between	IN	O
1980	CD	O
and	CC	O
2008	CD	O
,	,	O
age-standardised	JJ	O
mean	NN	O
global	JJ	O
BMI	NN	O
increased	VBD	B-REL
...	:	O

...	:	O
mean	VB	O
BMI	NNP	O
has	VBZ	O
increased	VBN	B-REL
since	IN	O
1980	CD	O
...	:	O

...	:	O
Obesity	NNP	O
has	VBZ	B-REL
doubled	VBN	I-REL
since	IN	O
1980	CD	O
...	:	O

...	:	O
women	NNS	O
are	VBP	O
the	DT	B-REL
most	RBS	I-REL
overweight	JJ	I-REL
...	:	O

are	VBP	O
more	RBR	O
likely	JJ	B-REL
.	.	O

...	:	O
obesity	NN	O
rates	NNS	O
worldwide	RB	O
have	VBP	B-REL
doubled	VBN	I-REL
in	IN	O
the	DT	O
last	JJ	O
three	CD	O
decades	NNS	O
.	.	O

Since	IN	O
1980	CD	O
the	DT	O
weight	NN	O
of	IN	O
the	DT	O
average	JJ	O
British	JJ	O
woman	NN	O
has	VBZ	B-REL
increased	VBN	I-REL
by	IN	O
more	JJR	O
than	IN	O
a	DT	O
stone	NN	O
.	.	O

...	:	O
men	NNS	O
's	POS	O
waistlines	NNS	O
have	VBP	B-REL
grown	VBN	I-REL
since	IN	O
1980	CD	O
...	:	O

...	:	O
Obesity	NN	O
affects	VBZ	B-REL
one	CD	O
in	IN	O
10	CD	O
adults	NNS	O
...	:	O

Exogenous	JJ	O
FUS	NN	O
expression	NN	O
significantly	RB	B-REL
inhibits	VBZ	I-REL
cells	NNS	O
growth	NN	O
.	.	O

FUS	NN	O
has	VBZ	O
some	DT	O
characteristics	NNS	O
of	IN	O
a	DT	O
putative	JJ	O
tumor	NN	O
suppressor	NN	O
,	,	O
as	IN	O
its	PRP$	O
overexpression	NN	O
promoted	VBD	B-REL
growth	NN	O
inhibition	NN	O
and	CC	O
apoptosis	NN	O
of	IN	O
prostate	NN	O
cancer	NN	O
cells	NNS	O
.	.	O

Key	NN	O
protein	NN	O
that	WDT	O
supresses	VBZ	B-REL
prostate	NN	O
cancer	NN	O
growth	NN	O
in	IN	O
the	DT	O
laboratory	NN	O
.	.	O

...	:	O
This	DT	O
outcome	NN	O
gives	VBZ	O
the	DT	O
picture	NN	O
of	IN	O
strong	JJ	B-REL
between-place	JJ	I-REL
interactions	NNS	I-REL
with	IN	O
backand	NN	O
-	:	O
forth	RB	O
waves	NNS	O
of	IN	O
transmission	NN	O
between	IN	O
the	DT	O
school	NN	O
,	,	O
the	DT	O
community	NN	O
,	,	O
and	CC	O
the	DT	O
households	NNS	O
...	:	O

This	DT	O
analysis	NN	O
shows	VBZ	O
the	DT	O
extent	NN	O
to	TO	O
which	WDT	O
clearly	RB	O
defined	VBN	O
social	JJ	O
networks	NNS	O
affect	VBP	O
influenza	NN	O
transmission	NN	O
,	,	O
revealing	VBG	B-REL
strong	JJ	I-REL
between-place	JJ	O
interactions	NNS	O
with	IN	O
back-and-forth	JJ	O
waves	NNS	O
of	IN	O
transmission	NN	O
between	IN	O
the	DT	O
school	NN	O
,	,	O
the	DT	O
community	NN	O
,	,	O
and	CC	O
the	DT	O
household	NN	O
.	.	O

Boys	NNS	O
predominantly	RB	B-REL
pass	VBP	I-REL
on	IN	I-REL
flu	NN	O
to	TO	O
other	JJ	O
boys	NNS	O
and	CC	O
girls	NNS	O
to	TO	O
girls	NNS	O
.	.	O

When	WRB	O
it	PRP	O
comes	VBZ	O
to	TO	O
swine	NNS	O
flu	NN	O
,	,	O
boys	NNS	O
will	MD	B-REL
infect	VB	I-REL
boys	NNS	O
.	.	O

Boys	NNS	O
will	MD	B-REL
infect	VB	I-REL
other	JJ	O
boys	NNS	O
with	IN	O
swine	NNS	O
flu	NN	O
.	.	O

HIV-exposed	JJ	O
uninfected	JJ	O
infants	NNS	O
have	VBP	B-REL
lower	JJR	I-REL
specific	JJ	O
antibody	NN	O
levels	NNS	O
at	IN	O
birth	NN	O
than	IN	O
their	PRP$	O
non-HIV-exposed	JJ	O
peers	NNS	O
.	.	O

Antenatal	JJ	O
HIV	NN	O
exposure	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
lower	JJR	O
specific	JJ	O
antibody	NN	O
responses	NNS	O
in	IN	O
exposed	VBN	O
uninfected	JJ	O
infants	NNS	O
compared	VBN	O
with	IN	O
unexposed	JJ	O
infants	NNS	O
at	IN	O
birth	NN	O
,	,	O
but	CC	O
with	IN	O
robust	JJ	O
responses	NNS	O
following	VBG	O
routine	JJ	O
vaccination	NN	O
.	.	O

HIV-uninfected	JJ	O
babies	NNS	O
born	VBN	O
to	TO	O
mothers	NNS	O
with	IN	O
HIV	NN	O
might	MD	B-REL
be	VB	I-REL
more	RBR	I-REL
vulnerable	JJ	O
to	TO	O
infections	NNS	O
.	.	O

No	DT	B-REL
difference	NN	I-REL
exists	VBZ	I-REL
between	IN	O
protease	NN	O
inhibitor	NN	O
and	CC	O
NNRTI	NN	O
containing	VBG	O
initial	JJ	O
ART	NN	O
regimens	NNS	O
in	IN	O
children	NNS	O
.	.	O

Good	JJ	O
long-term	JJ	O
outcomes	NNS	O
were	VBD	O
achieved	VBN	O
with	IN	B-REL
all	DT	I-REL
treatments	NNS	O
strategies	NNS	O
.	.	O

Major	JJ	O
trial	NN	O
suggests	VBZ	O
common	JJ	O
treatments	NNS	O
for	IN	O
treating	VBG	O
children	NNS	O
with	IN	O
HIV	NN	O
equally	RB	B-REL
effective	JJ	O
.	.	O

The	DT	O
behavior	NN	O
changes	NNS	O
associated	VBN	B-REL
with	IN	I-REL
the	DT	O
HIV	NN	O
decline	NN	O
in	IN	O
Zimbabwe	NNP	O
appears	VBZ	O
to	TO	O
have	VB	O
resulted	VBN	O
primarily	RB	O
from	IN	O
incrteased	JJ	O
interpersonal	JJ	O
communication	NN	O
about	IN	O
HIV	NN	O
and	CC	O
its	PRP$	O
association	NN	O
with	IN	O
risky	JJ	O
sexual	JJ	O
behavior	NN	O
,	,	O
due	JJ	O
to	TO	O
high	JJ	O
personal	JJ	O
exposure	NN	O
to	TO	O
AIDS	NNP	O
mortality	NN	O
and	CC	O
correct	JJ	O
understanding	NN	O
of	IN	O
sexual	JJ	O
HIV	NN	O
transmission	NN	O
-LRB-	-LRB-	O
due	JJ	O
to	TO	O
relatively	RB	O
high	JJ	O
education	NN	O
levels	NNS	O
along	IN	O
with	IN	O
information	NN	O
provided	VBN	O
by	IN	O
HIV	NN	O
communication	NN	O
programs	NNS	O
-RRB-	-RRB-	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
deteriorating	VBG	O
economic	JJ	O
situation	NN	O
.	.	O

The	DT	O
behavioural	JJ	O
changes	NNS	O
associated	VBN	B-REL
with	IN	I-REL
HIV	NN	O
reduction-mainly	JJ	O
reductions	NNS	O
in	IN	O
extramarital	JJ	O
,	,	O
commercial	JJ	O
,	,	O
and	CC	O
casual	JJ	O
sexual	JJ	O
relations	NNS	O
,	,	O
and	CC	O
associated	VBN	O
reductions	NNS	O
in	IN	O
partner	NN	O
concurrency-appear	NN	O
to	TO	O
have	VB	O
been	VBN	O
stimulated	VBN	O
primarily	RB	O
by	IN	O
increased	VBN	O
awareness	NN	O
of	IN	O
AIDS	NNP	O
deaths	NNS	O
and	CC	O
secondarily	RB	O
by	IN	O
the	DT	O
country	NN	O
's	POS	O
economic	JJ	O
deterioration	NN	O
.	.	O

Huge	JJ	O
decline	NN	O
in	IN	O
HIV	NN	O
rates	NNS	O
in	IN	O
Zimbabwe	NNP	O
driven	VBN	B-REL
by	IN	I-REL
fear	NN	O
of	IN	O
infection	NN	O
.	.	O

Fear	NN	O
of	IN	O
infection	NN	O
and	CC	O
mass	NN	O
social	JJ	O
change	NN	O
have	VBP	B-REL
driven	VBN	I-REL
a	DT	O
huge	JJ	O
decline	NN	O
in	IN	O
HIV	NN	O
rates	NNS	O
in	IN	O
Zimbabwe	NNP	O
,	,	O
offering	VBG	O
important	JJ	O
lessons	NNS	O
on	IN	O
how	WRB	O
to	TO	O
fight	VB	O
the	DT	O
AIDS	NNP	O
epidemic	JJ	O
in	IN	O
the	DT	O
rest	NN	O
of	IN	O
Africa	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
an	DT	O
intervention	NN	O
starting	VBG	O
at	IN	O
a	DT	O
few	JJ	O
weeks	NNS	O
into	IN	O
the	DT	O
epidemic	JJ	O
is	VBZ	O
almost	RB	B-REL
as	RB	I-REL
effective	JJ	I-REL
at	IN	O
reducing	VBG	O
epidemic	JJ	O
size	NN	O
and	CC	O
peak	NN	O
prevalence	NN	O
as	IN	O
one	CD	O
starting	VBG	O
at	IN	O
week	NN	O
0	CD	O
.	.	O

Mitigation	NN	O
of	IN	O
a	DT	O
severe	JJ	O
influenza	NN	O
pandemic	NN	O
can	MD	B-REL
be	VB	I-REL
achieved	VBN	I-REL
using	VBG	O
a	DT	O
range	NN	O
of	IN	O
interventions	NNS	O
to	TO	O
reduce	VB	O
transmission	NN	O
.	.	O

Mathematical	JJ	O
models	NNS	O
predict	VBP	B-REL
that	IN	O
some	DT	O
policy	NN	O
interventions	NNS	O
might	MD	O
not	RB	O
be	VB	O
best	JJS	O
employed	VBN	O
at	IN	O
the	DT	O
start	NN	O
of	IN	O
an	DT	O
epidemic	JJ	O
.	.	O

The	DT	O
main	JJ	O
findings	NNS	O
here	RB	O
are	VBP	O
a	DT	B-REL
direct	JJ	I-REL
association	NN	I-REL
of	IN	O
SSB	NN	O
consumption	NN	O
with	IN	O
BP	NN	O
,	,	O
and	CC	O
direct	JJ	O
associations	NNS	O
of	IN	O
fructose	NN	O
and	CC	O
glucose	NN	O
intake	NN	O
with	IN	O
BP	NN	O
that	WDT	O
were	VBD	O
stronger	JJR	O
among	IN	O
individuals	NNS	O
with	IN	O
higer	JJR	O
urinary	JJ	O
sodium	NN	O
excretion	NN	O
.	.	O

SSB	NN	O
intake	NN	O
higher	JJR	O
by	IN	O
1	CD	O
serving	VBG	O
per	IN	O
day	NN	O
was	VBD	B-REL
assocaited	VBN	I-REL
with	IN	I-REL
systolic/diastolic	JJ	O
BP	NN	O
differences	NNS	O
of	IN	O
+1.6	CD	O
/	:	O
0.8	CD	O
mm	NN	O
Hg	NN	O
.	.	O

Sugary	JJ	O
drinks	NNS	O
assocaited	VBN	B-REL
with	IN	I-REL
higher	JJR	O
blood	NN	O
pressure	NN	O
.	.	O

Fizzy	JJ	O
drinks	NNS	O
and	CC	O
other	JJ	O
cans	NNS	O
of	IN	O
sugary	JJ	O
drink	NN	O
push	NN	B-REL
up	RB	I-REL
blood	NN	O
pressure	NN	O
rates	NNS	O
.	.	O

Fizzy	JJ	O
drinks	NNS	O
and	CC	O
sugar-rich	JJ	O
fruit	NN	O
juices	NNS	O
increase	VBP	B-REL
blood	NN	O
pressure	NN	O
.	.	O

Drinking	VBG	O
too	RB	O
many	JJ	O
sugary	JJ	O
beverages	NNS	O
appears	VBZ	B-REL
to	TO	I-REL
raise	VB	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
high	JJ	O
blood	NN	O
pressure	NN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
known	JJ	O
and	CC	O
new	JJ	O
variants	NNS	O
were	VBD	B-REL
significantly	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
CAD	NN	O
risk	NN	O
in	IN	O
both	CC	O
the	DT	O
European	JJ	O
and	CC	O
South	JJ	O
Asian	JJ	O
populations	NNS	O
in	IN	O
the	DT	O
current	JJ	O
study	NN	O
.	.	O

Identified	VBN	O
five	CD	O
loci	NNS	O
newly	RB	O
associated	VBN	B-REL
with	IN	I-REL
CAD	NN	O
.	.	O

Five	CD	O
new	JJ	O
genetic	JJ	O
variants	NNS	O
linked	VBN	B-REL
to	TO	I-REL
heart	NN	O
disease	NN	O
.	.	O

17	CD	O
genetic	JJ	O
variants	NNS	O
that	WDT	B-REL
increase	VBP	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
narrowed	VBN	O
arteries	NNS	O
and	CC	O
blood	NN	O
clots	NNS	O
.	.	O

17	CD	O
previously	RB	O
unknown	JJ	O
genetic	JJ	O
causes	NNS	O
of	IN	O
conditions	NNS	O
that	WDT	B-REL
can	MD	I-REL
lead	VB	I-REL
to	TO	O
heart	NN	O
attacks	NNS	O
or	CC	O
strokes	NNS	O
.	.	O

Gene	NN	O
that	WDT	O
predicts	VBZ	B-REL
risk	NN	I-REL
of	IN	O
heart	NN	O
attack	NN	O
identified	VBN	O
by	IN	O
scientists	NNS	O
.	.	O

Breakthrough	NN	O
finds	VBZ	O
17	CD	O
new	JJ	O
genetic	JJ	O
links	NNS	O
that	WDT	O
raise	VBP	B-REL
risk	NN	I-REL
of	IN	O
heart	NN	O
disease	NN	O
.	.	O

SHARPIN	NNP	O
also	RB	O
has	VBZ	B-REL
a	DT	I-REL
physiological	JJ	I-REL
role	NN	I-REL
in	IN	I-REL
lymphoid	JJ	O
system	NN	O
development	NN	O
and	CC	O
suppression	NN	O
of	IN	O
inflammation	NN	O

SHARPIN	NNP	O
interferes	VBZ	O
with	IN	O
TNF-induced	JJ	O
cell	NN	O
death	NN	O
and	CC	O
,	,	B-REL
thereby	RB	B-REL
,	,	O
prevents	VBZ	B-REL
inflammation	NN	O

Scientists	NNS	O
have	VBP	O
discovered	VBN	O
an	DT	O
essential	JJ	O
protein	NN	O
that	WDT	O
controls	VBZ	B-REL
inflammation	NN	O
induced	VBN	O
by	IN	O
``	``	O
tumour	NN	O
necrosis	NN	O
factor	NN	O
''	''	O
-LRB-	-LRB-	O
TNF	NN	O
-RRB-	-RRB-	O

Our	PRP$	O
findings	NNS	O
indicate	VBP	O
the	DT	O
potential	JJ	O
importance	NN	O
of	IN	O
common	JJ	O
genetic	JJ	O
variants	NNS	O
influencing	VBG	B-REL
levels	NNS	O
of	IN	O
alcohol	NN	O
consumption	NN	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

Genome-wide	JJ	O
association	NN	O
and	CC	O
genetic	JJ	O
functional	JJ	O
studies	NNS	O
identify	VBP	O
autism	NN	O
susceptibility	NN	O
candidate	NN	O
2	CD	O
gene	NN	O
-LRB-	-LRB-	O
AUTS2	NN	O
-RRB-	-RRB-	O
in	IN	O
the	DT	B-REL
regulation	NN	I-REL
of	IN	O
alcohol	NN	O
consumed	VBN	O
.	.	O

Scientists	NNS	O
have	VBP	O
identified	VBN	O
a	DT	B-REL
gene	NN	O
that	WDT	O
appears	VBZ	B-REL
to	TO	I-REL
play	VB	I-REL
a	DT	O
role	NN	B-REL
in	IN	O
regulating	VBG	O
how	WRB	O
much	JJ	O
alcohol	NN	O
people	NNS	O
drink	VBP	O
.	.	O

Two	CD	O
version	NN	O
of	IN	O
the	DT	O
same	JJ	O
``	``	O
booze	NN	O
''	''	O
gene	NN	O
was	VBD	B-REL
responsible	JJ	I-REL
for	IN	I-REL
some	DT	O
people	NNS	O
drinking	VBG	O
5	CD	O
%	NN	O
less	JJR	O
.	.	O

A	DT	O
gene	NN	O
that	WDT	B-REL
influences	VBZ	I-REL
drinking	NN	O
habits	NNS	O
has	VBZ	O
been	VBN	O
discovered	VBN	O
.	.	O

Characterizing	VBG	O
the	DT	O
ontogeny	NN	O
of	IN	O
innate	JJ	O
immune	JJ	O
responses	NNS	O
may	MD	B-REL
eventually	RB	I-REL
inform	VB	I-REL
selection	NN	O
of	IN	O
adjuvant	JJ	O
vaccine	NN	O
formulations	NNS	O
.	.	O

These	DT	O
observation	NN	O
provide	VBP	O
fresh	JJ	O
insights	NNS	O
into	IN	O
the	DT	O
ontogeny	NN	O
of	IN	O
innate	JJ	O
immunity	NN	O
in	IN	O
African	JJ	O
children	NNS	O
,	,	O
and	CC	O
may	MD	B-REL
inform	VB	I-REL
development	NN	O
of	IN	O
age-specific	JJ	O
adjuvanted	JJ	O
vaccine	NN	O
formulations	NNS	O
important	JJ	O
for	IN	O
global	JJ	O
health	NN	O
.	.	O

Scientists	NNS	O
identify	VBP	O
new	JJ	O
stimulant	NN	O
that	WDT	B-REL
may	MD	I-REL
boost	VB	I-REL
vaccinations	NNS	O
at	IN	O
birth	NN	O
.	.	O

IBD	NN	O
patients	NNS	O
with	IN	O
co-existent	JJ	O
C.	NNP	O
difficile	NN	O
were	VBD	O
approximately	RB	O
six	CD	O
times	NNS	O
more	RBR	B-REL
likely	JJ	I-REL
to	TO	O
die	VB	O

Patients	NNS	O
with	IN	O
inflammatory	JJ	O
bowel	NN	O
disease	NN	O
admitted	VBD	O
to	TO	O
NHS	NNP	O
hospitals	NNS	O
in	IN	O
England	NNP	O
with	IN	O
co-existent	JJ	O
C.	NNP	O
difficile	NN	O
infection	NN	O
are	VBP	O
at	IN	O
risk	NN	B-REL
of	IN	I-REL
greater	JJR	I-REL
in-hospital	JJ	O
mortality	NN	O
and	CC	O
morbidity	NN	O

C.	NNP	O
difficile	NNP	O
increases	VBZ	B-REL
risk	NN	I-REL
of	IN	O
death	NN	O
sixfold	RB	O
in	IN	O
patients	NNS	O
with	IN	O
inflammatory	JJ	O
bowel	NN	O
disease	NN	O

A	DT	O
common	JJ	O
hospital	NN	O
bug	NN	O
increases	VBZ	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
death	NN	O

Current	JJ	O
UK	NNP	O
procedures	NNS	O
to	TO	B-REL
screen	VB	O
new	JJ	O
immigrants	NNS	O
for	IN	O
tuberculosis	NN	O
-LRB-	-LRB-	O
TB	NN	O
-RRB-	-RRB-	O
fail	VBP	B-REL
to	TO	O
detect	VB	B-REL
more	JJR	O
than	IN	O
70	CD	O
per	IN	O
cent	NN	O
of	IN	O
cases	NNS	O
of	IN	O
latent	JJ	O
infection	NN	O

The	DT	O
Health	NNP	O
Protection	NNP	O
Agency	NNP	O
is	VBZ	O
urging	VBG	O
officials	NNS	O
to	TO	O
act	VB	O
after	IN	O
a	DT	O
study	NN	O
found	VBD	O
that	IN	O
the	DT	O
current	JJ	O
screening	NN	O
system	NN	O
was	VBD	B-REL
missing	VBG	I-REL
70	CD	O
per	IN	O
cent	NN	O
of	IN	O
latent	JJ	O
TB	NN	O
infections	NNS	O
brought	VBN	O
in	IN	O
to	TO	O
Britain	NNP	O
.	.	O

TB	NN	O
screening	NN	O
is	VBZ	O
missing	VBG	B-REL
70	CD	O
%	NN	O
of	IN	O
latent	JJ	O
cases	NNS	O

TB	NN	O
screening	NN	O
`	``	O
missing	VBG	O
most	RBS	O
cases	NNS	O
'	POS	O

UK	NNP	O
immigrant	JJ	O
screening	NN	O
misses	VBZ	B-REL
most	RBS	I-REL
latent	JJ	O
TB	NN	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
treatment	NN	O
with	IN	O
this	DT	O
polypill	NN	O
achieved	VBD	B-REL
sizable	JJ	I-REL
reductions	NNS	I-REL
in	IN	O
SBP	NN	O
and	CC	O
LDL-cholesterol	NN	O
.	.	O

This	DT	O
polypill	NN	O
achieved	VBD	O
sizeable	JJ	B-REL
reductions	NNS	I-REL
in	IN	O
SBP	NN	O
and	CC	O
LDL-cholesterol	NN	O
but	CC	O
caused	VBD	O
side	JJ	O
effects	NNS	O
in	IN	O
about	IN	O
1	CD	O
in	IN	O
6	CD	O
people	NNS	O
.	.	O

Polypill	NNP	O
halves	VBZ	B-REL
predicted	VBN	I-REL
heart	NN	O
disease	NN	O
and	CC	O
stroke	NN	O
risk	NN	O
in	IN	O
international	JJ	O
trial	NN	O
.	.	O

New	NNP	O
miracle	NN	O
drug	NN	O
beats	VBZ	B-REL
both	CC	O
cancer	NN	O
and	CC	O
heart	NN	O
disease	NN	O
.	.	O

...	:	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
halve	VB	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
...	:	O

...	:	O
polypill	NN	O
contining	VBG	O
aspirin	NN	O
and	CC	O
statins	NNS	O
halves	VBZ	B-REL
the	DT	I-REL
risk	NN	I-REL
...	:	O

...	:	O
The	DT	O
pill	NN	O
to	TO	O
cure	VB	B-REL
...	:	O

...	:	O
the	DT	B-REL
results	NNS	O
of	IN	B-REL
this	DT	O
study	NN	O
challenge	NN	B-REL
the	DT	O
importance	NN	B-REL
of	IN	O
bolus	NN	B-REL
resuscitation	NN	I-REL
as	IN	I-REL
a	DT	I-REL
lifesaving	JJ	I-REL
intervention	NN	I-REL
in	IN	O
resource-limited	JJ	O
settings	NNS	O
for	IN	O
children	NNS	O
with	IN	O
shock	NN	O
who	WP	O
do	VBP	O
not	RB	O
have	VB	O
hypotension	NN	O
...	:	O

...	:	O
Fluid	NN	O
boluses	NNS	O
significantly	RB	B-REL
increased	VBD	I-REL
48-hour	JJ	I-REL
mortality	NN	I-REL
...	:	O

...	:	O
Giving	VBG	O
fluids	NNS	O
rapidly	RB	O
through	IN	O
a	DT	O
drip	NN	O
into	IN	O
a	DT	O
vein	NN	O
-LRB-	-LRB-	O
fluid	NN	O
resuscitation	NN	O
-RRB-	-RRB-	O
as	IN	O
an	DT	O
emergency	NN	O
treatment	NN	O
...	:	O
does	VBZ	B-REL
not	RB	I-REL
save	VB	I-REL
lives	NNS	O
...	:	O

...	:	O
results	NNS	O
showed	VBD	B-REL
excess	JJ	O
deaths	NNS	O

MIPs	NNS	O
are	VBP	B-REL
effective	JJ	I-REL
nucleation-inducing	JJ	I-REL
substrates	NNS	O
for	IN	O
both	CC	O
the	DT	O
screening	NN	O
and	CC	O
optimization	NN	O
stages	NNS	O
of	IN	O
crystallization	NN	O
.	.	O

Six	CD	O
different	JJ	O
MIPs	NNS	O
induced	VBD	B-REL
crystallization	NN	O
of	IN	O
nine	CD	O
proteins	NNS	O
,	,	O
yielding	VBG	O
crystals	NNS	O
in	IN	O
conditions	NNS	O
that	WDT	O
do	VBP	O
not	RB	O
give	VB	O
crystals	NNS	O
otherwise	RB	O
.	.	O

Smart	NNP	O
materials	NNS	O
'	POS	O
that	WDT	B-REL
make	VBP	I-REL
proteins	NNS	O
form	VB	O
crystals	NNS	O
.	.	O

We	PRP	O
also	RB	O
demonstrated	VBD	O
that	IN	O
gastric	JJ	O
bypass	NN	O
rats	NNS	O
have	VBP	O
a	DT	B-REL
reduced	VBN	I-REL
preference	NN	I-REL
for	IN	O
liquid	JJ	O
high	JJ	O
fat	JJ	O
Intralipid	NN	O
-LRB-	-LRB-	O
r	NN	O
-RRB-	-RRB-	O
relative	JJ	O
to	TO	O
water	NN	O
during	IN	O
ad	NN	O
libitum	NN	O
access	NN	O

Gastric	JJ	O
bypass	NN	O
surgery	NN	O
alters	VBZ	B-REL
people	NNS	O
's	POS	O
food	NN	O
preferences	NNS	O
so	IN	O
that	IN	O
they	PRP	O
eat	VBP	O
less	JJR	O
high	JJ	O
fat	NN	O
food	NN	O

Our	PRP$	O
results	NNS	O
obtained	VBN	O
in	IN	O
the	DT	O
MH	NN	O
and	CC	O
FH	NN	O
models	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
MFBs	NNS	O
play	VBP	B-REL
a	DT	I-REL
pivotal	JJ	I-REL
role	NN	I-REL
in	IN	O
the	DT	O
development	NN	O
of	IN	O
Fas	NN	O
during	IN	O
ICP	NNP	O

Taurocholate	NNP	O
in	IN	O
the	DT	O
FH	NN	O
model	NN	O
,	,	O
but	CC	O
not	RB	O
the	DT	O
MH	NN	O
model	NN	O
,	,	O
slowed	VBD	B-REL
conduction	NN	O
velocity	NN	O
from	IN	O
19	CD	O
to	TO	O
9	CD	O
cm/s	NNS	O

Bear	NNP	O
bile	NN	O
chemical	NN	O
could	MD	B-REL
help	VB	I-REL
keep	VB	O
hearts	NNS	O
in	IN	O
rhythm	NN	O

A	DT	O
synthesised	JJ	O
compound	NN	O
also	RB	O
found	VBN	O
in	IN	O
bear	NN	O
bile	NN	O
may	MD	B-REL
help	VB	I-REL
the	DT	O
recovery	NN	O
of	IN	O
some	DT	O
people	NNS	O
who	WP	O
have	VBP	O
had	VBN	O
a	DT	O
heart	NN	O
attack	NN	O

airway	NN	O
sensory	JJ	O
nerves	NNS	O
,	,	O
central	JJ	O
reflexes	NNS	O
and	CC	O
a	DT	B-REL
parasympathetic	JJ	O
effector	NN	O
arm	NN	O
leading	VBG	O
to	TO	O
cholinergic	JJ	O
constrictor	NN	O
responses	NNS	O
play	VBP	B-REL
a	DT	O
key	JJ	B-REL
role	NN	I-REL
in	IN	O
the	DT	O
LAR	NN	O
response	NN	O

allergen	NN	O
challenge	NN	O
triggering	VBG	O
airway	NN	O
sensory	JJ	O
nerves	NNS	O
via	IN	O
the	DT	O
activation	NN	O
of	IN	O
TRPA1	NN	O
channels	NNS	O
which	WDT	O
initiates	VBZ	B-REL
a	DT	O
central	JJ	O
reflex	JJ	O
event	NN	O
leading	VBG	O
to	TO	O
a	DT	O
parasympathetic	JJ	O
cholinergic	JJ	O
constrictor	NN	O
response	NN	O
.	.	O

blocking	VBG	O
sensory	JJ	O
nerve	NN	O
functions	NNS	O
stopped	VBD	B-REL
a	DT	O
``	``	O
late	JJ	O
asthmatic	JJ	O
response	NN	O
''	''	O

...	:	O
Children	NNP	O
undergoing	VBG	O
surgery	NN	O
for	IN	O
congenital	JJ	O
heart	NN	O
disease	NN	O
are	VBP	B-REL
at	IN	I-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	I-REL
intestinal	JJ	O
mucosal	JJ	O
injury	NN	O
and	CC	O
endotoxemia	NN	O
...	:	O

...	:	O
toddlers	NNS	O
with	IN	O
congenital	JJ	O
heart	NN	O
disease	NN	O
are	VBP	O
at	IN	O
an	DT	B-REL
increased	VBN	I-REL
risk	NN	I-REL
of	IN	O
having	VBG	O
harmful	JJ	O
toxins	NNS	O
in	IN	O
their	PRP$	O
blood	NN	O
,	,	O
particularly	RB	O
following	VBG	O
surgery	NN	O
...	:	O

...	:	O
we	PRP	O
report	VBP	O
a	DT	B-REL
long-term	JJ	O
follow-up	NN	O
of	IN	O
the	DT	O
benefits	NNS	O
of	IN	O
early	JJ	O
treatment	NN	O
of	IN	O
hypertensive	JJ	O
patients	NNS	O
with	IN	O
atorvastatin	NN	O
compared	VBN	O
with	IN	O
placebo	NN	O
on	IN	O
all-cause	JJ	O
mortality	NN	O
,	,	O
best	JJS	B-REL
attributed	VBN	I-REL
to	TO	I-REL
a	DT	O
reduction	NN	B-REL
in	IN	I-REL
non-CV	JJ	O
deaths	NNS	O
,	,	O
and	CC	O
contributed	VBD	O
to	TO	O
by	IN	O
a	DT	O
reduction	NN	O
in	IN	O
death	NN	O
from	IN	O
infection	NN	O
and	CC	O
respiratory	JJ	O
illness	NN	O
...	:	O

...	:	O
legacy	NN	O
effects	NNS	O
of	IN	O
those	DT	O
originally	RB	O
assigned	VBN	O
atorvastatin	NN	O
may	MD	B-REL
contribute	VB	I-REL
to	TO	I-REL
long-term	JJ	I-REL
benefits	NNS	I-REL
on	IN	O
all-cause	JJ	O
mortality	NN	O
...	:	O

...	:	O
statins	NNS	O
reduced	VBD	B-REL
deaths	NNS	O
from	IN	O
infection	NN	O
and	CC	O
respiratory	JJ	O
illness	NN	O
...	:	O

...	:	O
TAKING	VBG	O
cholesterol-busting	JJ	O
statins	NNS	O
cuts	VBZ	B-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	I-REL
dying	VBG	I-REL
from	IN	I-REL
infection	NN	O
and	CC	O
respiratory	JJ	O
illness	NN	O
such	JJ	O
as	IN	O
pneumonia	NN	O
...	:	O

...	:	O
CHOLESTEROL	NN	O
pills	NNS	O
taken	VBN	O
by	IN	O
millions	NNS	O
of	IN	O
Britons	NNPS	O
may	MD	B-REL
also	RB	I-REL
protect	VB	I-REL
people	NNS	O
from	IN	O
serious	JJ	O
infection	NN	O
and	CC	O
respiratory	JJ	O
illnesses	NNS	O
.	.	O

...	:	O
tatins	NNS	O
have	VBP	O
now	RB	O
also	RB	O
been	VBN	O
found	VBN	O
to	TO	B-REL
cut	VB	I-REL
death	NN	I-REL
from	IN	O
infections	NNS	O
...	:	O

...	:	O
now	RB	O
scientists	NNS	O
discover	VBP	O
statins	NNS	O
can	MD	B-REL
fight	VB	I-REL
many	JJ	O
killer	NN	O
diseases	NNS	O
...	:	O

...	:	O
statins	NNS	O
,	,	O
the	DT	O
drugs	NNS	O
designed	VBN	O
to	TO	O
prevent	VB	O
heart	NN	O
attacks	NNS	O
and	CC	O
strokes	NNS	O
,	,	O
are	VBP	B-REL
also	RB	I-REL
effective	JJ	I-REL
in	IN	I-REL
battling	VBG	O
respiratory	JJ	O
illness	NN	O
and	CC	O
other	JJ	O
infections	NNS	O
.	.	O

...	:	O
statins	NNS	O
'	POS	O
principal	JJ	O
long-term	JJ	O
benefit	NN	O
is	VBZ	B-REL
stopping	VBG	I-REL
deaths	NNS	I-REL
from	IN	O
infections	NNS	O
and	CC	O
respiratory	JJ	O
illness	NN	O
...	:	O

...	:	O
the	DT	O
duplication	NN	O
was	VBD	O
strongly	RB	B-REL
associated	VBN	I-REL
with	IN	O
lower	JJR	O
weight	NN	O
...	:	O

...	:	O
the	DT	O
phenotypes	NNS	O
correlate	VBP	B-REL
with	IN	I-REL
changes	NNS	I-REL
in	IN	I-REL
transcript	NN	O
levels	NNS	O
for	IN	O
genes	NNS	O
mapping	VBG	O
within	IN	O
the	DT	O
duplication	NN	O
...	:	O

...	:	O
gene	NN	O
overdose	NN	O
causes	VBZ	B-REL
extreme	JJ	O
thinness	NN	O
...	:	O

...	:	O
overdose	NN	O
of	IN	O
chromosomes	NNS	O
that	WDT	O
keep	VBP	B-REL
them	PRP	I-REL
thin	JJ	O
...	:	O

...	:	O
skinny	JJ	O
people	NNS	O
have	VBP	B-REL
extra	JJ	O
copies	NNS	O
of	IN	O
certain	JJ	O
genes	NNS	O
...	:	O

...	:	O
underweight	JJ	O
people	NNS	O
possess	VBP	B-REL
extra	JJ	O
copies	NNS	O
of	IN	O
certain	JJ	O
genes	NNS	O
...	:	O

Partial	JJ	O
cholesterol	NN	O
depletion	NN	O
reduced	VBD	B-REL
the	DT	O
pDC-activating	JJ	O
potential	NN	O
of	IN	O
HIV	NN	O

By	IN	O
depleting	VBG	O
envelope-associated	JJ	O
cholesterol	NN	O
to	TO	B-REL
different	JJ	O
degrees	NNS	O
,	,	O
we	PRP	O
generated	VBD	O
virions	NNS	O
with	IN	O
reduced	VBN	B-REL
ability	NN	I-REL
to	TO	O
activate	VB	B-REL
pDC	NN	O

found	VBN	O
a	DT	O
way	NN	O
to	TO	O
prevent	VB	B-REL
HIV	NN	O
from	IN	O
damaging	VBG	O
the	DT	O
immune	JJ	O
system	NN	O

a	DT	O
way	NN	O
to	TO	O
prevent	VB	B-REL
HIV	NN	O
damaging	JJ	O
immune	JJ	O
systems	NNS	O

found	VBN	O
a	DT	O
way	NN	O
to	TO	O
prevent	VB	B-REL
HIV	NN	O
from	IN	O
damaging	VBG	O
the	DT	O
immune	JJ	O
system	NN	O

Endog	JJ	O
loss	NN	O
of	IN	O
function	NN	O
as	IN	B-REL
a	DT	I-REL
primary	JJ	I-REL
determinant	NN	I-REL
of	IN	O
maladaptive	JJ	O
cardiac	JJ	O
hypertrophy	NN	O
that	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
mitochondrial	JJ	O
dysfunction	NN	O
and	CC	O
depletion	NN	O
and	CC	O
with	IN	O
marked	JJ	O
cardiomyocyte	NN	O
steatosis	NN	O

Inhibition	NN	O
of	IN	O
Endog	NNP	O
in	IN	B-REL
cultured	VBN	O
cardiomyocytes	NNS	O
resulted	VBD	B-REL
in	IN	O
an	DT	B-REL
increase	NN	I-REL
in	IN	O
cell	NN	O
size	NN	O
and	CC	O
hypertrophic	JJ	O
biomarkers	NNS	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
pro-hypertrophic	JJ	O
stimulation	NN	O

Endog	JJ	O
gene	NN	O
in	IN	O
rats	NNS	O
and	CC	O
mice	NNS	O
influences	VBZ	B-REL
the	DT	O
thickness	NN	O
of	IN	O
the	DT	O
muscular	JJ	O
heart	NN	O
wall	NN	O

Childhood	NNP	O
cognitive	JJ	O
abilities	NNS	O
,	,	O
particularly	RB	O
complex	JJ	O
functions	NNS	O
requiring	VBG	O
executive	JJ	O
function	NN	O
,	,	O
attention	NN	O
,	,	O
and	CC	O
planning	NN	O
,	,	O
are	VBP	O
directly	RB	B-REL
related	VBN	I-REL
to	TO	O
the	DT	O
growth	NN	O
of	IN	O
the	DT	O
cerebral	JJ	O
cortex	NN	O

The	DT	O
rate	NN	O
of	IN	O
cerebral	JJ	O
cortical	JJ	O
growth	NN	O
between	IN	O
24	CD	O
and	CC	O
44	CD	O
weeks	NNS	O
PMA	NN	O
predicts	VBZ	B-REL
global	JJ	O
ability	NN	O
in	IN	O
later	JJ	O
childhood	NN	O

The	DT	O
growth	NN	O
rates	NNS	O
of	IN	O
the	DT	O
brain	NN	O
's	POS	O
cerebral	JJ	O
cortex	NN	O
in	IN	O
babies	NNS	O
born	VBN	O
prematurely	RB	O
may	MD	B-REL
predict	VB	I-REL
how	WRB	O
well	RB	O
they	PRP	O
are	VBP	O
able	JJ	O
to	TO	O
think	VB	O
,	,	O
speak	VB	O
,	,	O
plan	NN	O
and	CC	O
pay	NN	O
attention	NN	O

continuous	JJ	O
SGK1	NN	O
activity	NN	O
in	IN	O
endometrial	JJ	O
surface	NN	O
epithelium	NN	O
selectively	RB	O
disrupts	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
implantation	NN	O
genes	NNS	O
and	CC	O
perturbs	VBZ	O
the	DT	O
local	JJ	O
fluid	NN	O
environment	NN	O
,	,	B-REL
leading	VBG	I-REL
to	TO	O
complete	VB	O
infertility	NN	O

depending	VBG	O
on	IN	O
the	DT	O
cellular	JJ	O
compartment	NN	O
,	,	O
deregulated	VBN	O
SGK1	NN	O
activity	NN	O
in	IN	O
cycling	NN	O
endometrium	NN	O
interferes	VBZ	O
with	IN	O
embryo	NN	O
implantation	NN	O
,	,	O
leading	VBG	B-REL
to	TO	O
infertility	NN	O
,	,	O
or	CC	O
predisposes	VBZ	O
to	TO	O
pregnancy	NN	O
complications	NNS	O
by	IN	O
rendering	VBG	O
the	DT	O
feto-maternal	JJ	O
interface	NN	O
vulnerable	JJ	O
to	TO	O
oxidative	JJ	O
damage	NN	O

Scientists	NNS	O
have	VBP	O
discovered	VBN	O
an	DT	O
enzyme	NN	O
that	WDT	O
acts	VBZ	B-REL
as	IN	I-REL
a	DT	O
`	``	O
fertility	NN	O
switch	NN	O
'	''	O

Too	RB	O
much	RB	O
of	IN	O
the	DT	O
protein	NN	O
SGK1	NN	O
in	IN	O
the	DT	O
lining	NN	O
of	IN	O
the	DT	O
womb	NN	O
makes	VBZ	B-REL
it	PRP	I-REL
harder	JJR	O
to	TO	O
get	VB	O
pregnant	JJ	O

A	DT	O
``	``	O
FERTILITY	NN	O
switch	NN	O
''	''	O
in	IN	O
the	DT	O
womb	NN	O
can	MD	B-REL
make	VB	I-REL
a	DT	O
woman	NN	O
less	RBR	O
likely	JJ	O
to	TO	O
conceive	VB	O
-	:	O
or	CC	O
increase	VB	O
her	PRP$	O
risk	NN	O
of	IN	O
miscarriage	NN	O

A	DT	O
FAULTY	NN	O
fertility	NN	O
switch	NN	O
can	MD	B-REL
stop	VB	I-REL
women	NNS	O
getting	VBG	O
pregnant	JJ	O
and	CC	O
cause	VB	O
miscarriages	NNS	O

Scientists	NNS	O
have	VBP	O
identified	VBN	O
a	DT	O
``	``	O
fertility	NN	O
switch	NN	O
''	''	O
protein	NN	O
which	WDT	O
appears	VBZ	B-REL
to	TO	I-REL
increase	VB	I-REL
infertility	NN	O
if	IN	O
levels	NNS	O
are	VBP	O
too	RB	O
high	JJ	O
and	CC	O
fuel	NN	O
miscarriage	NN	O
if	IN	O
too	RB	O
low	JJ	O

high	JJ	O
levels	NNS	O
of	IN	O
a	DT	O
protein	NN	O
called	VBN	O
SGK1	NN	O
are	VBP	B-REL
linked	VBN	I-REL
with	IN	I-REL
infertility	NN	O
,	,	O
while	IN	O
low	JJ	O
levels	NNS	O
of	IN	O
it	PRP	O
make	VB	O
a	DT	O
woman	NN	O
more	RBR	O
likely	JJ	O
to	TO	O
have	VB	O
a	DT	O
miscarriage	NN	O

...	:	O
iFR	NNP	O
,	,	O
a	DT	O
new	JJ	O
index	NN	O
based	VBN	O
on	IN	O
this	DT	O
principle	NN	O
,	,	O
has	VBZ	B-REL
an	DT	I-REL
excellent	JJ	I-REL
diagnostic	JJ	I-REL
efficiency	NN	O
in	IN	O
identifying	VBG	O
stenoses	NNS	O
with	IN	O
an	DT	O
FFR	NN	O
0.80	CD	O
and	CC	O
could	MD	O
be	VB	O
used	VBN	O
for	IN	O
intracoronary	JJ	O
functional	JJ	O
assessment	NN	O
when	WRB	O
administration	NN	O
of	IN	O
adenosine	NN	O
is	VBZ	O
not	RB	O
desirable	JJ	O
...	:	O

...	:	O
the	DT	O
instantaneous	JJ	O
wave-free	JJ	O
ratio	NN	O
calculated	VBN	O
over	IN	O
this	DT	O
period	NN	O
produces	VBZ	B-REL
a	DT	I-REL
drug-free	JJ	I-REL
index	NN	I-REL
of	IN	I-REL
stenosis	NN	I-REL
severity	NN	I-REL
comparable	JJ	I-REL
to	TO	I-REL
FFR	NN	O
...	:	O

...	:	O
improved	VBN	O
technology	NN	O
may	MD	B-REL
obviate	VB	I-REL
need	NN	I-REL
for	IN	I-REL
drug	NN	I-REL
when	WRB	O
assessing	VBG	O
patients	NNS	O
...	:	O

Differences	NNS	O
between	IN	O
individuals	NNS	O
in	IN	O
self-control	NN	O
are	VBP	O
present	JJ	O
in	IN	O
early	JJ	O
childhood	NN	O
and	CC	O
can	MD	B-REL
predict	VB	I-REL
multiple	JJ	O
indicators	NNS	O
of	IN	O
health	NN	O
,	,	O
wealth	NN	O
,	,	O
and	CC	O
crime	NN	O
across	IN	O
3	CD	O
decades	NNS	O
of	IN	O
life	NN	O
in	IN	O
both	CC	O
genders	NNS	O
.	.	O

Childhood	NN	O
self	NN	O
control	NN	O
predicts	VBZ	B-REL
physical	JJ	O
health	NN	O
,	,	O
substance	NN	O
dependence	NN	O
,	,	O
personal	JJ	O
finances	NNS	O
,	,	O
and	CC	O
criminal	JJ	O
offending	VBG	O
outcomes	NNS	O
,	,	O
following	VBG	O
a	DT	O
gradient	NN	O
of	IN	O
self-control	NN	O
.	.	O

Self	NN	O
control	NN	O
predicts	VBZ	B-REL
health	NN	O
and	CC	O
wealth	NN	O
.	.	O

When	WRB	O
added	VBN	O
to	TO	O
SMC	NNP	O
,	,	O
CBT	NNP	O
and	CC	O
GET	VB	O
had	VBD	O
greater	JJR	O
success	NN	O
in	IN	O
reducing	VBG	B-REL
fatigue	NN	O
and	CC	O
improving	VBG	O
physical	JJ	O
function	NN	O
than	IN	O
did	VBD	O
APT	NNP	O
or	CC	O
SMC	NNP	O
alone	RB	O
.	.	O

CBT	NNP	O
and	CC	O
GET	VB	O
can	MD	O
safely	RB	O
be	VB	O
added	VBN	O
to	TO	O
SMC	NN	O
to	TO	O
moderately	RB	B-REL
improve	VB	I-REL
outcomes	NNS	O
for	IN	O
chronic	JJ	O
fatigue	NN	O
syndrome	NN	O
.	.	O

Two	CD	O
effective	JJ	O
treatments	NNS	O
benefit	VBP	B-REL
up	RP	O
to	TO	O
60	CD	O
per	IN	O
cent	NN	O
of	IN	O
patients	NNS	O
with	IN	O
Chronic	JJ	O
Fatigue	NNP	O
Syndrome	NN	O
or	CC	O
Myalgic	JJ	O
Encephalomyelitis	NN	O
.	.	O

Up	IN	O
to	TO	O
60	CD	O
per	IN	O
cent	NN	O
of	IN	O
patients	NNS	O
improved	VBN	B-REL
if	IN	O
therapists	NNS	O
encouraged	VBD	O
them	PRP	O
gradually	RB	O
to	TO	O
do	VB	O
more	JJR	O
.	.	O

Patients	NNS	O
with	IN	O
ME	NN	O
,	,	O
also	RB	O
known	VBN	O
as	IN	O
chronic	JJ	O
fatigue	NN	O
sundrome	NN	O
,	,	O
who	WP	O
are	VBP	O
encouraged	VBN	O
to	TO	O
``	``	O
test	VB	O
their	PRP$	O
limits	NNS	O
''	''	O
mentally	RB	O
and	CC	O
physically	RB	O
do	VB	B-REL
better	JJR	I-REL
than	IN	I-REL
those	DT	O
whose	WP$	O
therapies	NNS	O
help	VBP	O
them	PRP	O
to	TO	O
adapt	VB	O
to	TO	O
the	DT	O
condition	NN	O
.	.	O

Up	IN	O
to	TO	O
60	CD	O
per	IN	O
cent	NN	O
of	IN	O
patients	NNS	O
improved	VBN	B-REL
if	IN	O
therapists	NNS	O
encouraged	VBD	O
them	PRP	O
gradually	RB	O
to	TO	O
do	VB	O
more	JJR	O
.	.	O

The	DT	O
described	VBN	O
protection	NN	B-REL
against	IN	I-REL
M.	NN	O
tuberculosis	NN	O
infection	NN	O
by	IN	O
I.n.	NNP	O
Treatment	NN	O
with	IN	O
human	JJ	O
IgA	NN	O
mAb	NN	O
and	CC	O
rIFM-gamma	NN	O
represents	VBZ	O
an	DT	O
important	JJ	O
step	NN	O
toward	IN	O
the	DT	O
possibility	NN	O
of	IN	O
passive	NN	O
immunotherapy	NN	O
in	IN	O
TB	NN	O
patients	NNS	O
.	.	O

The	DT	O
demonstration	NN	O
of	IN	O
the	DT	B-REL
mandatory	JJ	I-REL
role	NN	I-REL
of	IN	O
FcalphaRI	NN	O
for	IN	O
human	JJ	O
IgA-mediated	JJ	O
protection	NN	O
is	VBZ	O
important	JJ	O
for	IN	O
understanding	NN	O
of	IN	O
the	DT	O
mechanisms	NNS	O
involved	VBN	O
and	CC	O
also	RB	O
for	IN	O
translation	NN	O
of	IN	O
this	DT	O
approach	NN	O
toward	IN	O
development	NN	O
of	IN	O
passive	NN	O
immunotherapy	NN	O
of	IN	O
tuberculosis	NN	O
.	.	O

They	PRP	O
have	VBP	O
developed	VBN	O
a	DT	O
monoclonal	JJ	O
antibody	NN	O
which	WDT	O
was	VBD	B-REL
found	VBN	I-REL
to	TO	I-REL
offer	VB	I-REL
protection	NN	I-REL
against	IN	I-REL
tuberculosis	NN	O
infection	NN	O
.	.	O

We	PRP	O
found	VBD	O
8	CD	O
common	JJ	O
SNPs	NNS	O
that	WDT	B-REL
implicate	VBP	O
nearby	JJ	O
genes	NNS	O
that	WDT	O
are	VBP	B-REL
independently	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
serum	NN	O
DHEAS	NN	O
concentrations	NNS	O
and	CC	O
provide	VBP	O
clues	NNS	O
to	TO	O
its	PRP$	O
role	NN	O
in	IN	O
ageing	JJ	O
.	.	O

Several	JJ	O
SNPs	NNS	O
were	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
changes	NNS	O
in	IN	O
gene	NN	O
expression	NN	O
levels	NNS	O
.	.	O

Eight	CD	O
genes	NNS	O
which	WDT	O
control	VBP	B-REL
levels	NNS	O
of	IN	O
the	DT	O
main	JJ	O
steroid	NN	O
produced	VBN	O
by	IN	O
the	DT	O
adrenal	JJ	O
gland	NN	O
.	.	O

Scientists	NNS	O
have	VBP	O
identified	VBN	O
eight	CD	O
genes	NNS	O
that	WDT	B-REL
control	VBP	I-REL
levels	NNS	O
of	IN	O
a	DT	O
steroid	NN	O
linked	VBN	O
to	TO	O
age	NN	O
span	NN	O
.	.	O

...	:	O
This	DT	O
work	NN	O
clearly	RB	O
demonstrates	VBZ	O
that	IN	O
Lin	NNP	O
-	:	O
/	:	O
PDGFRa	NN	O
+	CC	O
cells	NNS	O
from	IN	O
BM	NN	O
significantly	RB	B-REL
contribute	VBP	I-REL
to	TO	O
the	DT	O
regeneration	NN	O
of	IN	O
the	DT	O
epidermis	NN	O
after	IN	O
skin	NN	O
grafting	NN	O
in	FW	O
vivo	FW	O
,	,	O
and	CC	O
that	IN	O
one	CD	O
biological	JJ	O
repair	NN	O
mechanism	NN	O
involves	VBZ	O
the	DT	O
key	JJ	O
cells	NNS	O
being	VBG	O
mobilized	VBN	O
in	IN	O
response	NN	O
to	TO	O
elevated	JJ	O
HMGB1	NN	O
levels	NNS	O
in	IN	O
serum	NN	O
...	:	O

...	:	O
grafting	NN	O
of	IN	B-REL
full	JJ	O
thickness	NN	O
wild-type	JJ	O
mouse	NN	O
skin	NN	O
onto	IN	O
mice	NNS	O
that	WDT	O
had	VBD	O
received	VBN	O
a	DT	O
green	JJ	O
fluorescent	JJ	O
protein-bone	JJ	O
marrow	NN	O
transplant	NN	O
after	IN	O
whole	JJ	O
body	NN	O
irradiation	NN	O
led	VBD	B-REL
to	TO	I-REL
an	DT	I-REL
abundance	NN	I-REL
of	IN	O
bone	NN	O
marrow-derived	JJ	O
epithelial	JJ	O
cells	NNS	O
in	IN	O
follicular	JJ	O
and	CC	O
interfollicular	JJ	O
epidermis	NN	O
that	WDT	O
persisted	VBD	O
for	IN	O
at	IN	O
least	JJS	O
5	CD	O
mo.	NN	O
.	.	O

We	PRP	O
identified	VBD	O
at	IN	O
genome-wide	JJ	O
significance	NN	O
an	DT	O
association	NN	B-REL
of	IN	O
AUTS2	NN	O
with	IN	O
alcohol	NN	O
intake	NN	O
.	.	O

AUTS2	NN	O
was	VBD	O
associated	VBN	B-REL
with	IN	I-REL
alcohol	NN	O
consumption	NN	O
at	IN	O
genome-wide	JJ	O
significance	NN	O
.	.	O

A	DT	O
gene	NN	O
that	WDT	O
appears	VBZ	B-REL
to	TO	I-REL
play	VB	I-REL
a	DT	I-REL
role	NN	I-REL
in	IN	O
regulating	VBG	O
how	WRB	O
much	JJ	O
alcohol	NN	O
people	NNS	O
drink	VBP	O
.	.	O

Scientists	NNS	O
discover	VBP	O
gene	NN	O
that	WDT	B-REL
influences	VBZ	I-REL
drinking	NN	O
habits	NNS	O
.	.	O

A	DT	O
gene	NN	O
that	WDT	O
appears	VBZ	O
to	TO	O
play	VB	B-REL
a	DT	I-REL
role	NN	I-REL
in	IN	I-REL
regulating	VBG	I-REL
how	WRB	O
much	JJ	O
alcohol	NN	O
people	NNS	O
drink	VBP	O
.	.	O

a	DT	O
new	JJ	O
test	NN	O
that	WDT	O
could	MD	B-REL
accurately	RB	I-REL
predict	VB	I-REL
.	.	O

...	:	O
heterozygous	JJ	O
gain-of-function	NN	O
mutations	NNS	O
in	IN	O
ARHGAP31	NN	O
cause	VBP	B-REL
an	DT	I-REL
autosomal-dominant	JJ	O
form	NN	O
of	IN	O
ACC-TTLD	NN	O
through	IN	O
introduction	NN	O
of	IN	O
premature	JJ	O
termination	NN	O
codons	NNS	O
in	IN	O
the	DT	O
terminal	JJ	O
exon	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

...	:	O
active	JJ	O
ARHGAP31	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
a	DT	O
loss	NN	O
of	IN	O
available	JJ	O
active	JJ	O
Cdc42	NN	O
and	CC	O
consequently	RB	O
disrupt	VB	B-REL
actin	NN	O
cytoskeletal	JJ	O
structures	NNS	O
...	:	O

...	:	O
uncovered	VBD	O
a	DT	O
gene	NN	O
responsible	JJ	B-REL
for	IN	I-REL
Adams-Oliver	NNP	O
Syndrome	NN	O
...	:	O

a	DT	O
genome-wide	JJ	O
significant	JJ	B-REL
linkage	NN	I-REL
on	IN	O
chromosome	NN	O
3p25-26	NN	O
.	.	O

genome	NN	O
-	:	O
wide-significant	JJ	O
linkage	NN	B-REL
for	IN	O
depression	NN	O
.	.	O

genetic	JJ	O
variations	NNS	O
on	IN	O
chromosome	NN	O
3	CD	O
may	MD	B-REL
cause	VB	I-REL
depression	NN	O
.	.	O

flaws	NNS	O
in	IN	O
people	NNS	O
's	POS	O
DNA	NN	O
which	WDT	O
may	MD	B-REL
make	VB	I-REL
them	PRP	I-REL
more	RBR	O
likely	JJ	O
to	TO	O
suffer	VB	O
from	IN	O
the	DT	O
condition	NN	O
.	.	O

genetic	JJ	O
variations	NNS	O
on	IN	O
a	DT	O
particular	JJ	O
chromosome	NN	O
could	MD	B-REL
cause	VB	I-REL
the	DT	O
illness	NN	O
.	.	O

a	DT	O
particular	JJ	O
chromosome	NN	O
could	MD	B-REL
cause	VB	I-REL
the	DT	O
disorder	NN	O
.	.	O

genetic	JJ	O
variations	NNS	O
in	IN	O
a	DT	O
chromosome	NN	O
could	MD	B-REL
cause	VB	I-REL
the	DT	O
disorder	NN	O
.	.	O

genetic	JJ	O
variations	NNS	O
on	IN	O
a	DT	O
particular	JJ	O
chromosome	NN	O
could	MD	B-REL
cause	VB	I-REL
the	DT	O
disorder	NN	O
.	.	O

established	VBN	O
a	DT	O
genetic	JJ	O
cause	NN	B-REL
for	IN	O
depression	NN	O
.	.	O

variations	NNS	O
in	IN	O
some	DT	O
peoples	NNS	O
'	POS	O
genes	NNS	O
may	MD	B-REL
cause	VB	I-REL
depression	NN	O
.	.	O

...	:	O
the	DT	O
data	NNS	O
we	PRP	O
present	VBP	O
here	RB	O
have	VB	O
provided	VBN	O
in	FW	B-REL
vivo	FW	O
evidence	NN	O
of	IN	O
the	DT	O
relative	JJ	O
functional	JJ	O
efficacy	NN	O
of	IN	O
human	JJ	O
alloantigen	NN	O
and	CC	O
polyclonal	JJ	O
Tregs	NNS	O
in	IN	O
ameliorating	VBG	O
immune-mediated	JJ	O
allograft	NN	O
pathology	NN	O
...	:	O

...	:	O
a	DT	B-REL
humanized	JJ	O
mouse	NN	O
model	NN	O
of	IN	O
alloimmune-mediated	JJ	O
injury	NN	O
of	IN	O
human	JJ	O
skin	NN	O
grafts	NNS	O
,	,	O
alloantigen-specific	JJ	O
Tregs	NNS	O
resulted	VBD	B-REL
in	IN	I-REL
a	DT	O
significant	JJ	B-REL
reduction	NN	I-REL
in	IN	O
clinically	RB	B-REL
relevant	JJ	I-REL
indicators	NNS	O
of	IN	O
dermal	JJ	O
tissue	NN	O
injury	NN	O
...	:	O

...	:	O
researchers	NNS	O
at	IN	O
King	NNP	O
's	POS	O
College	NNP	O
London	NNP	O
have	VBP	O
used	VBN	O
cells	NNS	O
found	VBD	O
naturally	RB	O
in	IN	O
the	DT	B-REL
body	NN	O
,	,	O
to	TO	B-REL
re-educate	VB	I-REL
the	DT	O
immune	JJ	B-REL
system	NN	I-REL
to	TO	O
prevent	VB	B-REL
rejection	NN	O
of	IN	O
an	DT	O
organ	NN	O
transplant	NN	O
...	:	O

a	DT	O
critical	JJ	B-REL
functional	JJ	I-REL
interplay	NN	I-REL
between	IN	O
these	DT	O
two	CD	O
molecular	JJ	O
pathways	NNS	O
in	IN	O
establishment	NN	O
of	IN	O
normal	JJ	O
and	CC	O
leukemic	JJ	O
stem	NN	O
cells	NNS	O

these	DT	O
results	NNS	O
reveal	VBP	O
an	DT	O
important	JJ	O
functional	JJ	B-REL
interplay	NN	O
between	IN	O
MLL/Hox	NN	O
and	CC	O
Bmi1	NN	O
in	IN	O
regulating	VBG	O
cellular	JJ	O
senescence	NN	O
for	IN	O
LSC	NNP	O
development	NN	O

leukaemic	JJ	O
stem	NN	O
cells	NNS	O
can	MD	B-REL
be	VB	I-REL
abolished	VBN	I-REL
by	IN	O
suppressing	VBG	O
two	CD	O
proteins	NNS	O

a	DT	O
discovery	NN	O
that	WDT	O
could	MD	B-REL
enable	VB	I-REL
leukaemia	NN	O
sufferers	NNS	O
to	TO	O
be	VB	O
completely	RB	O
rid	JJ	O
of	IN	O
the	DT	O
disease	NN	O

indicating	VBG	O
a	DT	B-REL
strong	JJ	I-REL
association	NN	I-REL
with	IN	I-REL
tooth	NN	O
wear	NN	O
in	IN	O
dentine	NN	O

tooth	NN	O
wear	NN	O
was	VBD	B-REL
associated	VBN	I-REL
to	TO	I-REL
a	DT	O
number	NN	O
of	IN	O
acidic	JJ	O
dietary	JJ	O
products	NNS	O

acidic	JJ	O
food	NN	O
and	CC	O
drink	NN	O
can	MD	B-REL
damage	VB	I-REL
teeth	NNS	O

anxiety-disordered	JJ	O
children	NNS	O
,	,	O
those	DT	O
with	IN	O
the	DT	O
5HTTLPR	NN	O
SS	NN	O
genotype	NN	O
were	VBD	O
20	CD	B-REL
%	NN	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
be	VB	O
disorder-free	JJ	O
by	IN	O
follow-up	NN	O
than	IN	O
those	DT	O
with	IN	O
SL/LL	NN	O
genotypes	NNS	O

Children	NNS	O
with	IN	O
the	DT	O
short-short	NN	O
genotype	NN	O
were	VBD	O
significantly	RB	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
respond	VB	O
to	TO	O
CBT	NNP	O
than	IN	O
those	DT	O
carrying	VBG	O
a	DT	O
long	JJ	O
allele	NN	O

Sensitivity	NN	O
gene	NN	O
predicts	VBZ	B-REL
CBT	NNP	O
benefit	NN	O

...	:	O
adverse	JJ	O
perinatal	JJ	O
outcomes	NNS	O
are	VBP	B-REL
uncommon	JJ	I-REL
in	IN	I-REL
all	DT	I-REL
settings	NNS	O
...	:	O

...	:	O
women	NNS	O
planning	VBG	O
birth	NN	O
in	IN	O
a	DT	O
midwifery	JJ	O
unit	NN	O
and	CC	O
multiparous	JJ	O
women	NNS	O
planning	VBG	O
birth	NN	O
at	IN	O
home	NN	O
experience	NN	B-REL
fewer	JJR	I-REL
interventions	NNS	I-REL
than	IN	I-REL
those	DT	I-REL
planning	VBG	O
birth	NN	O
in	IN	O
an	DT	O
obstetric	JJ	O
unit	NN	O
with	IN	O
no	DT	O
impact	NN	O
on	IN	O
perinatal	JJ	O
outcomes	NNS	O
...	:	O

...	:	O
first-time	JJ	O
mothers	NNS	O
who	WP	O
opt	VBP	O
for	IN	O
a	DT	O
home	NN	O
birth	NN	O
are	VBP	B-REL
almost	RB	I-REL
three	CD	I-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
have	VB	O
a	DT	O
baby	NN	O
who	WP	O
dies	VBZ	O
or	CC	O
suffers	VBZ	O
brain	NN	O
damage	NN	O
,	,	O
says	VBZ	O
a	DT	O
major	JJ	O
report	NN	O
...	:	O

...	:	O
FIRST-TIME	NN	O
mums	NNS	O
are	VBP	O
three	CD	B-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
lose	VB	O
their	PRP$	O
baby	NN	O
if	IN	O
they	PRP	O
give	VBP	O
birth	NN	O
at	IN	O
home	NN	O
,	,	O
a	DT	O
study	NN	O
reveals	VBZ	O
...	:	O

...	:	O
FIRST-time	JJ	O
mothers	NNS	O
who	WP	O
opt	VBP	O
for	IN	O
a	DT	O
home	NN	O
birth	NN	O
are	VBP	O
almost	RB	B-REL
three	CD	I-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
have	VB	O
a	DT	O
baby	NN	O
who	WP	O
dies	VBZ	O
or	CC	O
suffers	VBZ	O
brain	NN	O
damage	NN	O
...	:	O

...	:	O
first-time	JJ	O
mothers	NNS	O
who	WP	B-REL
plan	VBP	O
to	TO	B-REL
give	VB	O
birth	NN	O
at	IN	O
home	NN	O
are	VBP	B-REL
twice	RB	I-REL
as	RB	I-REL
likely	JJ	I-REL
to	TO	O
have	VB	B-REL
a	DT	I-REL
baby	NN	I-REL
who	WP	O
dies	VBZ	O
or	CC	O
is	VBZ	O
seriously	RB	O
harmed	VBN	O
as	IN	O
those	DT	O
giving	VBG	O
birth	NN	O
in	IN	O
hospital	NN	O
,	,	O
a	DT	O
landmark	NN	O
study	NN	O
has	VBZ	O
concluded	VBN	O
...	:	O

...	:	O
Giving	VBG	O
birth	NN	O
at	IN	O
home	NN	O
or	CC	O
in	IN	O
a	DT	O
midwife-led	JJ	O
birth	NN	O
centre	NN	O
is	VBZ	O
just	RB	O
as	RB	O
safe	JJ	O
as	IN	O
going	VBG	O
into	IN	O
hospital	NN	O
for	IN	O
women	NNS	O
who	WP	O
already	RB	O
have	VBP	O
a	DT	O
child	NN	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
a	DT	O
slight	JJ	B-REL
extra	JJ	I-REL
risk	NN	I-REL
of	IN	I-REL
problems	NNS	O
for	IN	O
the	DT	O
babies	NNS	O
of	IN	O
first-time	JJ	O
mothers	NNS	O
who	WP	O
opt	VBP	O
to	TO	O
stay	VB	O
at	IN	O
home	NN	O
...	:	O

...	:	O
first-time	JJ	O
mothers	NNS	O
who	WP	O
opt	VBP	O
for	IN	O
a	DT	O
home	NN	O
birth	NN	O
are	VBP	O
almost	RB	O
three	CD	B-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
suffer	VB	O
complications	NNS	O
...	:	O

...	:	O
hospital	NN	O
obstetric	JJ	O
units	NNS	O
are	VBP	B-REL
safer	JJR	I-REL
than	IN	I-REL
home	NN	O
births	NNS	O
for	IN	O
first	JJ	O
babies	NNS	O
...	:	O

...	:	O
first-time	JJ	O
mothers	NNS	O
who	WP	O
choose	VBP	O
to	TO	O
give	VB	O
birth	NN	O
at	IN	O
home	NN	O
are	VBP	O
almost	RB	B-REL
three	CD	I-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	O
have	VB	O
a	DT	O
baby	NN	O
who	WP	O
suffers	VBZ	O
a	DT	O
bad	JJ	O
outcome	NN	O
...	:	O

...	:	O
BABIES	NNS	O
born	VBN	O
at	IN	O
home	NN	O
to	TO	O
first-time	JJ	O
mothers	NNS	O
are	VBP	O
almost	RB	B-REL
three	CD	I-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	O
to	TO	O
die	VB	O
or	CC	O
suffer	VB	O
complications	NNS	O
than	IN	O
in	IN	O
hospital	NN	O
...	:	O

TRPA1	NN	O
is	VBZ	B-REL
required	VBN	I-REL
for	IN	O
the	DT	O
antinociceptive	JJ	O
effects	NNS	O

...	:	O
here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
antinociceptive	JJ	O
effects	NNS	O
of	IN	O
spinal	JJ	O
and	CC	O
systemic	JJ	O
administration	NN	O
of	IN	O
acetaminophen	NN	O
-LRB-	-LRB-	O
paracetamol	NNP	O
-RRB-	-RRB-	O
are	VBP	B-REL
lost	VBN	I-REL
in	IN	I-REL
Trpa1	NN	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
.	.	O

...	:	O
paracetamol	NNP	O
does	VBZ	B-REL
not	RB	I-REL
work	VB	I-REL
if	IN	O
a	DT	O
protein	NN	O
on	IN	O
the	DT	O
surface	NN	O
of	IN	O
nerve	NN	O
cells	NNS	O
called	VBN	O
TRA1	NN	O
is	VBZ	O
removed	VBN	O
...	:	O

...	:	O
the	DT	O
drug	NN	O
...	:	O
interacts	VBZ	B-REL
with	IN	I-REL
a	DT	O
protein	NN	O
found	VBN	O
in	IN	O
nerve	NN	O
cells	NNS	O
...	:	O

Under	IN	B-REL
these	DT	I-REL
conditions	NNS	I-REL
,	,	O
rather	RB	O
than	IN	O
the	DT	O
expected	VBN	O
outcomes	NNS	O
of	IN	O
abnormal	JJ	O
morphogenesis	NN	O
or	CC	O
complete	JJ	O
arrest	NN	O
,	,	O
tooth	NN	O
development	NN	O
stalls	VBZ	O
until	IN	O
the	DT	O
optimal	JJ	O
level	NN	O
is	VBZ	O
reached	VBN	O
to	TO	O
form	VB	O
the	DT	O
correct	JJ	O
cusp	NN	O
pattern	NN	O

suboptimal	JJ	O
levels	NNS	O
of	IN	O
BMP	NN	O
signaling	NN	O
do	VBP	O
not	RB	O
lead	VB	B-REL
to	TO	O
abnormal	JJ	O
morphogenesis	NN	O
,	,	O
as	IN	O
suggested	VBN	O
by	IN	O
mutants	NNS	O
affecting	VBG	O
BMP	NN	O
signaling	NN	O
,	,	O
but	CC	O
to	TO	O
a	DT	O
24-h	JJ	O
stalling	VBG	O
of	IN	O
the	DT	O
intrinsic	JJ	O
developmental	JJ	O
clock	NN	O
of	IN	O
the	DT	O
tooth	NN	O

our	PRP$	O
findings	NNS	O
provide	VBP	O
preliminary	JJ	O
evidence	NN	O
that	IN	O
,	,	O
even	RB	O
for	IN	O
patients	NNS	O
with	IN	O
a	DT	O
`	``	O
less	RBR	O
extreme	JJ	O
'	''	O
-LRB-	-LRB-	O
or	CC	O
intermediate	JJ	O
-RRB-	-RRB-	O
type	NN	O
of	IN	O
outcome	NN	O
,	,	O
it	PRP	B-REL
is	VBZ	I-REL
possible	JJ	I-REL
to	TO	I-REL
predict	VB	I-REL
,	,	O
to	TO	O
a	DT	O
certain	JJ	O
extent	NN	O
,	,	O
who	WP	O
will	MD	O
develop	VB	O
further	JJ	O
episodes	NNS	O
and	CC	O
who	WP	O
will	MD	O
be	VB	O
less	RBR	O
likely	JJ	O
to	TO	O
do	VB	O
so	RB	O

preliminary	JJ	O
evidence	NN	O
of	IN	O
MRI	NNP	O
application	NN	O
in	IN	O
the	DT	O
individualized	JJ	O
prediction	NN	B-REL
of	IN	O
future	JJ	O
illness	NN	O
course	NN	O

Computer	NN	O
analysis	NN	O
of	IN	O
brain	NN	O
scans	NNS	O
could	MD	B-REL
help	VB	I-REL
predict	VB	I-REL
how	WRB	O
severe	JJ	O
the	DT	O
future	JJ	O
illness	NN	O
course	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
psychosis	NN	O
will	MD	O
be	VB	O

...	:	O
this	DT	O
provoked	VBN	B-REL
low	JJ	O
but	CC	O
reproducible	JJ	O
T	NN	O
helper	NN	O
2	CD	O
-LRB-	-LRB-	O
TH2	NN	O
-RRB-	-RRB-	O
immune	JJ	O
responses	NNS	O
in	IN	O
STg	NN	O
mice	NNS	O
...	:	O

...	:	O
we	PRP	O
found	VBD	O
that	IN	O
antigens	NNS	O
encountered	VBN	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
as	IN	O
cutaneous	JJ	O
epithelial	JJ	O
stress	NN	O
induced	VBD	B-REL
strong	JJ	I-REL
primary	JJ	O
and	CC	O
secondary	JJ	O
systemic	JJ	O
,	,	O
T	NN	O
helper	NN	O
2	CD	O
-LRB-	-LRB-	O
TH2	NN	O
-RRB-	-RRB-	O
-	:	O
associated	VBN	O
atopic	JJ	O
responses	NNS	O
in	IN	O
mice	NNS	O
...	:	O

It	PRP	O
is	VBZ	O
unsurprising	JJ	O
that	IN	O
inhalers	NNS	O
have	VBP	B-REL
higher	JJR	I-REL
rates	NNS	I-REL
of	IN	O
administration	NN	O
errors	NNS	O
than	IN	O
tablets	NNS	O
and	CC	O
capsules	NNS	O
.	.	O

Inhalers	NNS	O
and	CC	O
liquid	JJ	O
medicines	NNS	O
were	VBD	O
associated	VBN	B-REL
with	IN	I-REL
significantly	RB	O
increased	VBN	O
odds	NNS	O
of	IN	O
administration	NN	O
errors	NNS	O
.	.	O

Errors	NNS	O
are	VBP	B-REL
common	JJ	I-REL
when	WRB	I-REL
care	NN	O
home	NN	O
staff	NN	O
help	NN	O
older	JJR	O
people	NNS	O
to	TO	O
use	VB	O
medical	JJ	O
inhalers	NNS	O

We	PRP	O
found	VBD	O
no	DT	B-REL
evidence	NN	I-REL
that	IN	O
therapeutic	JJ	O
low	JJ	O
dose	NN	O
,	,	O
high	JJ	O
hertz	NN	O
frequency	NN	O
ultrasound	NN	O
delivered	VBN	O
once	RB	O
a	DT	O
week	NN	O
improves	VBZ	O
the	DT	O
healing	NN	O
of	IN	O
venous	JJ	O
leg	NN	O
ulcers	NNS	O
.	.	O

Low	JJ	O
dose	NN	O
,	,	O
high	JJ	O
frequency	NN	O
ultrasound	NN	O
administered	VBN	O
weekly	JJ	O
for	IN	O
12	CD	O
weeks	NNS	O
during	IN	O
dressing	VBG	O
changes	NNS	O
in	IN	O
addition	NN	O
to	TO	O
standard	JJ	O
care	NN	O
did	VBD	B-REL
not	RB	I-REL
increase	VB	I-REL
ulcer	NN	O
healing	NN	O
rates	NNS	O
,	,	O
affect	VBP	O
quality	NN	O
of	IN	O
life	NN	O
,	,	O
or	CC	O
reduce	VB	O
ulcer	NN	O
recurrence	NN	O
.	.	O

Laughter	NN	O
really	RB	B-REL
is	VBZ	I-REL
the	DT	O
best	JJS	O
medicine	NN	O
-LRB-	-LRB-	O
for	IN	O
leg	NN	O
ulcers	NNS	O
-RRB-	-RRB-	O
.	.	O

Laughter	NN	O
can	MD	B-REL
be	VB	I-REL
the	DT	O
best	JJS	O
medicine	NN	O
...	:	O
for	IN	O
leg	NN	O
ulcers	NNS	O
.	.	O

Laugh	NNP	O
and	CC	O
be	VB	B-REL
healthy	JJ	O

Laughter	NN	O
really	RB	O
can	MD	B-REL
be	VB	I-REL
the	DT	O
best	JJS	O
medicine	NN	O
,	,	O
say	VBP	O
university	NN	O
researchers	NNS	O
.	.	O

cDNA	NN	O
libraries	NNS	O
transferred	VBN	O
into	IN	O
VSV	NN	O
express	VBP	O
tissue-specific	JJ	O
sequences	NNS	O
and	CC	O
proteins	NNS	O
and	CC	O
can	MD	B-REL
induce	VB	I-REL
antigen	NN	O
specific	JJ	O
immune	JJ	O
responses	NNS	O
.	.	O

a	DT	O
cDNA	NN	O
library	NN	O
of	IN	O
normal	JJ	O
tissue	NN	O
,	,	O
expressed	VBN	O
from	IN	O
a	DT	O
highly	RB	O
immunogenic	JJ	O
viral	JJ	O
platform	NN	O
,	,	O
cures	NNS	B-REL
established	VBD	O
tumors	NNS	O
of	IN	O
the	DT	O
same	JJ	O
histological	JJ	O
type	NN	O
from	IN	O
which	WDT	O
the	DT	O
cDNA	NN	O
library	NN	O
was	VBD	O
derived	VBN	O
.	.	O

New	NNP	O
approach	NN	O
to	TO	O
cancer	NN	O
vaccines	NNS	O
proves	VBZ	B-REL
successful	JJ	I-REL

A	DT	O
vaccine	NN	O
that	WDT	O
destroys	VBZ	B-REL
prostate	NN	O
cancer	NN	O
tumour	NN	O
while	IN	O
leaving	VBG	O
healthy	JJ	O
tissue	NN	O
untouched	VBD	O
has	VBZ	O
been	VBN	O
developed	VBN	O
.	.	O

Cancer	NN	O
vaccines	NNS	O
could	MD	B-REL
become	VB	I-REL
the	DT	O
next	JJ	O
generation	NN	O
of	IN	O
therapy	NN	O
after	IN	O
a	DT	O
new	JJ	O
method	NN	O
of	IN	O
treatment	NN	O
was	VBD	O
discovered	VBN	O
.	.	O

A	DT	O
cancer	NN	O
jab	NN	O
that	WDT	O
can	MD	B-REL
wipe	VB	I-REL
out	RP	I-REL
tumours	NNS	O
has	VBZ	O
been	VBN	O
hailed	VBN	O
as	IN	O
a	DT	O
major	JJ	O
step	NN	O
forward	RB	O
in	IN	O
tackling	VBG	O
the	DT	O
disease	NN	O
.	.	O

Scientists	NNS	O
developed	VBD	O
a	DT	O
vaccine	NN	O
that	WDT	O
cured	VBD	B-REL
prostate	NN	O
cancer	NN	O
in	IN	O
mice	NNS	O
.	.	O

DNA	NN	O
from	IN	O
healthy	JJ	O
cells	NNS	O
was	VBD	O
used	VBN	O
to	TO	O
create	VB	O
a	DT	O
vaccine	NN	O
which	WDT	O
cured	VBD	B-REL
80	CD	O
%	NN	O
of	IN	O
mice	NNS	O
.	.	O

their	PRP$	O
experimental	JJ	O
vaccine	NN	O
was	VBD	B-REL
able	JJ	I-REL
to	TO	I-REL
shrink	VB	O
tumours	NNS	O
.	.	O

...	:	O
no	DT	B-REL
improvement	NN	I-REL
was	VBD	I-REL
seen	VBN	I-REL
in	IN	O
the	DT	O
rate	NN	O
of	IN	O
disease-free	JJ	O
survival	NN	O
,	,	O
the	DT	O
primary	JJ	O
end	NN	O
point	NN	O
of	IN	O
the	DT	O
study	NN	O
;	:	O
rates	NNS	O
of	IN	O
invasive-disease-free	JJ	O
survival	NN	O
and	CC	O
overall	JJ	O
survival	NN	O
were	VBD	O
similar	JJ	O
in	IN	O
the	DT	O
two	CD	O
study	NN	O
groups	NNS	O
...	:	O

...	:	O
there	EX	O
was	VBD	O
no	DT	B-REL
significant	JJ	I-REL
between-group	NN	I-REL
difference	NN	I-REL
...	:	O

...	:	O
Although	IN	O
rates	NNS	B-REL
of	IN	I-REL
male	JJ	I-REL
breast	NN	I-REL
cancer	NN	I-REL
are	VBP	I-REL
increasing	VBG	I-REL
,	,	O
the	DT	O
cancer	NN	O
remains	VBZ	O
rare	JJ	O
...	:	O

...	:	O
the	DT	O
review	NN	O
clearly	RB	O
showed	VBD	O
an	DT	B-REL
increase	NN	I-REL
in	IN	O
the	DT	O
incidence	NN	O
of	IN	O
male	JJ	O
breast	NN	O
cancer	NN	O
...	:	O

...	:	O
In	IN	O
summary	NN	O
,	,	O
we	PRP	O
have	VBP	O
shown	VBN	O
that	IN	O
regular	JJ	O
weekend	NN	O
and	CC	O
holiday	NN	O
sun	NN	O
exposure	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
higher	JJR	O
blood	NN	O
levels	NNS	O
of	IN	O
vitamin	NN	O
D	NN	O
although	IN	O
optimal	JJ	O
levels	NNS	O
appeared	VBD	O
to	TO	O
occur	VB	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
weekend	NN	O
exposure	NN	O
only	RB	O
when	WRB	O
the	DT	O
participants	NNS	O
reported	VBD	O
exposure	NN	O
in	IN	O
the	DT	O
order	NN	O
of	IN	O
6	CD	O
h/day	NN	O
...	:	O

...	:	O
sun	NN	O
exposure	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
increased	VBN	O
vitamin	NN	O
D	NN	O
levels	NNS	O
...	:	O

...	:	O
fair-skinned	JJ	O
people	NNS	O
who	WP	O
burn	VBP	O
easily	RB	O
may	MD	B-REL
need	VB	I-REL
to	TO	I-REL
take	VB	I-REL
supplements	NNS	O
...	:	O

AMPK	NNP	O
is	VBZ	O
associated	VBN	B-REL
with	IN	I-REL
hyperpolarizing	VBG	O
shifts	NNS	O
in	IN	O
voltage	NN	O
dependence	NN	O

Treatment	NN	O
of	IN	O
HEK293	NN	O
cells	NNS	O
expressing	VBG	O
Kv2	NN	O
.1	NN	O
with	IN	O
the	DT	O
AMPK	NNP	O
activator	NN	O
A-769662	NN	O
caused	VBD	B-REL
hyperpolarizing	VBG	O
shifts	NNS	O
in	IN	O
the	DT	O
current-voltage	JJ	O
relationship	NN	O
for	IN	O
channel	NN	O
activation	NN	O
and	CC	O
inactivation	NN	O

...	:	O
a	DT	O
parasite	NN	O
can	MD	B-REL
directly	RB	I-REL
alter	VB	I-REL
dopamine	NN	O
signalling	NN	O
to	TO	O
mediate	VB	O
host	NN	O
behavior	NN	O
changes	NNS	O
...	:	O

...	:	O
infection	NN	O
of	IN	B-REL
mammalian	JJ	O
dopaminergic	JJ	O
cells	NNS	O
with	IN	O
T.	NNP	O
gondii	NN	O
enhanced	VBD	B-REL
the	DT	I-REL
levels	NNS	I-REL
of	IN	O
K	NN	O
+	CC	O
-	:	O
induced	VBN	O
release	NN	B-REL
of	IN	O
dopamine	NN	O
several-fold	NN	O
...	:	O

...	:	O
shows	NNS	O
infection	NN	O
by	IN	O
the	DT	B-REL
brain	NN	O
parasite	NN	O
Toxoplasma	NNP	O
gondii	NN	O
,	,	O
found	VBN	O
in	IN	O
10-20	CD	O
per	IN	O
cent	NN	O
of	IN	O
the	DT	O
UK	NNP	O
's	POS	O
population	NN	O
,	,	O
directly	RB	B-REL
affects	VBZ	I-REL
the	DT	O
production	NN	O
of	IN	O
dopamine	NN	O
...	:	O

We	PRP	O
identified	VBD	O
mutations	NNS	O
in	IN	O
MEGF10	NN	O
as	IN	O
the	DT	O
cause	NN	B-REL
of	IN	O
EMARDD	NN	O

Mutations	NNS	O
in	IN	O
MEGF10	NN	O
,	,	O
a	DT	O
regulator	NN	O
of	IN	O
satellite	NN	O
cell	NN	O
myogenesis	NN	O
,	,	O
cause	VBP	B-REL
early	JJ	O
onset	NN	O
myopathy	NN	O
,	,	O
areflexia	NN	O
,	,	O
respiratory	JJ	O
distress	NN	O
and	CC	O
dysphagia	NN	O
-LRB-	-LRB-	O
EMARDD	NN	O
-RRB-	-RRB-	O

CMR	NN	O
is	VBZ	O
an	DT	O
alternative	JJ	O
to	TO	O
SPECT	NNP	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
clinically	RB	O
significant	JJ	O
coronary	JJ	O
heart	NN	O
disease	NN	O
,	,	O
with	IN	O
better	JJR	B-REL
sensitivity	NN	O
and	CC	O
negative	JJ	O
predictive	JJ	O
values	NNS	O

CMR	NNP	O
's	POS	O
high	JJ	O
diagnostic	JJ	O
accuracy	NN	O
in	IN	O
coronary	JJ	O
heart	NN	O
disease	NN	O
and	CC	O
superiority	NN	B-REL
over	IN	I-REL
SPECT	NNP	O

MRI	NNP	O
scan	VB	O
for	IN	O
coronary	JJ	O
heart	NN	O
disease	NN	O
is	VBZ	O
better	JJR	B-REL
than	IN	I-REL
the	DT	O
most	RBS	O
commonly-used	JJ	O
alternative	NN	O

MRI	NNP	O
was	VBD	O
better	RBR	B-REL
at	IN	I-REL
detecting	VBG	O
the	DT	O
condition	NN	O

When	WRB	O
asked	VBN	O
which	WDT	O
foods	NNS	O
they	PRP	O
would	MD	O
like	VB	O
to	TO	O
eat	VB	O
after	IN	O
exposure	NN	O
to	TO	O
the	DT	O
DVDs	NNS	O
,	,	O
children	NNS	O
selected	VBN	O
more	RBR	B-REL
branded	JJ	O
and	CC	O
more	RBR	O
nonbranded	JJ	O
items	NNS	O
after	IN	O
food	NN	O
commercials	NNS	O

Exposure	NN	O
to	TO	O
television	NN	O
food	NN	O
commercials	NNS	O
enhanced	VBD	B-REL
high	JJ	O
television	NN	O
viewers	NNS	O
'	POS	O
preferences	NNS	O
fro	RB	O
branded	VBD	O
foods	NNS	O
and	CC	O
increased	VBD	O
reported	VBN	O
preferences	NNS	O
for	IN	O
all	DT	O
food	NN	O
items	NNS	O
-LRB-	-LRB-	O
branded	JJ	O
and	CC	O
nonbranded	JJ	O
-RRB-	-RRB-	O
relative	JJ	O
to	TO	O
the	DT	O
low	JJ	O
television	NN	O
viewers	NNS	O
.	.	O

TV	NN	O
food	NN	O
advertising	NN	O
increases	VBZ	B-REL
children	NNS	O
's	POS	O
preference	NN	O
for	IN	O
unhealthy	JJ	O
foods	NNS	O

children	NNS	O
are	VBP	B-REL
influenced	VBN	I-REL
by	IN	O
what	WP	O
they	PRP	O
see	VBP	O
on	IN	O
television	NN	O

...	:	O
CPM	NNP	O
relatively	RB	O
easily	RB	B-REL
and	CC	I-REL
quickly	RB	I-REL
take	VB	O
recourse	NN	O
to	TO	O
anger	NN	O
irrespective	RB	O
of	IN	O
age	NN	O
,	,	O
to	TO	O
resolve	VB	O
an	DT	O
argument	NN	O
or	CC	O
gridlock	NN	O
in	IN	O
negotiations	NNS	O
in	IN	O
their	PRP$	O
and	CC	O
hence	RB	O
their	PRP$	O
organization	NN	O
's	POS	O
favour	NN	O
...	:	O

...	:	O
anger	NN	O
is	VBZ	O
frequently	RB	B-REL
enacted	VBN	I-REL
to	TO	I-REL
help	VB	I-REL
individuals	NNS	I-REL
ensure	VB	I-REL
the	DT	O
progress	NN	O
of	IN	O
a	DT	O
project	NN	O
...	:	O

...	:	O
anger	NN	O
used	VBN	O
by	IN	O
managers	NNS	O
in	IN	O
the	DT	O
construction	NN	O
industry	NN	O
has	VBZ	B-REL
a	DT	I-REL
positive	JJ	I-REL
impact	NN	O
...	:	O

Substantial	JJ	O
declines	NNS	O
in	IN	O
mortality	NN	O
can	MD	B-REL
happen	VB	I-REL
rapidly	RB	I-REL
after	IN	I-REL
individual	JJ	O
or	CC	O
population-wide	JJ	O
changes	NNS	O
in	IN	O
diet	NN	O
or	CC	O
smoking	NN	O

a	DT	O
decrease	NN	O
in	IN	O
smoking	NN	O
rapidly	RB	B-REL
reduces	VBZ	I-REL
mortality	NN	O
rates	NNS	O

We	PRP	O
found	VBD	O
a	DT	O
considerable	JJ	O
number	NN	O
of	IN	O
genes	NNS	O
overexpressed	VBN	B-REL
in	IN	O
the	DT	O
naked	JJ	O
mole	NN	O
rat	NN	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
genes	NNS	O
associated	VBN	O
with	IN	O
oxidoreduction	NN	O
and	CC	O
mitochondria	NN	O
were	VBD	O
expressed	VBN	B-REL
at	IN	I-REL
higher	JJR	I-REL
relative	JJ	I-REL
levels	NNS	I-REL
in	IN	O
naked	JJ	O
mole-rats	NNS	O

Genes	NNS	O
that	WDT	O
may	MD	B-REL
signal	VB	I-REL
long	JJ	O
life	NN	O
in	IN	O
naked	JJ	O
mole-rats	NNS	O

there	EX	O
is	VBZ	B-REL
a	DT	I-REL
deficit	NN	I-REL
in	IN	I-REL
force	NN	I-REL
compared	VBN	I-REL
with	IN	I-REL
non-diabetic	JJ	O
patients	NNS	O

These	DT	O
are	VBP	O
the	DT	O
first	JJ	O
data	NNS	O
investigating	VBG	O
myometrium	NN	O
in	IN	O
diabetic	JJ	O
patients	NNS	O
and	CC	O
they	PRP	O
support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
there	EX	B-REL
is	VBZ	I-REL
poorer	JJR	I-REL
contractility	NN	I-REL

the	DT	O
strength	NN	O
of	IN	O
uterine	JJ	O
contractions	NNS	O
in	IN	B-REL
diabetic	JJ	O
pregnant	JJ	O
women	NNS	O
is	VBZ	B-REL
significantly	RB	I-REL
weaker	JJR	I-REL
than	IN	I-REL
in	IN	O
non-diabetic	JJ	O
women	NNS	O

5-HTTLPR	NN	O
`	``	O
long	RB	O
'	''	O
--	:	O
is	VBZ	B-REL
identified	VBN	I-REL
as	IN	I-REL
having	VBG	I-REL
a	DT	I-REL
sizeable	JJ	I-REL
positive	JJ	I-REL
association	NN	I-REL
with	IN	I-REL
self-reported	JJ	O
life	NN	O
satisfaction	NN	O

individuals	NNS	O
with	IN	O
the	DT	O
transcriptionally	RB	O
more	RBR	O
efficient	JJ	O
version	NN	O
of	IN	O
the	DT	O
serotonin	NN	O
transporter	NN	O
gene	NN	O
,	,	O
report	NN	B-REL
significantly	RB	I-REL
higher	JJR	I-REL
levels	NNS	I-REL
of	IN	O
life	NN	O
satisfaction	NN	O

``	``	O
happiness	NN	O
gene	NN	O
''	''	O
in	IN	O
the	DT	B-REL
brain	NN	O
which	WDT	O
they	PRP	O
believe	VBP	O
is	VBZ	B-REL
the	DT	O
key	JJ	B-REL
to	TO	O
our	PRP$	O
basic	JJ	O
level	NN	O
of	IN	O
contentment	NN	O

some	DT	O
people	NNS	O
are	VBP	O
blessed	VBN	O
with	IN	O
a	DT	O
longer	JJR	O
and	CC	O
more	RBR	O
efficient	JJ	O
version	NN	O
of	IN	O
it	PRP	O
than	IN	O
others	NNS	O
,	,	O
enabling	VBG	B-REL
them	PRP	O
to	TO	O
be	VB	O
in	IN	O
good	JJ	O
spirits	NNS	O
more	RBR	O
often	RB	O

Your	PRP$	O
overall	JJ	O
happiness	NN	O
may	MD	B-REL
depend	VB	I-REL
in	IN	I-REL
part	NN	I-REL
on	IN	O
whether	IN	O
you	PRP	O
drew	VBD	O
the	DT	O
long	JJ	O
or	CC	O
short	JJ	O
version	NN	O
of	IN	O
a	DT	O
gene	NN	O

